
<html lang="en"     class="pb-page"  data-request-id="5f3bbb5f-152a-48c8-b042-d2f0994e69c1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2018.61.issue-8;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.7b01769;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Identification of a Novel Positron Emission Tomography (PET) Ligand for Imaging β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) in Brain" /></meta><meta name="dc.Creator" content="Lei  Zhang" /></meta><meta name="dc.Creator" content="Laigao  Chen" /></meta><meta name="dc.Creator" content="Jason K.  Dutra" /></meta><meta name="dc.Creator" content="Elizabeth M.  Beck" /></meta><meta name="dc.Creator" content="Sangram  Nag" /></meta><meta name="dc.Creator" content="Akihiro  Takano" /></meta><meta name="dc.Creator" content="Nahid  Amini" /></meta><meta name="dc.Creator" content="Ryosuke  Arakawa" /></meta><meta name="dc.Creator" content="Michael A.  Brodney" /></meta><meta name="dc.Creator" content="Leanne M.  Buzon" /></meta><meta name="dc.Creator" content="Shawn D.  Doran" /></meta><meta name="dc.Creator" content="Lorraine F.  Lanyon" /></meta><meta name="dc.Creator" content="Timothy J.  McCarthy" /></meta><meta name="dc.Creator" content="Kelly R.  Bales" /></meta><meta name="dc.Creator" content="Charles E.  Nolan" /></meta><meta name="dc.Creator" content="Brian T.  O’Neill" /></meta><meta name="dc.Creator" content="Klaas  Schildknegt" /></meta><meta name="dc.Creator" content="Christer  Halldin" /></meta><meta name="dc.Creator" content="Anabella  Villalobos" /></meta><meta name="dc.Description" content="Alzheimer’s disease (AD) is characterized by accumulation of β-amyloid (Aβ) plaques and neurofibrillary tau tangles in the brain. β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) plays a ..." /></meta><meta name="Description" content="Alzheimer’s disease (AD) is characterized by accumulation of β-amyloid (Aβ) plaques and neurofibrillary tau tangles in the brain. β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) plays a ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 22, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01769" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01769" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01769" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01769" /></link>
        
    
    

<title>Identification of a Novel Positron Emission Tomography (PET) Ligand for Imaging β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) in Brain | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01769" /></meta><meta property="og:title" content="Identification of a Novel Positron Emission Tomography (PET) Ligand for Imaging β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) in Brain" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0012.jpeg" /></meta><meta property="og:description" content="Alzheimer’s disease (AD) is characterized by accumulation of β-amyloid (Aβ) plaques and neurofibrillary tau tangles in the brain. β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) plays a key role in the generation of Aβ fragments via extracellular cleavage of the amyloid precursor protein (APP). We became interested in developing a BACE1 PET ligand to facilitate clinical assessment of BACE1 inhibitors and explore its potential in the profiling and selection of patients for AD trials. Using a set of PET ligand design parameters, compound 3 (PF-06684511) was rapidly identified as a lead with favorable in vitro attributes and structural handles for PET radiolabeling. Further evaluation in an LC-MS/MS “cold tracer” study in rodents revealed high specific binding to BACE1 in brain. Upon radiolabeling, [18F]3 demonstrated favorable brain uptake and high in vivo specificity in nonhuman primate (NHP), suggesting its potential for imaging BACE1 in humans." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01769"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01769">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01769&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01769&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01769&amp;href=/doi/10.1021/acs.jmedchem.7b01769" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3296-3308</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00474" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Featured Article</span><a href="/doi/10.1021/acs.jmedchem.7b01691" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of a Novel Positron Emission Tomography (PET) Ligand for Imaging β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) in Brain</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Lei Zhang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lei Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (617) 395-0640. E-mail: <a href="/cdn-cgi/l/email-protection#fab69f93d4a0929b949dc9ba8a9c93809f88d4999597"><span class="__cf_email__" data-cfemail="aae6cfc384f0c2cbc4cd99eadaccc3d0cfd884c9c5c7">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Zhang">Lei Zhang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8118-1402" title="Orcid link">http://orcid.org/0000-0001-8118-1402</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laigao Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laigao Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Clinical & Translational Imaging, Early Clinical Development, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laigao++Chen">Laigao Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jason K. Dutra</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jason K. Dutra</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jason+K.++Dutra">Jason K. Dutra</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elizabeth M. Beck</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elizabeth M. Beck</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth+M.++Beck">Elizabeth M. Beck</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sangram Nag</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sangram Nag</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-17176 Stockholm, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sangram++Nag">Sangram Nag</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Akihiro Takano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Akihiro Takano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-17176 Stockholm, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Akihiro++Takano">Akihiro Takano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nahid Amini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nahid Amini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-17176 Stockholm, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nahid++Amini">Nahid Amini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ryosuke Arakawa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ryosuke Arakawa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-17176 Stockholm, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ryosuke++Arakawa">Ryosuke Arakawa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael A. Brodney</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael A. Brodney</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+A.++Brodney">Michael A. Brodney</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Leanne M. Buzon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Leanne M. Buzon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Leanne+M.++Buzon">Leanne M. Buzon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shawn D. Doran</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shawn D. Doran</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shawn+D.++Doran">Shawn D. Doran</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lorraine F. Lanyon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lorraine F. Lanyon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lorraine+F.++Lanyon">Lorraine F. Lanyon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Timothy J. McCarthy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Timothy J. McCarthy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Clinical & Translational Imaging, Early Clinical Development, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+J.++McCarthy">Timothy J. McCarthy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kelly R. Bales</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kelly R. Bales</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Internal Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kelly+R.++Bales">Kelly R. Bales</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Charles E. Nolan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Charles E. Nolan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Internal Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Charles+E.++Nolan">Charles E. Nolan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brian T. O’Neill</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian T. O’Neill</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian+T.++O%E2%80%99Neill">Brian T. O’Neill</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1928-4803" title="Orcid link">http://orcid.org/0000-0002-1928-4803</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Klaas Schildknegt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Klaas Schildknegt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceutical Sciences, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Klaas++Schildknegt">Klaas Schildknegt</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christer Halldin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christer Halldin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-17176 Stockholm, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christer++Halldin">Christer Halldin</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Anabella Villalobos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anabella Villalobos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Synthesis Technologies, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anabella++Villalobos">Anabella Villalobos</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01769&amp;href=/doi/10.1021%2Facs.jmedchem.7b01769" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3296–3308</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 22, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 November 2017</li><li><span class="item_label"><b>Published</b> online</span>22 January 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 April 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01769" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01769</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3296%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLei%2BZhang%252C%2BLaigao%2BChen%252C%2BJason%2BK.%2BDutra%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D8%26contentID%3Dacs.jmedchem.7b01769%26title%3DIdentification%2Bof%2Ba%2BNovel%2BPositron%2BEmission%2BTomography%2B%2528PET%2529%2BLigand%2Bfor%2BImaging%2B%25CE%25B2-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B1%2B%2528BACE-1%2529%2Bin%2BBrain%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3308%26publicationDate%3DApril%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01769"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1983</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01769" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of a Novel Positron Emission Tomography (PET) Ligand for Imaging β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) in Brain&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Laigao&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;K. Dutra&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;M. Beck&quot;},{&quot;first_name&quot;:&quot;Sangram&quot;,&quot;last_name&quot;:&quot;Nag&quot;},{&quot;first_name&quot;:&quot;Akihiro&quot;,&quot;last_name&quot;:&quot;Takano&quot;},{&quot;first_name&quot;:&quot;Nahid&quot;,&quot;last_name&quot;:&quot;Amini&quot;},{&quot;first_name&quot;:&quot;Ryosuke&quot;,&quot;last_name&quot;:&quot;Arakawa&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;A. Brodney&quot;},{&quot;first_name&quot;:&quot;Leanne&quot;,&quot;last_name&quot;:&quot;M. Buzon&quot;},{&quot;first_name&quot;:&quot;Shawn&quot;,&quot;last_name&quot;:&quot;D. Doran&quot;},{&quot;first_name&quot;:&quot;Lorraine&quot;,&quot;last_name&quot;:&quot;F. Lanyon&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;J. McCarthy&quot;},{&quot;first_name&quot;:&quot;Kelly&quot;,&quot;last_name&quot;:&quot;R. Bales&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;E. Nolan&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;T. O’Neill&quot;},{&quot;first_name&quot;:&quot;Klaas&quot;,&quot;last_name&quot;:&quot;Schildknegt&quot;},{&quot;first_name&quot;:&quot;Christer&quot;,&quot;last_name&quot;:&quot;Halldin&quot;},{&quot;first_name&quot;:&quot;Anabella&quot;,&quot;last_name&quot;:&quot;Villalobos&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;3296-3308&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01769&quot;},&quot;abstract&quot;:&quot;Alzheimer’s disease (AD) is characterized by accumulation of β-amyloid (Aβ) plaques and neurofibrillary tau tangles in the brain. β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) plays a key role in the generation of Aβ fragments via extracellular cleavage of the amyloid precursor protein (APP). We became interested in developing a BACE1 PET ligand to facilitate clinical assessment of BACE1 inhibitors and explore its potential in the profiling and selection of patients for AD trials. Using a set of PET ligand design parameters, compound 3 (PF-06684511) was rapidly identified as a lead with favorable in vitro attributes and structural handles for PET radiolabeling. Further evaluation in an LC-MS/MS “cold tracer” study in rodents revealed high specific binding to BACE1 in brain. Upon radiolabeling, [18F]3 demonstrated favorable brain uptake and high in vivo specificity in nonhuman primate (NHP), suggesting its potential for imaging BACE1 in humans.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01769&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01769" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01769&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01769" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01769&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01769" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01769&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01769&amp;href=/doi/10.1021/acs.jmedchem.7b01769" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01769" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01769" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01769%26sid%3Dliteratum%253Aachs%26pmid%3D29356535%26genre%3Darticle%26aulast%3DZhang%26date%3D2018%26atitle%3DIdentification%2Bof%2Ba%2BNovel%2BPositron%2BEmission%2BTomography%2B%2528PET%2529%2BLigand%2Bfor%2BImaging%2B%25CE%25B2-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B1%2B%2528BACE-1%2529%2Bin%2BBrain%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D8%26spage%3D3296%26epage%3D3308%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291663" title="Positron emission tomography">Positron emission tomography</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/jmcmar.2018.61.issue-8/20180426/jmcmar.2018.61.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Alzheimer’s disease (AD) is characterized by accumulation of β-amyloid (Aβ) plaques and neurofibrillary tau tangles in the brain. β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) plays a key role in the generation of Aβ fragments via extracellular cleavage of the amyloid precursor protein (APP). We became interested in developing a BACE1 PET ligand to facilitate clinical assessment of BACE1 inhibitors and explore its potential in the profiling and selection of patients for AD trials. Using a set of PET ligand design parameters, compound <b>3</b> (PF-06684511) was rapidly identified as a lead with favorable in vitro attributes and structural handles for PET radiolabeling. Further evaluation in an LC-MS/MS “cold tracer” study in rodents revealed high specific binding to BACE1 in brain. Upon radiolabeling, [<sup>18</sup>F]<b>3</b> demonstrated favorable brain uptake and high in vivo specificity in nonhuman primate (NHP), suggesting its potential for imaging BACE1 in humans.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a highly debilitating neurodegenerative disorder with significant unmet medical need for disease-modifying therapy.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> During the past decade, the pharmaceutical industry has made significant investment on the advancement of potential disease-modifying therapies as evidenced by a number of clinical entries. However, the AD field as a whole has suffered from a high rate of clinical attrition<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> which may have been driven in part by the heterogeneous nature of patients enrolled in large and expensive phase II/III studies. In AD trials, patients have been typically recruited under broad diagnostic categories, a practice that may have led to a dilution in signals of clinical efficacy and inconclusive or negative trial outcomes. To help address this issue, clinical studies have recently started to employ noninvasive positron emission tomography (PET) imaging agents to choose more homogeneous patient groups. As such, the use of PET ligands for Aβ plaques<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and neurofibrillary tau tangles<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> have become more routine in clinical trials, providing “PET imaging-based phenotypic signatures” and enabling better definition of optimal patient groups for late-stage clinical trials. As part of our BACE1 inhibitor program, we became interested in developing a BACE1-selective PET ligand to further enable clinical studies. A BACE1 PET ligand would serve as a valuable translational tool to help clinical characterization of BACE1 inhibitors by measuring in vivo target occupancy and its relationship to reduction of cerebrospinal fluid (CSF) Aβ levels. Furthermore, on the basis of reports that BACE1 enzyme level is elevated in AD brains,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> specifically in presynaptic dystrophic neurites surrounding amyloid plaques,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> we were keen to understand if the brain BACE1 enzyme levels of AD patients could be quantified by clinical PET imaging. Such information could in turn be combined with other biomarkers (e.g., amyloid plaque and tau imaging) to ultimately provide a more comprehensive understanding of AD etiology.</div><div class="NLM_p">Development of BACE1 inhibitors has been a major effort across the pharmaceutical industry for over a decade, which has led to extensive literature disclosures featuring chemical matter with significant diversity in structure and properties.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Our BACE1 PET efforts started with a survey of existing BACE1 inhibitor chemical matters from the literature and our internal effort. Identifying a potential PET ligand from existing chemical matter was greatly facilitated by using our central nervous system (CNS) PET ligand discovery process illustrated in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> As a first step in our PET ligand discovery effort, we sought to determine the maximum concentration of target binding sites (<i>B</i><sub>max</sub>) of BACE1 in brain early in the process to inform PET viability. Favorable BACE1 brain expression would trigger subsequent lead triaging, guided by a set of CNS PET design and selection criteria previously disclosed by our group.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Specifically, compounds with the following attributes would be prioritized: high BACE1 potency and selectivity, favorable physicochemical properties as measured by CNS PET multiparameter optimization (MPO), fraction unbound in brain (Fu_b) > 0.05 for low risk of nonspecific binding (NSB), high passive permeability (RRCK <i>P</i><sub>app</sub> AB > 5 × 10<sup>–6</sup>cm/s), and low P-glycoprotein (P-gp) transporter activity (MDR1 BA/AB ≤ 2.5) for brain permeability. PET ligand leads emerging from the triaging process would be assessed via a liquid chromatography–mass spectroscopy/mass spectroscopy (LC-MS/MS) “cold tracer” method<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> in rodents for in vivo specific binding. Implementation of these steps would allow effective prioritization and make it possible to advance only one or two best PET leads into subsequent nonhuman primate (NHP) PET imaging and dosimetry studies, ultimately enabling clinical imaging of BACE1. Herein, we describe our efforts in the identification of [<sup>18</sup>F]PF-06684511 ([<sup>18</sup>F]<b>3</b>) as a promising PET ligand with favorable brain uptake and high specific binding to BACE1 in NHP via effective utilization of PET ligand design parameters and LC-MS/MS cold tracer method.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. A rational and cost-effective CNS PET ligand discovery process.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84533" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84533" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> BACE1 Brain Expression (<i>B</i><sub>max</sub>) Determinations</h3><div class="NLM_p">As part of our initial efforts in developing a PET ligand for BACE1, we were keen to identify a tool compound that could be tritiated and used for ex vivo saturation binding studies to determine BACE1 <i>B</i><sub>max</sub> in brain tissue. It was necessary for such a tool compound to be potent and selective for BACE1 and have low NSB in brain tissue but not necessarily be brain permeable. Compound <b>1</b>, derived from a chemotype previously reported by Eisai,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> caught our attention. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, compound <b>1</b> exhibited good potency at BACE1 with a whole cell IC<sub>50</sub> of 1.4 nM and a cell-free fluorescence polarization (FP) IC<sub>50</sub> of 12 nM. While <b>1</b> did have limited selectivity (4.5×) over BACE2,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> a BACE1 homologue protein, it demonstrated remarkable selectivity over cathepsin D (CatD) and other targets. As BACE2 is mainly expressed in peripheral tissues (e.g., kidney, pancreas, etc.) and has minimal expressions centrally,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> we anticipated that the BACE2 activity of compound <b>1</b> would not significantly interfere with the determination of BACE1 <i>B</i><sub>max</sub> in brain. Properties such as low lipophilicity (eLogD = 1.1) and fraction unbound in brain (Fu_b = 0.06) suggested a low risk of NSB. Compound <b>1</b> displayed moderate transporter activity (MDR1 BA/AB = 3.94), however, it is fit-for-purpose for ex vivo saturation binding studies in brain tissue where brain permeability is not required. Structurally, compound <b>1</b> bears a methoxy group amenable for tritiation. The <sup>3</sup>H-labeling of <b>1</b> was readily achieved via alkylation of the corresponding hydroxyl pyrazine precursor <b>5</b> with [<sup>3</sup>H]CH<sub>3</sub>I (Chemistry section, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Profile of <b>1</b> and binding studies of [<sup>3</sup>H]<b>1</b>: (A) saturation binding of [<sup>3</sup>H]<b>1</b> in brain frontal cortex homogenates of wild-type (WT), BACE1 heterozygous knockout (KO) and BACE1 homozygous KO mice; (B) BACE1 expression (<i>B</i><sub>max</sub>) and <i>K</i><sub>d</sub> determination in WT mice frontal cortex homogenate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">With [<sup>3</sup>H]<b>1</b> in hand, we carried out saturation binding studies in mouse brain tissue to understand the level of BACE1 brain expression. It is well-known that BACE1 is expressed throughout various brain regions.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The mouse frontal cortex brain homogenate was used as a representative brain region for <i>B</i><sub>max</sub> determination. We first carried out binding studies with [<sup>3</sup>H]<b>1</b> (vehicle + 3 dosing groups) in wild-type (WT) as well as BACE1 heterozygous and homozygous knockout (KO) mouse frontal cortex tissues to confirm its BACE1 specificity in brain and minimum interference due to its BACE2 activity. We were gratified to see that different levels of specific binding of [<sup>3</sup>H]<b>1</b> indeed were observed (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). The highest brain binding was seen in WT mice, which was reduced to roughly 50% in heterozygous BACE1 KO mice. Importantly, no specific binding was observed in homozygous BACE1 KO mice, confirming that even with comparable activity at BACE2, [<sup>3</sup>H]<b>1</b> only labeled BACE1 specifically in brain, likely due to low brain expression of BACE2. These results boosted our confidence in the <i>B</i><sub>max</sub> value determined by this radiotracer as an accurate measure of BACE1 expression in brain. Subsequently, a thorough saturation binding (vehicle + 8 dosing groups) using WT frontal cortex homogenate (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B) yielded a <i>K</i><sub>d</sub> value of 1.8 nM, comparable to the in vitro whole cell (WC) potency, and a <i>B</i><sub>max</sub> value of 144 fmol/mg protein (∼7 nM assuming 50 mg protein/g wet tissue) residing in a range favorable for PET consideration. This <i>B</i><sub>max</sub> value suggested that a potent compound, with WC IC<sub>50</sub> most likely in the sub-nM range, would be desirable to achieve a favorable <i>B</i><sub>max</sub>/<i>K</i><sub>d</sub> ratio > 10, which is typically associated with successful PET ligands.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div></div><div id="sec2-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> PET Ligand Lead Triaging</h3><div class="NLM_p">With sufficient BACE1 expression in brain confirmed, we turned our attention to identifying suitable leads for PET consideration. Ideal candidates would retain the desired pharmacology, selectivity, and low NSB profile of <b>1</b> and, in addition, have high passive permeability and low transporter activities for better brain permeability. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, starting from roughly 800 BACE1 inhibitors (literature leads and internal Pfizer compounds), we quickly narrowed down the list to 256 compounds (represented by solid green circles) upon filtering by favorable MDR1 BA/AB (≤2.5) and RRCK (>5 × 10<sup>–6</sup> cm/s) values. Among these, 32 compounds displayed BACE1 WC IC<sub>50</sub> values less than 5 nM. Further prioritization using calculated Fu_b<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (>0.05) narrowed the list down to 16 compounds. From this cohort, compounds <b>2</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and <b>3</b> (PF-06684511, a compound previously reported by Eisai<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a>) were chosen for further follow-up as they both had structure moieties amenable to either <sup>11</sup>C- or <sup>18</sup>F-labeling. The pharmacology and PET-specific properties of compound <b>2</b> and <b>3</b> are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. In terms of pharmacology, compound <b>3</b> was the more potent of the two with sub-nM WC BACE1 IC<sub>50</sub> and around 15-fold selective over BACE2. Both compounds were highly selective against CatD and other targets in broad-spectrum CEREP selectivity panel evaluations. Compounds <b>2</b> and <b>3</b> showed low lipophilicity (Log <i>D</i> < 2) and resided in favorable CNS drug space. Compound <b>3</b> had a slightly lower CNS PET MPO score, mainly due to a high number of H-bond donors. Nevertheless, both compounds displayed aligned in vitro ADME parameters for CNS PET ligand consideration, with low MDR1 effux, high passive permeability and favorable calculated Fu_b (>0.05) suggesting low risk of NSB.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. BACE1 PET ligand triaging based on CNS PET ligand design parameters.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Pharmacology and Property Profile of BACE1 PET Ligand Leads <b>2</b> and <b>3</b> (PF-06684511)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0011.gif" alt="" id="gr11" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><b>2</b></th><th class="colsep0 rowsep0" align="center"><b>3</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">Pharmacology</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BACE1 WC IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">4 ± 0.5</td><td class="colsep0 rowsep0" align="center">0.7 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BACE1 FP IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">53 ± 7</td><td class="colsep0 rowsep0" align="center">16 ± 2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BACE2 FP IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">265 ± 32</td><td class="colsep0 rowsep0" align="center">239 ± 18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CatD FP IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">13600 ± 3600</td><td class="colsep0 rowsep0" align="center">206000 ± 13000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">Physicochemical Properties</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CNS PET MPO<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">3.9</td><td class="colsep0 rowsep0" align="center">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">eLogD<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="center">1.2</td><td class="colsep0 rowsep0" align="center">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">In Vitro PK Properties</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RRCK <i>P</i><sub>app</sub> AB (10<sup>–6</sup> cm/s)<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="center">17.7 ± 3</td><td class="colsep0 rowsep0" align="center">17.5 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDR BA/AB<a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="center">1.92 ± 0.8</td><td class="colsep0 rowsep0" align="center">1.55 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cFu_b<a class="ref internalNav" href="#t1fn9" aria-label="I">I</a></td><td class="colsep0 rowsep0" align="center">0.13</td><td class="colsep0 rowsep0" align="center">0.08</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values obtained from BACE1 whole cell (WC) assay; values represent the geometric mean of at least three experiments with standard error.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> values obtained from BACE1 cell free fluorescence polarization (FP) assay; values represent the geometric mean of at least three experiments with standard error.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> values obtained from BACE2 cell free FP assay; values represent the geometric mean of at least three experiments with standard error.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">IC<sub>50</sub> values obtained from CatD cell free FP assay; values represent the geometric mean of at least three experiments with standard error.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">CNS PET MPO represents the summation of scores of six commonly used individual physicochemical properties using the transformed functions described in ref <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a>.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">Experimentally measured Log <i>D</i> using a reverse phase HPLC method.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></p></div><div class="footnote" id="t1fn7"><sup><sup>g</sup></sup><p class="last">RRCK cells with low transporter activity were isolated from Mardin–Darby canine kidney (MDCK) cells and were used to estimate passive permeability.</p></div><div class="footnote" id="t1fn8"><sup><sup>h</sup></sup><p class="last">Ratio from the MS-based quantification of <i>P</i><sub>app,A→B</sub> and <i>P</i><sub>app,B→A</sub> of the test compound (1 μM) across contiguous monolayers from MDR1-transfected MDCK cells;</p></div><div class="footnote" id="t1fn9"><sup><sup>I</sup></sup><p class="last">In silico calculated fraction unbound in brain.</p></div></div></div><div class="NLM_p">Prompted by their overall favorable profiles, <b>2</b> and <b>3</b> were further assessed for brain permeability in vivo. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, both compounds demonstrated favorable measured fractions unbound in brain and plasma, confirming good alignment of experimental and in silico predicted values. Indeed, rodent neuropharmacokinetic studies showed favorable brain permeability with a free brain to plasma ratio (<i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub>) of 0.53 for compound <b>2</b> and 0.45 for compound <b>3</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Neuropharmacokinetic (NeuroPK) Profile of <b>2</b> and <b>3</b> in CD-1 Mice</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">Fu_b<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">mFu_p<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>p,u</sub> (h·nM) (AUC<sub>0–Tlast</sub>)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>b,u</sub> (h·nM) (AUC<sub>0–Tlast</sub>)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="char" char=".">1321</td><td class="colsep0 rowsep0" align="char" char=".">701</td><td class="colsep0 rowsep0" align="char" char=".">0.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">718</td><td class="colsep0 rowsep0" align="char" char=".">321</td><td class="colsep0 rowsep0" align="char" char=".">0.45</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Fraction unbound in brain homogenate.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Fraction unbound in mouse plasma.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">AUC<sub>0–Tlast</sub>-derived ratio of plasma unbound compound concentration in CD-1 mice (10 mg/kg PO).</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">AUC<sub>0–Tlast</sub>-derived ratio of brain unbound compound concentration in CD-1 mice (10 mg/kg, PO).</p></div></div></div></div><div id="sec2-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Chemistry</h3><div class="NLM_p">The tritiation of compound <b>1</b>, illustrated in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, started from a known aniline intermediate <b>4</b>.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Amide coupling with 5-hydroxypyrazine 2-carboxylic acid yielded the hydroxyl pyrazine precursor <b>5</b>. The subsequent methylation step was first explored using nonradioactive methyl iodide with anticipation of an <i>O</i>- versus <i>N</i>-alkylation selectivity challenge. Typical methylation conditions using cesium carbonate as base gave predominantly undesired <i>N</i>-methylation product. Changing the base to silver carbonate yielded a 1:1 mixture of the desired compound <b>1</b> and the <i>N</i>-methylation product that could be easily separated. Using this improved methylation condition and subsequent Boc removal, [<sup>3</sup>H]<b>1</b> was obtained in high radiochemical purity (>99%) and specific radioactivity (80 Ci/mmol).</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 5-hydroxypyrazine-2-carboxylic acid, HBTU, DIPEA, DMF, rt, 34%; (b) [<sup>3</sup>H]CH<sub>3</sub>I, Ag<sub>2</sub>CO<sub>3</sub>, CHCl<sub>3</sub>, rt; (c) TFA, DCM, rt, 80 Ci/mmol specific activity, >99% radiochemical purity.</p></p></figure><div class="NLM_p">Our synthesis of <b>3</b> was accomplished from known intermediate <b>6</b><a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> using modified procedures from the literature (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The trityl group of <b>6</b> was removed through a two-step process involving solvolysis in formic acid to afford formate ester <b>7</b> and subsequent hydrolysis to provide alcohol <b>8</b>. The fluoride group was then installed, at this early stage, by activation of alcohol <b>8</b> with perfluorobutanesulfonyl fluoride (NfF) to give intermediate <b>9</b>. Introduction of the amide functionality was achieved by first converting the bromide of <b>9</b> to an azide via copper catalysis followed by concomitant reduction mediated by <span class="smallcaps smallerCapital">l</span>-ascorbate to afford aniline <b>10</b>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The amide was then installed under standard coupling conditions using HATU to afford <b>11</b>. Benzoyl deprotection in basic MeOH provided compound <b>3</b> with no amide cleavage observed.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HCO<sub>2</sub>H (neat), 0 °C to rt; (b) LiOH, THF/H<sub>2</sub>O (1/1 v/v), rt; (c) perfluorobutanesulfonyl fluoride (NfF), Et<sub>3</sub>N·3HF, Et<sub>3</sub>N, THF, 0–40 °C, 52% for 3 steps; (d) NaN<sub>3</sub>, <i>N</i>,<i>N</i>′-dimethylcyclohexane-1, 2-diamine, sodium <span class="smallcaps smallerCapital">l</span>-ascorbate, CuI, EtOH/H<sub>2</sub>O (3/1 v/v), 70 °C, 72%; (e) 5-methoxypyrazine-2-carboxylic acid, HATU, DIPEA, CH<sub>3</sub>CN, rt, 93%; (f) DBU, MeOH, 60 °C, 77%.</p></p></figure><div class="NLM_p">For the preparation of the <sup>18</sup>F-labeling precursor <b>18</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>), we modified the synthesis used for <b>3</b> to enable a late-stage fluorination. As shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, copper-catalyzed azide formation and subsequent in situ reduction by <span class="smallcaps smallerCapital">l</span>-ascorbate converted intermediate <b>6</b> to the corresponding aniline <b>12</b>. Introduction of the amide was accomplished in the presence of propylphosphonic anhydride (T3P) to provide <b>13</b>. In preparation for the late-stage fluorination, the trityl group of <b>13</b> was removed in two steps involving formic acid solvolysis and base catalyzed hydrolysis to give intermediate <b>15</b>. To better accommodate the short half-life of <sup>18</sup>F radionuclide (<i>T</i><sub>1/2</sub> = 110 min), we next carried out a protecting group exchange by first removing the benzoyl protecting group with DBU in MeOH to give <b>16</b>, followed by Boc-protection under standard conditions to give compound <b>17</b> in 58% yield over two steps. We expected that the eventual <i>t</i>-Boc removal would be mild and rapid under acidic conditions. Finally, tosylation of the hydroxyl group provided the desired labeling precursor <b>18</b> in good yields. <sup>18</sup>F-Labeling proceeded by nucleophilic displacement of the tosyl group using [<sup>18</sup>F]fluoride/kryptofix 222 in DMSO, followed by rapid Boc-removal by aqueous HCl. Upon purification by semipreparative HPLC, [<sup>18</sup>F]<b>3</b> was generated in high radiochemical purity (>99%) and molar activity (84 and 175GBq/μmol at the time of injection).</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaN<sub>3</sub>, <i>N</i>,<i>N</i>′-dimethylcyclohexane-1, 2-diamine, sodium <span class="smallcaps smallerCapital">l</span>-ascorbate, CuI, EtOH/H<sub>2</sub>O (3.5/1 v/v), 70 °C; (b) 5-methoxypyrazine-2-carboxylic acid, propane phosphonic acid anhydride (T3P), pyridine, DCM, rt, 41% over two steps; (c) HCO<sub>2</sub>H (neat), 0 °C to rt; (d) LiOH, THF/H<sub>2</sub>O (1/1 v/v), rt, quantitative yield; (e) DBU, MeOH, 60 °C; (f) Boc<sub>2</sub>O, Et<sub>3</sub>N, THF, 60 °C, 58% over two steps; (g) TsCl, DIPEA, DMAP, DCM, rt, 56%; (h) [<sup>18</sup>F]fluoride/kryptofix 222, DMSO, 150 °C, 5 min, followed by 1.5 M HCl, 100 °C, 3 min, 4% and 7% radiochemical yield (>99% purity), 187 and 417 MBq of delivered radioactivity, and 84 and 175 GBq/μmol of specific radioactivity at the time of injection.</p></p></figure></div><div id="sec2-4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> LC-MS/MS “Cold Tracer” Study in Rodents</h3><div class="NLM_p">As both compounds <b>2</b> and <b>3</b> demonstrated suitable PET properties and good brain permeability, we sought an early read for BACE1 specific binding to differentiate these two leads prior to triggering radiochemistry and PET imaging. Toward this end, we utilized a LC-MS/MS based “cold tracer” method,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> in which nonradioactive <b>2</b> and <b>3</b> were dosed intravenously in mice at tracer level (10 μg/kg). Concentrations in four brain regions (cerebellum, frontal cortex, hippocampus, and striatum) and plasma were quantified. As there is no reference region due to the widespread expression of BACE1 throughout the brain, we performed studies with baseline (vehicle) and blocking (pretreatment of a BACE1 selective inhibitor) arms to determine whether compound concentrations in the four main brain regions could be reduced as an indication of BACE1 specific binding. The results of the LC-MS/MS studies are illustrated in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A, no significant reduction in the concentration of <b>2</b> in the brain regions examined other than frontal cortex could be observed after pretreatment with a high dose of BACE1 inhibitor A<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (100 mg/kg, SC), suggesting a lack of in vivo specific binding. In contrast, the concentration of <b>3</b> was dose dependently reduced in all four brain regions upon pretreatment of BACE1 inhibitor B<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (1, 10, 80 mg/kg, SC, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). To further validate that the specific binding of <b>3</b> was BACE1-driven, we further examined the distribution of <b>3</b> in WT and BACE1 KO mice following the same protocol (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). We were gratified to see significant reduction in the concentration of <b>3</b> across the four brain regions of BACE1 KO mice compared to WT mice. These data indicated that compound <b>3</b> displayed the desired BACE1 specific binding in vivo and was a good candidate for further PET evaluation. While <b>2</b> had many desirable properties that met our PET ligand criteria, its potency may have not been sufficient to achieve specific binding in vivo.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo specific binding assessment of <b>2</b> and <b>3</b> in male 129/sve mice using LC-MS/MS “cold tracer” method. (A) Distribution of <b>2</b> in cerebellum, frontal cortex, hippocampus, striatum, and plasma, pretreated with either vehicle or BACE1 inhibitor A<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (100 mg/kg, SC) 60 min prior to ligand administration. (B) Distribution of <b>3</b> in cerebellum, frontal cortex, hippocampus, striatum, and plasma, pretreated with either vehicle or BACE1 inhibitor B<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (1, 10, 80 mg/kg, SC) 60 min prior to ligand administration. For both studies, brain tissues and plasma were collected at 45 min post administration (<i>n</i> = 5 per animal group) at which the highest brain tissue/plasma ratios were achieved for <b>2</b> and <b>3</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01769/suppl_file/jm7b01769_si_001.pdf" class="ext-link">Supporting Information</a>, section 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo specific binding assessment of <b>3</b> in BACE1 WT and KO mice, using LC-MS/MS “cold tracer” method: four brain regions (cerebellum, frontal cortex, hippocampus, and striatum) and plasma were collected at 45 min post administration (<i>n</i> = 5 per animal group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2-5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> NHP PET Imaging</h3><div class="NLM_p">The favorable binding profile of <b>3</b> in the LC-MS/MS “cold tracer” experiment prompted us to advance this lead to subsequent radiochemistry and PET imaging studies. Radiofluorination of <b>3</b> was achieved in high radiochemical purity and delivered radioactivity as illustrated in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The specific binding of [<sup>18</sup>F]<b>3</b> was evaluated in NHP by PET under both baseline and blocking conditions. A total of two PET scans (one female NHP, one baseline scan, and one blocking scan) were performed with injected radioactivity of 154 and 117 MBq, specific radioactivities at the time of injection of 84 and 175 GBq/μmol, and injected mass of 0.8 and 0.3 μg. The summed PET images of baseline and blocking conditions, as well as the coregistered MRI image, of the NHP are shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>. Consistent with LC-MS/MS study results, [<sup>18</sup>F]<b>3</b> demonstrated good brain uptake and widespread distribution in various brain regions, with enriched signal in hippocampus and striatum (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). The peak of the brain uptake reached at approximately 20 min and reduced to half at 120 min under baseline condition. In addition, upon administration of a BACE1 inhibitor (LY2886721,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> 5 mg/kg, PO, 2 h prior to PET scanning), the radio signal of [<sup>18</sup>F]<b>3</b> decreased significantly (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C) across different brain regions (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), demonstrating BACE1 specificity.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. MRI (A) and PET images of [<sup>18</sup>F]<b>3</b> in NHP summed from 32 to 180 min under (B) baseline and (C) blocking (pretreatment with a BACE1 inhibitor, LY2886721, 5 mg/kg, PO) conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Standardized uptake values (SUVs) of [<sup>18</sup>F]<b>3</b> in representative brain regions under baseline and blocking conditions. CB, cerebellum; ACC, anterior cingulate cortex; FC, frontal cortex; TC, temporal cortex; CAU, caudate; PUT, putamen; THA, thalamus; OC, occipital cortex; PC, parietal cortex; AMY, amygdala; HIP, hippocampus.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">BACE1 is an aspartyl protease that plays a key role in the generation of Aβ fragments via extracellular cleavage of the amyloid precursor protein (APP). BACE1 expression level has been reported to be elevated in AD patients. However, no BACE1 specific PET ligand has been reported to date, which allows in vivo quantification of BACE1 expression and target occupancy measurement. Through an efficient and cost-effective CNS PET ligand discovery process, we have successfully identified [<sup>18</sup>F]<b>3</b> as a novel PET ligand specific to BACE1 in brain.</div><div class="NLM_p">As a first step, we determined <i>B</i><sub>max</sub> in brain tissue using an earlier non-brain penetrant radiotracer [<sup>3</sup>H]<b>1</b> and established the PET viability of this target. The PET ligand selection criteria previously reported by our group was applied to narrow an extensive collection of literature and in-house BACE1 inhibitors to just two leads, <b>2</b> and <b>3</b>, based on key pharmacological, physicochemical, and ADME properties as well as structural amenability to <sup>11</sup>C- or <sup>18</sup>F- labeling. Prior to PET radiolabeling, these two leads were advanced into rodent LC-MS/MS “cold tracer” studies for specific binding evaluation, from which compound <b>3</b> emerged as a promising PET ligand lead with the desired level of BACE1 specific binding. The favorable outcome from the LC-MS/MS “cold tracer” studies successfully translated to NHP PET imaging, where [<sup>18</sup>F]<b>3</b> demonstrated excellent brain uptake and high BACE1 specific binding under baseline and blocking conditions. These results confirmed [<sup>18</sup>F]<b>3</b> as a suitable PET ligand for BACE1 PET imaging in vivo and reinforced the value of our overall PET discovery approach. This and previous work from our laboratories demonstrate that we have put in place a rational and cost-efficient paradigm for the development of novel PET ligands that can successfully identify a small number of candidate ligands (<b>n</b> = 1–3) from a large set of compounds.<a onclick="showRef(event, 'ref9 ref27'); return false;" href="javascript:void(0);" class="ref ref9 ref27">(9,27)</a></div><div class="NLM_p last">We envision that BACE1 PET ligand [<sup>18</sup>F]<b>3</b> could facilitate the development of AD therapeutics in multiple ways. First, successful translation of this PET ligand to the clinic would enable target occupancy measurement of clinical BACE1 inhibitors and relationship of target occupancy to reduction of Aβ levels in CSF. Furthermore, [<sup>18</sup>F]<b>3</b> could enable the examination of brain BACE1 enzyme levels in AD patients across the disease continuum. A robust correlation of BACE1 level with AD progression would render this BACE1 PET ligand as a valuable AD biomarker, which in turn could be used in conjunction with other established imaging-based AD biomarkers, such as amyloid plaque and tau PET imaging as well as hippocampus volume, to enable a deeper understanding of AD etiology. On the basis of the favorable outcome of the first NHP PET imaging studies, [<sup>18</sup>F]<b>3</b> has been investigated for detailed quantitative analysis and a target occupancy study in NHPs. It has also been advanced to test-retest and dosimetry studies in humans. The results from these studies will be communicated in future publications.</div></div><div id="sec3-1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26036" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26036" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3-1-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Biology</h3><div class="NLM_p last">The sAPPβ whole-cell assay, BACE1 enzyme cell-free assay, BACE2 enzyme cell-free assay, and cathepsin D enzyme cell-free assay were performed following the protocols that were previously described.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec3-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Pharmacokinetics</h3><div class="NLM_p last">NeuroPK study in male CD-1 mice was carried out following the same protocol described in ref <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a>. The unbound fraction in mixed gender mouse (CD-1) plasma (Fu_p) was determined using the Rapid Equilibrium Device (RED, Thermo Scientific). A spiked mice plasma (2 μM) sample was prepared and added (220 μL) to the donor side, followed by addition of buffer (350 μL) to the receiver side. The RED device was then incubated at 37 °C for 4 h. Following the incubation, plasma (15 μL) and buffer (45 μL) were sampled and mixed with the appropriate blank matrix to prepare mixed matrix samples. Samples were protein precipitated with acetonitrile containing internal standard (200 μL), vortexed, and centrifuged. Supernatants were analyzed using an LC-MS/MS assay. The buffer dilution factor was 0.33 (15 μL/45 μL). Fu_p was then calculated using (concentration in buffer sample × 0.33)/(concentration in plasma sample). The unbound fraction in brain tissue homogenate (Fu_b) was determined using the 96-well equilibrium dialysis method described by Kalvass et al.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> with the following exceptions. Brain homogenates were prepared from freshly harvested rat whole brains (Wistar han) following dilution with a 10-fold volume of phosphate buffer and spiked with 2 μM test compound. The homogenates were dialyzed against an equal volume (150 μL) of phosphate buffer at 37 °C for 6 h. Following the incubation, equal volumes (50 μL) of brain homogenate and buffer samples were collected and mixed with 50 μL of buffer or control homogenate, respectively, for preparation of mixed matrix samples. All samples were then precipitated with internal standard in acetonitrile (200 μL), vortexed, and centrifuged. Supernatants were analyzed using an LC–MS/MS assay. A dilution factor of 10 was applied to the calculation of brain fraction unbound.</div></div><div id="sec3-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Saturation Binding</h3><div class="NLM_p last">The saturation binding of [<sup>3</sup>H]<b>1</b> in mouse brain tissue was performed using filtration separation of ligand bound in crude tissue homogenate. The source of tissue was frontal cortex from wild-type, heterozygous, and homozygous BACE1 KO mice. The [<sup>3</sup>H]<b>1</b> was titrated from 0.1 to 10 nM and incubated for 60 min at rt with 2.4 mg of tissue homogenate (homogenized at 12 mg/mL on ice for 8 s using polytron setting 5) in 250 μL of 50 mM Tris, pH 7.4, containing 2 mM MgCl<sub>2</sub>. Following incubation, samples were separated over GF/B filters that were presoaked in 0.1% polyethyleneimine followed by three washes with cold assay buffer. The amount of specific binding was calculated as the counts bound in the presence of 0.1% DMSO vehicle minus the counts bound in the presence of excess BACE1 inhibitor (10 μM).</div></div><div id="sec3-4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div id="sec3-4-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> General Methods</h4><div class="NLM_p last">All solvents and reagents were of reagent grade and were used as supplied by the manufacturer. All reactions were run under a N<sub>2</sub> atmosphere. Organic extracts were routinely dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> or MgSO<sub>4</sub>. Concentration in vacuo refers to rotary evaporation under reduced pressure. Chromatography refers to flash chromatography using disposable RediSepRf 4 to 120 g silica columns or Biotage disposable columns on a CombiFlash Companion or Biotage Horizon automatic purification system. Purification by mass-triggered HPLC was carried out using Waters XTerra PrepMS C18 columns, 5 μm, 30 mm × 100 mm. Compounds were presalted as TFA salts and diluted with 1 mL of DMSO. Samples were purified by mass-triggered collection using a mobile phase of acetonitrile and 0.1% TFA in water, with a gradient of 100% aqueous to 100% acetonitrile over 10 min at a flow rate of 20 mL/min. All target compounds were analyzed using ultra high performance liquid chromatography/ultraviolet/evaporative light scattering detection coupled to time-of-flight mass spectrometry (UHPLC/UV/ELSD/TOFMS). LC-MS analyses were performed on a Waters Acquity UPLC-MS system with a Waters Aquity HSS T3, 1.7 μm C18 column (50 mm × 2.1 mm). UPLC conditions: mobile phase A = 0.1% formic acid in water (v/v), mobile phase B = 0.1% formic acid in acetonitrile; flow rate = 1.25 mL/min; compounds were eluted with a gradient of 5% B/A to 95% B/A for 1.1 min. All tested compounds were found to be >95% pure by this method.</div></div><div id="sec3-4-1-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> <i>N</i>-(3-((4a<i>S</i>,5<i>S</i>,7a<i>S</i>)-2-Amino-5-(fluoromethyl)-4a,5-dihydro-4<i>H</i>-furo[3,4-<i>d</i>][1,3]thiazin-7a(7<i>H</i>)-yl)-4-fluorophenyl)-5-methoxypyrazine-2-carboxamide (<b>3</b>)</h4><div class="NLM_p last">To a stirring mixture of <b>11</b> (360 mg, 0.667 mmol) in anhydrous MeOH (6.5 mL) was added DBU (71.3 mg, 0.468 mmol, 0.070 mL) at rt. The reaction mixture was stirred at 60 °C for 6 h, during which time a white solid formed. The reaction was stirred at 60 °C for an additional 2.5 h then at rt overnight. The resulted white solid was collected by filtration, rinsed with cold MeOH (3 mL), and then dried in vacuo to afford <b>3</b> (224 mg, 77% yield) as a white solid. HRMS: calculated for C<sub>19</sub>H<sub>20</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 436.1249, found 436.1256. Anal. Calcd for C<sub>19</sub>H<sub>19</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub>S: C, 52.41; H, 4.40; N, 16.08. Found: C, 52.16; H, 4.35; N, 15.93. [α]<sub>D</sub><sup>23.0</sup> = +121.9° (<i>c</i> 0.36, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.56 (s, 1H), 8.89 (d, <i>J</i> = 1.3 Hz, 1H), 8.40 (d, <i>J</i> = 1.3 Hz, 1H), 7.89 (dd, <i>J</i> = 7.3, 2.6 Hz, 1H), 7.84 (ddd, <i>J</i> = 8.6, 4.0, 2.8 Hz, 1H), 7.15 (dd, <i>J</i> = 11.9, 8.8 Hz, 1H), 6.03 (s, 2H), 4.68–4.43 (m, 2H), 4.34 (dddd, <i>J</i> = 23.5, 7.7, 5.1, 2.4 Hz, 1H), 4.24 (d, <i>J</i> = 8.2 Hz, 1H), 4.02 (s, 3H), 3.79 (dd, <i>J</i> = 8.1, 3.2 Hz, 1H), 3.13 (dd, <i>J</i> = 13.5, 3.6 Hz, 1H), 3.00 (dd, <i>J</i> = 13.5, 3.8 Hz, 1H), 2.75 (dt, <i>J</i> = 7.8, 3.7, 3.7 Hz, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.63, 161.45, 155.99 (d, <i>J</i> = 243.6 Hz), 148.36, 141.53, 137.92, 134.37 (d, <i>J</i> = 2.3 Hz), 133.53, 130.14 (d, <i>J</i> = 12.4 Hz), 122.12 (d, <i>J</i> = 4.1 Hz), 120.91 (d, <i>J</i> = 8.4 Hz), 116.16 (d, <i>J</i> = 25.0 Hz), 83.56 (d, <i>J</i> = 169.7 Hz), 78.52 (d, <i>J</i> = 18.2 Hz), 77.53 (d, <i>J</i> = 6.1 Hz), 65.80–65.36 (m), 54.29, 35.51 (dd, <i>J</i> = 5.1, 2.4 Hz), 22.97.</div></div><div id="sec3-4-1-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>tert</i>-Butyl ((4a<i>R</i>,8a<i>S</i>)-8a-(2-Fluoro-5-(5-hydroxypyrazine-2-carboxamido)phenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)carbamate (<b>5</b>)</h4><div class="NLM_p last">To a stirring solution of 5-hydroxypyrazine-2-carboxylic acid (74.7 mg, 0.53 mmol) in DMF (2 mL) were added DIPEA (116 uL, 0.67 mmol), HBTU (230 mg, 0.58 mmol), and <b>4</b><a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (170 mg, 0.45 mmol) in that order. The reaction was flushed with nitrogen and stirred at rt for 3 h. The reaction was diluted with EtOAc and saturated aqueous NaHCO<sub>3</sub> solution and extracted. The organic extract was washed with water and brine then dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to afford the crude product. Purification via flash column chromatography (silica gel, gradient 50% → 100% EtOAc in heptanes) afforded <b>5</b> (76 mg, 34%) as an off-white solid. LC-MS <i>m</i>/<i>z</i> 504.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.13 (d, <i>J</i> = 1.3 Hz, 1H), 8.08 (d, <i>J</i> = 1.3 Hz, 1H), 7.84 (ddd, <i>J</i> = 2.7, 4.2, 8.8 Hz, 1H), 7.68 (dd, <i>J</i> = 2.6, 7.1 Hz, 1H), 7.18 (dd, <i>J</i> = 8.9, 12.2 Hz, 1H), 4.07 (td, <i>J</i> = 3.9, 11.3, 11.9 Hz, 2H), 3.78 (d, <i>J</i> = 11.8 Hz, 1H), 3.70 (td, <i>J</i> = 2.2, 12.2, 12.2 Hz, 1H), 3.14–3.07 (m, 1H), 2.98 (dd, <i>J</i> = 3.8, 13.0 Hz, 1H), 2.74 (dd, <i>J</i> = 3.0, 12.9 Hz, 1H), 2.15–2.03 (m, 1H), 1.62 (ddt, <i>J</i> = 1.6, 1.6, 3.3, 13.0 Hz, 1H), 1.52 (s, 9H).</div></div><div id="sec3-4-1-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> ((4a<i>S</i>,5<i>S</i>,7a<i>S</i>)-2-Benzamido-7a-(5-bromo-2-fluorophenyl)-4a,5,7,7a-tetrahydro-4<i>H</i>-furo[3,4-<i>d</i>][1,3]thiazin-5-yl)methyl formate (<b>7</b>)</h4><div class="NLM_p last">A mixture of <b>6</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (10.0 g, 14.131 mmol) in formic acid (70 mL) was stirred at rt overnight. LC/MS showed <b>6</b> was consumed completely and the major peak was the desired formate ester. The solid was removed by filtration and the filtrate was washed with petroleum ether (75 mL × 3). The formic acid layer was concentrated to give crude <b>7</b> (7.00 g) as yellow oil, which was carried directly into the next reaction.</div></div><div id="sec3-4-1-4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>-((4a<i>S</i>,5<i>S</i>,7a<i>S</i>)-7a-(5-Bromo-2-fluorophenyl)-5-(hydroxymethyl)-4a,5,7,7a-tetrahydro-4<i>H</i>-furo[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (<b>8</b>)</h4><div class="NLM_p last">A mixture of the crude formate ester <b>7</b> (7.00 g, 14.19 mmol) and LiOH (1.70 g, 70.9 mmol) in THF/H<sub>2</sub>O (100 mL, 1/1 v/v) was stirred at rt for 1 h. LC/MS showed the reaction was complete. The organic layer was removed in vacuo, and water (50 mL) was added. The mixture was extracted with DCM (150 mL × 3). The organic layer was washed with brine solution (100 mL), dried, filtered, and concentrated to afford crude <b>8</b> (5.60 g) as a light-yellow solid, which was carried directly into the next reaction without further purification.</div></div><div id="sec3-4-1-5" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>N</i>-((4a<i>S</i>,5<i>S</i>,7a<i>S</i>)-7a-(5-Bromo-2-fluorophenyl)-5-(fluoromethyl)-4a,5,7,7a-tetrahydro-4<i>H</i>-furo[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (<b>9</b>)</h4><div class="NLM_p last">To a stirred solution of the crude primary alcohol <b>8</b> (5.60 g, 12.03 mmol) in dry THF (150 mL) was added triethylamine (12.2 g, 120 mmol), triethylamine trihydrofluoride (6.6 g, 40.9 mmol), and perfluorobutane sulfonylfluoride (12.4 g, 40.9 mmol) in that order at 0 °C under nitrogen. After addition, the mixture was stirred at 30–40 °C for 3 h. TLC (petroleum ether:EtOAc = 3:1) showed the reaction was complete. The mixture was poured into ice–water (200 mL), saturated aqueous NaHCO<sub>3</sub> (200 mL) was added, and the mixture was extracted with EtOAc (200 mL × 2). The organic layer was washed with brine solution (150 mL × 2), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give a residue, which was purified by flash column chromatography (silica gel; gradient 0% → 30% EtOAc in petroleum ether) to afford <b>9</b> (3.40 g, 60.5%) as a white solid. LC-MS <i>m</i>/<i>z</i> 468.7 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.13–7.99 (m, 2H), 7.60–7.41 (m, 5H), 7.03 (dd, <i>J</i> = 8.7, 11.7 Hz, 1H), 4.73–4.53 (m, 3H), 4.52–4.46 (m, 1H), 4.03–3.95 (m, 1H), 3.36–3.28 (m, 1H), 3.27–3.17 (m, 1H), 2.85–2.76 (m, 1H).</div></div><div id="sec3-4-1-6" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>N</i>-((4a<i>S</i>,5<i>S</i>,7a<i>S</i>)-7a-(5-Amino-2-fluorophenyl)-5-(fluoromethyl)-4a,5,7,7a-tetrahydro-4<i>H</i>-furo[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (<b>10</b>)</h4><div class="NLM_p last">To a solution of <b>9</b> (865 mg, 1.81 mmol) in absolute EtOH (35 mL) was added <i>N</i>,<i>N</i>′-dimethylcyclohexane-1,2-diamine (300 mg, 2.11 mmol), followed by addition of sodium azide (1.20 g, 18.46 mmol) and a solution of sodium <span class="smallcaps smallerCapital">l</span>-ascorbate (185 mg, 0.93 mmol) in water (10 mL) at rt. The mixture was stirred under nitrogen for 15 min, then copper(I) iodide (175 mg, 0.92 mmol) was added and the mixture was heated at 70 °C for 2 h. LC/MS showed the reaction was complete. The mixture was concentrated in vacuo then partitioned between brine solution (50 mL) and EtOAc (100 mL). The phases were separated, and the aqueous layer was extracted three times with additional EtOAc. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give crude product which was purified by flash column chromatography (silica gel, gradient 0% → 100% EtOAc in heptanes) to afford <b>10</b> (524 mg, 72%) as a white solid. LC-MS <i>m</i>/<i>z</i> 404.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.03 (s, 1H), 8.17 (d, <i>J</i> = 7.1 Hz, 2H), 7.56–7.50 (m, 1H), 7.45 (t, <i>J</i> = 7.5, 7.5 Hz, 2H), 6.92 (dd, <i>J</i> = 8.7, 11.9 Hz, 1H), 6.70 (dd, <i>J</i> = 2.6, 6.5 Hz, 1H), 6.61 (dt, <i>J</i> = 3.3, 3.3, 8.5 Hz, 1H), 4.74–4.49 (m, 4H), 4.08–3.98 (m, 1H), 3.69 (s, 2H), 3.46–3.38 (m, 1H), 3.29 (dd, <i>J</i> = 3.4, 13.8 Hz, 1H), 2.81 (dd, <i>J</i> = 3.6, 13.8 Hz, 1H).</div></div><div id="sec3-4-1-7" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>N</i>-(3-((4a<i>S</i>,5<i>S</i>,7a<i>S</i>)-2-Benzamido-5-(fluoromethyl)-4a,5-dihydro-4<i>H</i>-furo[3,4-<i>d</i>][1,3]thiazin-7a(7<i>H</i>)-yl)-4-fluorophenyl)-5-methoxypyrazine-2-carboxamide (<b>11</b>)</h4><div class="NLM_p last">To a solution of 5-methoxypyrazine-2-carboxylic acid (120 mg, 0.78 mmol) and <b>10</b> (300 mg, 0.74 mmol) in acetonitrile (10 mL) was added DIPEA (300 μL, 1.72 mmol) followed by HATU (300 mg, 0.79 mmol) at rt. The mixture was stirred at rt for 30 min. LC-MS showed the reaction was completed. The mixture was concentrated in vacuo, diluted with EtOAc (40 mL), then washed with water (15 mL) and brine solution (15 mL). The organic extract was dried over Na<sub>2</sub>SO<sub>4</sub> filtered and concentrated to give crude product, which was purified by flash column chromatography (24 g silica gel, gradient 0% → 100% EtOAc in heptanes) to afford compound <b>11</b> (374 mg, 93%) as a white solid. LC-MS <i>m</i>/<i>z</i> 540.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.66 (s, 1H), 9.56 (s, 1H), 9.00 (s, 1H), 8.25–8.05 (m, 3H), 7.91 (d, <i>J</i> = 7.7 Hz, 1H), 7.72–7.64 (m, 1H), 7.57–7.50 (m, 1H), 7.46 (t, <i>J</i> = 7.3, 7.3 Hz, 2H), 7.18 (dd, <i>J</i> = 8.9, 11.5 Hz, 1H), 4.76–4.54 (m, 3H), 4.51 (d, <i>J</i> = 9.3 Hz, 1H), 4.12 (q, <i>J</i> = 7.1, 7.1, 7.1 Hz, 1H), 4.06 (s, 3H), 3.50–3.32 (m, 2H), 2.94–2.81 (m, 1H).</div></div><div id="sec3-4-1-8" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-((4a<i>S</i>,5<i>S</i>,7a<i>S</i>)-7a-(5-Amino-2-fluorophenyl)-5-((trityloxy)methyl)-4a,5,7,7a-tetrahydro-4<i>H</i>-furo[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (<b>12</b>)</h4><div class="NLM_p last">To a solution of compound <b>6</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (7.08 g, 10.00 mmol) in EtOH (210 mL) was added <i>N</i>,<i>N</i>′-dimethylcyclohexane-1,2-diamine (1.71 g, 12.0 mmol), followed by addition of solid sodium azide (6.18 g, 95.06 mmol) and a solution of sodium <span class="smallcaps smallerCapital">l</span>-ascorbate (931 mg, 4.70 mmol) in water (60 mL) at rt under a nitrogen atmosphere. Then copper(I) iodide (895 mg, 4.70 mmol) was added, and the mixture was heated at 70 °C for 2 h. The mixture was diluted with water (300 mL) and EtOAc (200 mL) and extracted with additional EtOAc (100 mL × 2). The combined organic layers were washed with brine solution (200 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give crude aniline <b>12</b> (6.44g, 72% purity) as yellow oil, which was used directly in the next step without further purification. LC-MS <i>m</i>/<i>z</i> 666.1 [M + Na]<sup>+</sup>.</div></div><div id="sec3-4-1-9" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-(3-((4a<i>S</i>,5<i>S</i>,7a<i>S</i>)-2-Benzamido-5-((trityloxy)methyl)-4a,5-dihydro-4<i>H</i>-furo[3,4-<i>d</i>][1,3]thiazin-7a(7<i>H</i>)-yl)-4-fluorophenyl)-5-methoxypyrazine-2-carboxamide (<b>13</b>)</h4><div class="NLM_p last">To a mixture of the aniline <b>12</b> (6.44 g, ∼ 72% purity, 7.2 mmol) and commercially available 5-methoxypyrazine-2-carboxylic acid (1.33 g, 8.64 mmol) in DCM (100 mL) was added pyridine (2.28 g, 28.8 mmol) at rt, followed by addition of a solution of propylphosphonic anhydride solution (aka T3P, 50% by wt. in EtOAc, 13.8 g, 21.6 mmol) dropwise at rt and stirred at that temperature for 16 h. The mixture was quenched with water (200 mL) and extracted with DCM (2 × 100 mL). The combined organic layers were washed with brine solution (300 mL), dried, and concentrated to give crude product, which was purified by flash column chromatography on silica gel (40 g silica gel, 0% →15% EtOAc in petroleum ether) to afford <b>13</b> (2.3 g, 41% over two steps) as a yellow semisolid. LC-MS <i>m</i>/<i>z</i> 780.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.54 (s, 1H), 9.00 (s, 1H), 8.20–8.14 (m, 2H), 8.13 (s, 1H), 8.01–7.95 (m, 1H), 7.56 (d, <i>J</i> = 5.2 Hz, 1H), 7.53–7.50 (m, 1H), 7.49–7.42 (m, 7H), 7.35–7.29 (m, 5H), 7.28–7.21 (m, 5H), 7.16 (dd, <i>J</i> = 9.2, 11.7 Hz, 1H), 4.62–4.52 (m, 2H), 4.12–4.09 (m, 1H), 4.06 (s, 3H), 3.48–3.42 (m, 1H), 3.41–3.31 (m, 2H), 3.28–3.21 (m, 1H), 2.71 (dd, <i>J</i> = 3.4, 13.9 Hz, 1H).</div></div><div id="sec3-4-1-10" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> ((4a<i>S</i>,5<i>S</i>,7a<i>S</i>)-2-Benzamido-7a-(2-fluoro-5-(5-methoxypyrazine-2-carboxamido)phenyl)-4a,5,7,7a-tetrahydro-4<i>H</i>-furo[3,4-<i>d</i>][1,3]thiazin-5-yl)methyl formate (<b>14</b>)</h4><div class="NLM_p last">Formic acid (30 mL) was added to <b>13</b> (2.30 g, 2.95 mmol) neat at 0 °C. After the addition, the mixture was warmed to rt and stirred at ambient temperature for 16 h. TLC (petroleum ether/EtOAc = 3/1) showed the reaction was complete. The mixture was concentrated in vacuo to give the corresponding formate ester <b>14</b> (1.67 g, crude, quant) as a yellow solid, which was used directly in the next step.</div></div><div id="sec3-4-1-11" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-(3-((4a<i>S</i>,5<i>S</i>,7a<i>S</i>)-2-Benzamido-5-(hydroxymethyl)-4a,5-dihydro-4<i>H</i>-furo[3,4-<i>d</i>][1,3]thiazin-7a(7<i>H</i>)-yl)-4-fluorophenyl)-5-methoxypyrazine-2-carboxamide (<b>15</b>)</h4><div class="NLM_p last">To a solution of crude formate ester <b>14</b> (1.67 g, 2.95 mmol) in THF/water (40 mL, 1/1 v/v) was added LiOH (141 mg, 5.91 mmol) at rt and stirred at the same temperature for 20 min. TLC (pet ether/EtOAc = 1:1, UV) showed the reaction was complete. The reaction was diluted with water (100 mL) and extracted with EtOAc (30 mL × 2). The organic layer was washed with brine solution (50 mL × 2), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated afford compound <b>15</b> (1.59 g, quant. over two steps) as a yellow semisolid. LC-MS <i>m</i>/<i>z</i> 538.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.55 (s, 1H), 8.99 (s, 1H), 8.20–8.10 (m, 3H), 7.91–7.84 (m, 1H), 7.71–7.65 (m, 1H), 7.54–7.49 (m, 1H), 7.48–7.41 (m, 2H), 7.16 (dd, <i>J</i> = 8.8, 11.7 Hz, 1H), 4.57–4.52 (m, 1H), 4.50 (d, <i>J</i> = 9.6 Hz, 1H), 4.18–4.11 (m, 1H), 4.06 (s, 3H), 3.96 (dd, <i>J</i> = 2.6, 11.8 Hz, 1H), 3.75 (dd, <i>J</i> = 3.5, 11.5 Hz, 1H), 3.44–3.33 (m, 2H), 2.87 (dd, <i>J</i> = 2.1, 14.1 Hz, 1H), 2.04 (s, 1H).</div></div><div id="sec3-4-1-12" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-(3-((4a<i>S</i>,5<i>S</i>,7a<i>S</i>)-2-Amino-5-(hydroxymethyl)-4a,5-dihydro-4<i>H</i>-furo[3,4-<i>d</i>][1,3]thiazin-7a(7<i>H</i>)-yl)-4-fluorophenyl)-5-methoxypyrazine-2-carboxamide (<b>16</b>)</h4><div class="NLM_p last">To a solution of compound <b>15</b> (700 mg, 1.30 mmol) in MeOH (25 mL) was added DBU (1.98 g, 13.0 mmol) at rt. The reaction mixture was stirred at 60 °C for 3 h, during which time a white solid formed and LC/MS showed the reaction was complete. The reaction was filtered, and the white solid was dried to afford crude compound <b>16</b> (500 mg, 80% purity by LC-MS), which was advanced as-is into the next step. LC-MS <i>m</i>/<i>z</i> 456.0 [M + Na]<sup>+</sup>.</div></div><div id="sec3-4-1-13" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>tert</i>-Butyl ((4a<i>S</i>,5<i>S</i>,7a<i>S</i>)-7a-(2-Fluoro-5-(5-methoxypyrazine-2-carboxamido)phenyl)-5-(hydroxymethyl)-4a,5,7,7a-tetrahydro-4<i>H</i>-furo[3,4-<i>d</i>][1,3]thiazin-2-yl)carbamate (<b>17</b>)</h4><div class="NLM_p last">To a suspension of compound <b>16</b> (500 mg, 1.15 mmol) in tetrahydrofuran (200 mL) was added Boc<sub>2</sub>O (378 mg, 1.73 mmol) and triethylamine (233 mg, 2.31 mmol) at rt. The suspension was stirred at 60 °C for 16 h. The mixture was concentrated to afford the crude product (0.95 g), which was subjected to flash column chromatography (4 g silica gel, 0% → 5% in DCM) followed by repurification via preparative HPLC (Column, Agella Durashell C18 250 mm × 21.2 mm 5 μm particle size; mobile phase, from 36% → 56% acetonitrile in aqueous ammonia (pH 10) to 56% acetonitrile in ammonia). The pure preparative HPLC fractions were concentrated and lyophilized to afford compound <b>17</b> (400 mg, 58% over 2 steps) as a white solid. LC-MS <i>m</i>/<i>z</i> 556.1 [M + Na]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.53 (s, 1H), 9.01 (d, <i>J</i> = 1.3 Hz, 1H), 8.18 (d, <i>J</i> = 1.3 Hz, 1H), 7.97–7.89 (m, 1H), 7.56–7.41 (m, 1H), 7.11 (dd, <i>J</i> = 8.9, 11.6 Hz, 1H), 4.50 (d, <i>J</i> = 9.0 Hz, 1H), 4.48–4.44 (m, 1H), 4.07 (s, 3H), 3.99–3.85 (m, 2H), 3.76–3.68 (m, 1H), 3.27–3.05 (m, 2H), 2.74 (dd, <i>J</i> = 2.7, 12.6 Hz, 1H), 2.14 (s, 1H), 1.52 (s, 9H).</div></div><div id="sec3-4-1-14" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> ((4a<i>S</i>,5<i>S</i>,7a<i>S</i>)-2-((<i>tert</i>-Butoxycarbonyl)amino)-7a-(2-fluoro-5-(5-methoxypyrazine-2-carboxamido)phenyl)-4a,5,7,7a-tetrahydro-4<i>H</i>-furo[3,4-<i>d</i>][1,3]thiazin-5-yl)methyl 4-methylbenzenesulfonate (<b>18</b>)</h4><div class="NLM_p last">To a stirred solution of <b>17</b> (135 mg, 0325 mmol) in DCM (1.1 mL) were added tosyl chloride (160 mg, 0.839 mmol), DIPEA (111 mg, 0.861 mmol, 0.150 mL), and DMAP (11 mg, 0.09 mmol) in that order. The reaction was stirred at rt for 20 h. The reaction was diluted with DCM (10 mL) then washed sequentially with 0.25 N aqueous HCl (3 mL), water (2 mL), saturated aqueous NaHCO<sub>3</sub> solution (1 mL), and brine solution (1 mL). The organic extract was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford a crude product. Purification via flash column chromatography (silica gel, gradient 0 → 100% EtOAc in heptanes) to afforded a white solid (123 mg), which was further purified by flash column chromatography (silica gel, gradient 5 → 20% acetonitrile in DCM) to afford <b>18</b> (98 mg, 56% yield) as a white solid. HRMS: calculated for C<sub>31</sub>H<sub>35</sub>FN<sub>5</sub>O<sub>8</sub>S<sub>2</sub> [M + H]<sup>+</sup> 688.1906, found 688.1907. Anal. Calcd for C<sub>31</sub>H<sub>34</sub>FN<sub>5</sub>O<sub>8</sub>S<sub>2</sub>: C, 54.14; H, 4.98; N, 10.18. Found: C, 53.88; H, 4.94; N, 9.85. [α]<sub>D</sub><sup>23.1</sup> = +67.8° (c 0.345, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ 9.67 (s, 1H), 8.91 (s, 1H), 8.35 (s, 1H), 8.22 (d, <i>J</i> = 1.3 Hz, 1H), 7.88 (ddd, <i>J</i> = 8.8, 4.1, 2.8 Hz, 1H), 7.79 (d, <i>J</i> = 8.3 Hz, 2H), 7.62 (dd, <i>J</i> = 7.1, 2.6 Hz, 1H), 7.42 (d, <i>J</i> = 8.0 Hz, 2H), 7.12 (dd, <i>J</i> = 12.0, 8.9 Hz, 1H), 4.37 (ddd, <i>J</i> = 8.2, 5.2, 3.6 Hz, 1H), 4.31 (d, <i>J</i> = 8.9 Hz, 1H), 4.25–4.12 (m, 2H), 4.03 (s, 3H), 3.74 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 3.00–2.91 (m, 1H), 2.91–2.84 (m, 1H), 2.72–2.62 (m, 1H), 2.42 (s, 3H), 1.46 (s, 9H). <sup>13</sup>C NMR (101 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ 163.38, 162.46, 157.06 (d, <i>J</i> = 243.5 Hz), 146.54, 142.54, 138.46, 135.52 (d, <i>J</i> = 2.5 Hz), 134.63, 133.64, 131.03, 128.92 (d, <i>J</i> = 11.5 Hz), 128.81, 122.85 (m, br), 122.15 (d, <i>J</i> = 8.7 Hz), 117.65 (d, <i>J</i> = 25.0 Hz), 81.55, 78.31, 77.55 (d, <i>J</i> = 6.5 Hz), 71.40, 67.29 (d, <i>J</i> = 5.1 Hz), 55.12, 40.18 (d, <i>J</i> = 3.1 Hz), 28.35, 23.64, 21.67.</div></div></div><div id="sec3-5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Radiosynthesis of [<sup>3</sup>H]<b>1</b></h3><div class="NLM_p last">A stirred solution of [<sup>3</sup>H]methyl iodide (1 Ci, 80 Ci/mmol, 12.5 μmol) in 0.5 mL of CHCl<sub>3</sub> was placed under N<sub>2</sub>, cooled in an ice bath, and treated with a suspension of <b>5</b> (6.3 mg, 12.5 μmol, 1.0 equiv) in 0.5 mL of CHCl<sub>3</sub> and solid Ag<sub>2</sub>CO<sub>3</sub> (3.5 mg, 12.7 μmol, 1.0 equiv). The reaction mixture was then warmed to rt and stirred for 30 h. The reaction mixture was filtered, and the solvent was removed in vacuo. The residue was then treated with 1 mL of trifluoroacetic acid, and the resulting solution was stirred at rt for 2 h. The reaction was then concentrated, and the residue was dissolved in 4 mL of EtOAc and washed with 4 mL of saturated aqueous solution of NaHCO<sub>3</sub>. The organic layer was concentrated, and the residue was purified by reverse phase HPLC to yield 20 mCi of [<sup>3</sup>H]<b>1</b> with specific activity of 80 Ci/mmol and radiochemical purity >99%. The HPLC condition is as follows: Column, Zorbax SB-C18, 5 μm, 4.6 mm × 250 mm; column temperature, ambient; mobile phase A, 0.1% formic acid in H<sub>2</sub>O; mobile phase B, acetonitrile; gradient, 10–100% B in 30 min; flow rate, 1 mL/min; run time, 30 min; detection, 254 nm.</div></div><div id="sec3-6" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> LC-MS/MS Cold Tracer Method</h3><div class="NLM_p">Brain binding of compounds <b>2</b> and <b>3</b> in mice were evaluated with a LC-MS/MS based “cold tracer” assay. A total of three studies were performed. All procedures in this study were in compliance with the U.S. Department of Agriculture’s (USDA) Animal Welfare Act (9 CFR Parts 1, 2, and 3); the Guide for the Care and Use of Laboratory Animals: Eighth Edition, (Institute for Laboratory Animal Research, The National Academies Press, Washington, DC, 2010); and the National Institutes of Health, Office of Laboratory Animal Welfare. Whenever possible, procedures in this study were designed to avoid or minimize discomfort, distress, and pain to animals. In study 1, male CD-1 mice (25–35 g) were dosed with 100 mg/kg of BACE1 inhibitor A<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (100 mg/kg, SC) or vehicle (<i>n</i> = 5 per treatment group), followed by intravenous administration of the tracer, compound <b>2</b>, at 10 μg/kg dose 60 min post blocking compound or vehicle dosing. Mice were euthanized by live decapitation at 45 min post the tracer administration, and four brain tissues (cerebellum, frontal cortex, hippocampus and striatum) were dissected and the plasma samples were collected to measure the tracer concentration using LC-MS/MS.</div><div class="NLM_p">In study 2, male 129/sve mice (20–25 g) were dosed with varying doses of BACE1 inhibitor B<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (1, 10, or 80 mg/kg, SC) or vehicle (<i>n</i> = 5 per treatment group), followed by intravenous administration of the tracer, compound <b>3</b>, at 10 μg/kg dose 60 min inhibitor or vehicle dosing. Mice were then euthanized by live decapitation at 45 min post the tracer administration. The same four brain tissues plus plasma samples used in study 1 were collected to measure the tracer concentration.</div><div class="NLM_p last">In study 3, BACE1 KO and WT mice (<i>n</i> = 5 per group) were evaluated following the same procedure used in previous two studies, with the exception that no blocking compound was dosed.</div></div><div id="sec3-7" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> PET Radiochemistry</h3><div class="NLM_p last">No-carrier-added [<sup>18</sup>F]fluoride was produced from a GEMS PET trace Cyclotron using 16.4 MeV protons via the <sup>18</sup>O(p,n)<sup>18</sup>F reaction on <sup>18</sup>O enriched water ([<sup>18</sup>O]H<sub>2</sub>O). [<sup>18</sup>F]Fluoride was isolated from [<sup>18</sup>O]H<sub>2</sub>O on a preconditioned SepPak QMA light anion exchange cartridge and subsequently eluted from the cartridge with a solution of K<sub>2</sub>CO<sub>3</sub> (1.8 mg, 13 μmol), Kryptofix 2.2.2 (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo- [8.8.8]hexacosane-K2.2.2) (9.8 mg, 26 μmol) in water (85 μL, 18 MΩ) ,and CH<sub>3</sub>CN (2 mL) to a reaction vessel (10 mL). The solvents were evaporated at 160 °C for 10–12 min under continuous nitrogen flow (70 mL/min) to form a dry complex of [<sup>18</sup>F]fluoride/K2.2.2, and the residue was cooled to rt. The precursor <b>18</b> (∼0.007 mmol, ∼5 mg) in DMSO (600 μL) was added to the dry complex of [<sup>18</sup>F]fluoride/K2.2.2. The closed reaction vessel was heated at 110 °C for 10 min and cooled down to rt. Removal of the Boc protecting group was carried out by adding aqueous HCl (2.0 N, 200 μL) to the reaction mixture and heated at 100 °C for 5 min. The reaction mixture was cooled to rt and was diluted with water to a total volume of 2.0 mL before injecting to HPLC for purification. A radioactive fraction corresponding to [<sup>18</sup>F]<b>3</b> (retention time = 15–17 min) was collected and diluted with sterile water (50 mL). The resulting mixture was loaded onto a preconditioned SepPak tC18 plus cartridge. The cartridge was washed with water (10 mL), and the desired product [<sup>18</sup>F]<b>3</b> was eluted with EtOH (1 mL) into a sterile vial containing phosphate buffer saline solution (PBS, 9 mL). [<sup>18</sup>F]<b>3</b> was successfully radiosynthesized in 80–95 min from end of beam (<i>n</i> = 2) in 4 and 7% radiochemical yield (>99% purity), 187 and 417 MBq of delivered radioactivity, and 84 and 175 GBq/μmol of specific radioactivity at the time of injection, respectively.</div></div><div id="sec3-8" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> NHP PET Imaging</h3><div class="NLM_p">[<sup>18</sup>F]<b>3</b> was evaluated with PET imaging in one female cynomolgus monkey (body weight approximately 5500 g). The monkey was scanned twice with PET, one baseline scan, and one blocking scan with pretreatment of a BACE1 inhibitor LY2886721.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Approximately 2 months separated the baseline and blocking scans. The study was approved by the Animal Ethics Committee of the Swedish Animal Welfare Agency and was performed according to the “Guidelines for Planning, Conducting, And Documenting Experimental Research” (Dnr 4820/06-600) of Karolinska Institutet (KI).</div><div class="NLM_p">The monkey was immobilized and transported from its housing facility to the KI PET center after intramuscular injection of ketamine hydrochloride (approximately 10 mg/kg). The anesthesia was maintained by the administration of a mixture of isoflurane (1.5–2.0%), oxygen, and medical air after endotracheal intubation at the KI PET center. For the blocking study, 5 mg/kg of LY2886721in 0.5% methylcellulose with a dosing volume of 2 mL/kg, followed with 2 mL of tap water, was administrated orally (via gavage) approximately 2 h before PET scanning. The monkey’s head was immobilized with a fixation device, and its body temperature was maintained by a Bair Hugger model 505 (Arizant Healthcare, MN) and monitored with an esophageal thermometer. The ECG, heart rate, respiratory rate, and oxygen saturation of the monkey were continuously monitored throughout the experiment. The monkey’s fluid balance was maintained by a continuous infusion of saline.</div><div class="NLM_p last">Dynamic PET scan of 3 h was conducted using a High Resolution Research Tomograph (HRRT) (Siemens Molecular Imaging) following iv injection of the radioligand [<sup>18</sup>F]<b>3</b>. A transmission scan of 6 min using a single <sup>137</sup>Cs source was performed before the radioligand injection. List-mode data were reconstructed using the ordinary Poisson 3D-ordered subset expectation maximization (OP-3D-OSEM) algorithm, with 10 iterations and 16 subsets including modeling of the point spread function.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01769" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73173" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73173" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01769" class="ext-link">10.1021/acs.jmedchem.7b01769</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra for compound <b>3</b> and tosylate precursor <b>18</b> with peak assignments; selectivity profile of compound <b>3</b> in the CEREP selectivity panel; uptake and tissue distribution of compounds <b>2</b> and <b>3</b> (5–75 min survival interval) in male wild-type mice (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01769/suppl_file/jm7b01769_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01769/suppl_file/jm7b01769_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01769/suppl_file/jm7b01769_si_001.pdf">jm7b01769_si_001.pdf (753.4 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01769/suppl_file/jm7b01769_si_002.csv">jm7b01769_si_002.csv (0.49 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01769" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06782" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06782" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Zhang</span> - <span class="hlFld-Affiliation affiliation">Medicine Design,
Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8118-1402" title="Orcid link">http://orcid.org/0000-0001-8118-1402</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f1bd9498dfab99909f96c2b18197988b9483df929e9c"><span class="__cf_email__" data-cfemail="c68aa3afe89caea7a8a1f586b6a0afbca3b4e8a5a9ab">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laigao Chen</span> - <span class="hlFld-Affiliation affiliation">Clinical & Translational Imaging, Early Clinical Development, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason K. Dutra</span> - <span class="hlFld-Affiliation affiliation">Medicine Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth M. Beck</span> - <span class="hlFld-Affiliation affiliation">Medicine Design,
Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sangram Nag</span> - <span class="hlFld-Affiliation affiliation">Department of Clinical Neuroscience, Center
for Psychiatry Research, Karolinska Institutet
and Stockholm County Council, SE-17176 Stockholm, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akihiro Takano</span> - <span class="hlFld-Affiliation affiliation">Department of Clinical Neuroscience, Center
for Psychiatry Research, Karolinska Institutet
and Stockholm County Council, SE-17176 Stockholm, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nahid Amini</span> - <span class="hlFld-Affiliation affiliation">Department of Clinical Neuroscience, Center
for Psychiatry Research, Karolinska Institutet
and Stockholm County Council, SE-17176 Stockholm, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ryosuke Arakawa</span> - <span class="hlFld-Affiliation affiliation">Department of Clinical Neuroscience, Center
for Psychiatry Research, Karolinska Institutet
and Stockholm County Council, SE-17176 Stockholm, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael A. Brodney</span> - <span class="hlFld-Affiliation affiliation">Medicine Design,
Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leanne M. Buzon</span> - <span class="hlFld-Affiliation affiliation">Medicine Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shawn D. Doran</span> - <span class="hlFld-Affiliation affiliation">Medicine Design, Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lorraine F. Lanyon</span> - <span class="hlFld-Affiliation affiliation">Medicine Design, Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy J. McCarthy</span> - <span class="hlFld-Affiliation affiliation">Clinical & Translational Imaging, Early Clinical Development, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kelly R. Bales</span> - <span class="hlFld-Affiliation affiliation">Internal Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles E. Nolan</span> - <span class="hlFld-Affiliation affiliation">Internal Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian T. O’Neill</span> - <span class="hlFld-Affiliation affiliation">Medicine Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1928-4803" title="Orcid link">http://orcid.org/0000-0002-1928-4803</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Klaas Schildknegt</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Sciences, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christer Halldin</span> - <span class="hlFld-Affiliation affiliation">Department of Clinical Neuroscience, Center
for Psychiatry Research, Karolinska Institutet
and Stockholm County Council, SE-17176 Stockholm, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anabella Villalobos</span> - <span class="hlFld-Affiliation affiliation">Medicinal Synthesis Technologies, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20400" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20400" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Pfizer ADME technology group for generating the in vitro PK data and developing the in silico RRCK, MDR1 BA/AB, and brain fractions unbound models; BioDuro Inc. for performing the neuroPK study; Covance Inc. for performing the LC-MS/MS cold tracer study; all members of the PET group at the Karolinska Institutet for their kind assistance during the PET imaging study; Yong Zhang, Aijia Yu, and Jinlong Wang and their teams at WUXI Apptec for synthesis and scale-up efforts.</p></div><table summary="" class="NLM_def-list" id="DEF-LIST-d7e3058-autogenerated"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid</p></td></tr><tr><td class="NLM_term">BACE1</td><td class="NLM_def"><p class="first last">β-site amyloid precursor protein cleaving enzyme 1</p></td></tr><tr><td class="NLM_term">B/P</td><td class="NLM_def"><p class="first last">brain to plasma ratio</p></td></tr><tr><td class="NLM_term"><i>B</i><sub>max</sub></td><td class="NLM_def"><p class="first last">the maximum concentration of target binding sites</p></td></tr><tr><td class="NLM_term">CatD</td><td class="NLM_def"><p class="first last">cathepsin D</p></td></tr><tr><td class="NLM_term">CPM</td><td class="NLM_def"><p class="first last">count per minute</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">fluorescence polarization</p></td></tr><tr><td class="NLM_term">Fu_b</td><td class="NLM_def"><p class="first last">fraction unbound in brain</p></td></tr><tr><td class="NLM_term">KO</td><td class="NLM_def"><p class="first last">knockout</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Mardin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">MPO</td><td class="NLM_def"><p class="first last">multiparameter optimization</p></td></tr><tr><td class="NLM_term">NHP</td><td class="NLM_def"><p class="first last">nonhuman primate</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeability coefficient</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">RED</td><td class="NLM_def"><p class="first last">rapid equilibrium device</p></td></tr><tr><td class="NLM_term">RRCK</td><td class="NLM_def"><p class="first last">Ralph–Russ canine kidney</p></td></tr><tr><td class="NLM_term">SUV</td><td class="NLM_def"><p class="first last">standardized uptake values</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild-type</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83176" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83176" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 29 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span> <i>2012
Alzheimer’s Disease facts and figures</i>; <span class="NLM_publisher-name">Alzheimer’s Association</span>: <span class="NLM_publisher-loc">Washington
DC</span>, <span class="NLM_year">2012</span>; <a href="https://www.alz.org/downloads/facts_figures_2012.pdf" class="extLink">https://www.alz.org/downloads/facts_figures_2012.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+2012%0AAlzheimer%E2%80%99s+Disease+facts+and+figures%3B+Alzheimer%E2%80%99s+Association%3A+Washington%0ADC%2C+2012%3B+https%3A%2F%2Fwww.alz.org%2Fdownloads%2Ffacts_figures_2012.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3D2012%250AAlzheimer%25E2%2580%2599s%2520Disease%2520facts%2520and%2520figures%26pub%3DAlzheimer%25E2%2580%2599s%2520Association%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morstorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, K.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease drug-development pipeline: few candidates, frequent failures</span>. <i>Alzheimer’s Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">37</span>, <span class="refDoi"> DOI: 10.1186/alzrt269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1186%2Falzrt269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=25024750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=37&author=J.+L.+Cummingsauthor=T.+Morstorfauthor=K.+Zhong&title=Alzheimer%E2%80%99s+disease+drug-development+pipeline%3A+few+candidates%2C+frequent+failures&doi=10.1186%2Falzrt269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease drug-development pipeline: few candidates, frequent failures</span></div><div class="casAuthors">Cummings Jeffrey L; Zhong Kate; Morstorf Travis</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    </div><div class="casAbstract">INTRODUCTION:  Alzheimer's disease (AD) is increasing in frequency as the global population ages.  Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist.  We have an urgent need to find new therapies for AD.  METHODS:  We examined Clinicaltrials.gov, a public website that records ongoing clinical trials.  We examined the decade of 2002 to 2012, to better understand AD-drug development.  We reviewed trials by sponsor, sites, drug mechanism of action, duration, number of patients required, and rate of success in terms of advancement from one phase to the next.  We also reviewed the current AD therapy pipeline.  RESULTS:  During the 2002 to 2012 observation period, 413 AD trials were performed: 124 Phase 1 trials, 206 Phase 2 trials, and 83 Phase 3 trials.  Seventy-eight percent were sponsored by pharmaceutical companies.  The United States of America (U.S.) remains the single world region with the greatest number of trials; cumulatively, more non-U.S. than U.S. trials are performed.  The largest number of registered trials addressed symptomatic agents aimed at improving cognition (36.6%), followed by trials of disease-modifying small molecules (35.1%) and trials of disease-modifying immunotherapies (18%).  The mean length of trials increases from Phase 2 to Phase 3, and the number of participants in trials increases between Phase 2 and Phase 3.  Trials of disease-modifying agents are larger and longer than those for symptomatic agents.  A very high attrition rate was found, with an overall success rate during the 2002 to 2012 period of 0.4% (99.6% failure).  CONCLUSIONS:  The Clinicaltrials.gov database demonstrates that relatively few clinical trials are undertaken for AD therapeutics, considering the magnitude of the problem.  The success rate for advancing from one phase to another is low, and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area.  The AD drug-development ecosystem requires support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__DMPwHFhGGPgL4LrC-0VfW6udTcc2eZ0rH2VsbBPfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D&md5=85b84800ce02d7031a4c1046e837e568</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1186%2Falzrt269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt269%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DMorstorf%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DK.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520drug-development%2520pipeline%253A%2520few%2520candidates%252C%2520frequent%2520failures%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D37%26doi%3D10.1186%2Falzrt269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangialasche, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreasen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacobini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantua, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecocci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winblad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kivipelto, M.</span></span> <span> </span><span class="NLM_article-title">Clinical trials and late-stage drug development for Alzheimer’s disease: an appraisal from 1984 to 2014</span>. <i>J. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1111/joim.12191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1111%2Fjoim.12191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=24605808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A280%3ADC%252BC2crhsFaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2014&pages=251-283&author=L.+S.+Schneiderauthor=F.+Mangialascheauthor=N.+Andreasenauthor=H.+Feldmanauthor=E.+Giacobiniauthor=R.+Jonesauthor=V.+Mantuaauthor=P.+Mecocciauthor=L.+Paniauthor=B.+Winbladauthor=M.+Kivipelto&title=Clinical+trials+and+late-stage+drug+development+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+from+1984+to+2014&doi=10.1111%2Fjoim.12191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014</span></div><div class="casAuthors">Schneider L S; Mangialasche F; Andreasen N; Feldman H; Giacobini E; Jones R; Mantua V; Mecocci P; Pani L; Winblad B; Kivipelto M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of internal medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The modern era of drug development for Alzheimer's disease began with the proposal of the cholinergic hypothesis of memory impairment and the 1984 research criteria for Alzheimer's disease.  Since then, despite the evaluation of numerous potential treatments in clinical trials, only four cholinesterase inhibitors and memantine have shown sufficient safety and efficacy to allow marketing approval at an international level.  Although this is probably because the other drugs tested were ineffective, inadequate clinical development methods have also been blamed for the failures.  Here, we review the development of treatments for Alzheimer's disease during the past 30 years, considering the drugs, potential targets, late-stage clinical trials, development methods, emerging use of biomarkers and evolution of regulatory considerations in order to summarize advances and anticipate future developments.  We have considered late-stage Alzheimer's disease drug development from 1984 to 2013, including individual clinical trials, systematic and qualitative reviews, meta-analyses, methods, commentaries, position papers and guidelines.  We then review the evolution of drugs in late clinical development, methods, biomarkers and regulatory issues.  Although a range of small molecules and biological products against many targets have been investigated in clinical trials, the predominant drug targets have been the cholinergic system and the amyloid cascade.  Trial methods have evolved incrementally: inclusion criteria have largely remained focused on mild-to-moderate Alzheimer's disease criteria, recently extending to early or prodromal Alzheimer disease or 'mild cognitive impairment due to Alzheimer's disease', for drugs considered to be disease modifying.  The duration of trials has remained at 6-12 months for drugs intended to improve symptoms; 18- to 24-month trials have been established for drugs expected to attenuate clinical course.  Cognitive performance, activities of daily living, global change and severity ratings have persisted as the primary clinically relevant outcomes.  Regulatory guidance and oversight have evolved to allow for enrichment of early-stage Alzheimer's disease trial samples using biomarkers and phase-specific outcomes.  In conclusion, validated drug targets for Alzheimer's disease remain to be developed.  Only drugs that affect an aspect of cholinergic function have shown consistent, but modest, clinical effects in late-phase trials.  There is opportunity for substantial improvements in drug discovery and clinical development methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSiLqeiU50WDCA3UY9EwTNrfW6udTcc2eYUyg9mjO3MZ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crhsFaqug%253D%253D&md5=7e34762560c7cb2ce25084827c348cdc</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1111%2Fjoim.12191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjoim.12191%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DL.%2BS.%26aulast%3DMangialasche%26aufirst%3DF.%26aulast%3DAndreasen%26aufirst%3DN.%26aulast%3DFeldman%26aufirst%3DH.%26aulast%3DGiacobini%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DMantua%26aufirst%3DV.%26aulast%3DMecocci%26aufirst%3DP.%26aulast%3DPani%26aufirst%3DL.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DKivipelto%26aufirst%3DM.%26atitle%3DClinical%2520trials%2520and%2520late-stage%2520drug%2520development%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520from%25201984%2520to%25202014%26jtitle%3DJ.%2520Intern.%2520Med.%26date%3D2014%26volume%3D275%26spage%3D251%26epage%3D283%26doi%3D10.1111%2Fjoim.12191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nordberg, A.</span></span> <span> </span><span class="NLM_article-title">PET imaging of amyloid in Alzheimer’s disease</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">527</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(04)00853-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1016%2FS1474-4422%2804%2900853-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=15324720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFKjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=519-527&author=A.+Nordberg&title=PET+imaging+of+amyloid+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS1474-4422%2804%2900853-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">PET imaging of amyloid in Alzheimer's disease</span></div><div class="casAuthors">Nordberg, Agneta</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">519-527</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Lancet Neurology</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia and is characterized by progressive impairment in cognitive function and behavior.  The pathol. features of AD include neuritic plaques composed of amyloid-β peptide (Aβ) fibrils, neurofibrillary tangles of hyperphosphorylated tau, and neurotransmitter deficits.  Increases in the concn. of Aβ in the course of the disease with subtle effects on synaptic efficacy will lead to gradual increase in the load of amyloid plaques and progression in cognitive impairment.  Direct imaging of amyloid load in patients with AD in vivo would be very useful for the early diagnosis of AD and the development and assessment of new treatment strategies.  Three different strategies are being used to develop compds. suitable for in vivo imaging of amyloid deposits in human brains.  Monoclonal antibodies against Aβ and peptide fragments have had limited uptake by the brain when tested in patients with AD.  When putrescine-gadolinium-Aβ has been injected into transgenic mice overexpressing amyloid, labeling has been obsd. with MRI.  The small mol. approach for amyloid imaging has so far been most successful.  The binding of different derivs. of Congo red and thioflavin has been studied in human autopsy brain tissue and in transgenic mice.  Two compds., fluorine-18-labeled-FDDNP and carbon-11-labeled-PIB , both show more binding in the brains of patients with AD than in those of healthy people.  Addnl. compds. will probably be developed that are suitable not only for PET but also for single photon emission CT (SPECT).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtXFlYIU0ZiLVg90H21EOLACvtfcHk0li2o11Dcql_Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFKjtL4%253D&md5=63b16473fbf8954c74566fda57fd9e71</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2804%2900853-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252804%252900853-1%26sid%3Dliteratum%253Aachs%26aulast%3DNordberg%26aufirst%3DA.%26atitle%3DPET%2520imaging%2520of%2520amyloid%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%2520Neurol.%26date%3D2004%26volume%3D3%26spage%3D519%26epage%3D527%26doi%3D10.1016%2FS1474-4422%2804%2900853-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Landau, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurfjell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margolin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontecorvo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagust, W. J.</span></span> <span> </span><span class="NLM_article-title">Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1398</span>– <span class="NLM_lpage">1407</span>, <span class="refDoi"> DOI: 10.1007/s00259-014-2753-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1007%2Fs00259-014-2753-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=24647577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslSqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=1398-1407&author=S.+M.+Landauauthor=B.+A.+Thomasauthor=L.+Thurfjellauthor=M.+Schmidtauthor=R.+Margolinauthor=M.+Mintunauthor=M.+Pontecorvoauthor=S.+L.+Bakerauthor=W.+J.+Jagust&title=Amyloid+PET+imaging+in+Alzheimer%E2%80%99s+disease%3A+a+comparison+of+three+radiotracers&doi=10.1007%2Fs00259-014-2753-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers</span></div><div class="casAuthors">Landau, S. M.; Thomas, B. A.; Thurfjell, L.; Schmidt, M.; Margolin, R.; Mintun, M.; Pontecorvo, M.; Baker, S. L.; Jagust, W. J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1398-1407</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: The increasing use of amyloid PET in Alzheimer's disease research and clin. trials has motivated efforts to standardize methodol.  We compared retention of the 11C radiotracer Pittsburgh Compd. B (PiB) and that of two 18F amyloid radiotracers (florbetapir and flutemetamol) using two study populations.  We also examd. the feasibility of converting between tracer-specific measures, using PiB as the common link between the two 18F tracers.  Methods: One group of 40 subjects underwent PiB and flutemetamol imaging sessions and a sep. group of 32 subjects underwent PiB and florbetapir imaging sessions.  We compared cortical and white matter retention for each 18F tracer relative to that of PiB, as well as retention in several ref. regions and image anal. methods.  Correlations between tracer pairs were used to convert tracer-specific threshold values for amyloid positivity between tracers.  Results: Cortical retention for each pair of tracers was strongly correlated regardless of ref. region (PiB-flutemetamol, ρ = 0.84-0.99; PiB-florbetapir, ρ = 0.83-0.97) and anal. method (ρ = 0.90-0.99).  Compared to PiB, flutemetamol had higher white matter retention, while florbetapir had lower cortical retention.  Two previously established independent thresholds for amyloid positivity were highly consistent when values were converted between tracer pairs.  Conclusion: Despite differing white and gray matter retention characteristics, cortical retention for each 18F tracer was highly correlated with that of PiB, enabling conversion of thresholds across tracer measurement scales with a high level of internal consistency.  Standardization of anal. methods and measurement scales may facilitate the comparison of amyloid PET data obtained using different tracers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn78zTuzp6drVg90H21EOLACvtfcHk0li2o11Dcql_Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslSqu7o%253D&md5=dec3dc2c6e9eed9370697afa921ea999</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1007%2Fs00259-014-2753-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-014-2753-3%26sid%3Dliteratum%253Aachs%26aulast%3DLandau%26aufirst%3DS.%2BM.%26aulast%3DThomas%26aufirst%3DB.%2BA.%26aulast%3DThurfjell%26aufirst%3DL.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DMargolin%26aufirst%3DR.%26aulast%3DMintun%26aufirst%3DM.%26aulast%3DPontecorvo%26aufirst%3DM.%26aulast%3DBaker%26aufirst%3DS.%2BL.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26atitle%3DAmyloid%2520PET%2520imaging%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520comparison%2520of%2520three%2520radiotracers%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2014%26volume%3D41%26spage%3D1398%26epage%3D1407%26doi%3D10.1007%2Fs00259-014-2753-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Okamura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudo, Y.</span></span> <span> </span><span class="NLM_article-title">Tau PET imaging in Alzheimer’s disease</span>. <i>Curr. Neurol. Neurosci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">500</span>, <span class="refDoi"> DOI: 10.1007/s11910-014-0500-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1007%2Fs11910-014-0500-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=25239654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A280%3ADC%252BC2M7jsFSrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=500&author=N.+Okamuraauthor=R.+Haradaauthor=S.+Furumotoauthor=H.+Araiauthor=K.+Yanaiauthor=Y.+Kudo&title=Tau+PET+imaging+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs11910-014-0500-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Tau PET imaging in Alzheimer's disease</span></div><div class="casAuthors">Okamura Nobuyuki; Harada Ryuichi; Furumoto Shozo; Arai Hiroyuki; Yanai Kazuhiko; Kudo Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Current neurology and neuroscience reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">500</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In several neurodegenerative diseases that are collectively called tauopathies, progressive accumulation of tau in the brain is closely associated with neurodegeneration and cognitive impairment.  Noninvasive detection of tau protein deposits in the brain would be useful to diagnose tauopathies as well as to track and predict disease progression.  Recently, several tau PET tracers including T807, THK-5117, and PBB3 have been developed and succeeded in imaging neurofibrillary pathology in vivo.  For use of tau PET as a biomarker of tau pathology in Alzheimer's disease, PET tracers should have high affinity to PHF-tau and high selectivity for tau over amyloid-β and other protein deposits.  PET tau imaging enables the longitudinal assessment of the spatial pattern of tau deposition and its relation to amyloid-β pathology and neurodegeneration.  This technology could also be applied to the pharmacological assessment of anti-tau therapy, thereby allowing preventive interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTy6LVoglwXzIqdXsLcGTEUfW6udTcc2eaoPuwV2V1_RLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7jsFSrtA%253D%253D&md5=343715c63553be883942f9829da91648</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1007%2Fs11910-014-0500-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11910-014-0500-6%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DTau%2520PET%2520imaging%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Neurol.%2520Neurosci.%2520Rep.%26date%3D2014%26volume%3D14%26spage%3D500%26doi%3D10.1007%2Fs11910-014-0500-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">James, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doraiswamy, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges-Neto, S.</span></span> <span> </span><span class="NLM_article-title">PET imaging of Tau pathology in Alzheimer’s disease and tauopathies</span>. <i>Front. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">38</span>, <span class="refDoi"> DOI: 10.3389/fneur.2015.00038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.3389%2Ffneur.2015.00038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=25806018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A280%3ADC%252BC2MnnslShsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=38&author=O.+G.+Jamesauthor=P.+M.+Doraiswamyauthor=S.+Borges-Neto&title=PET+imaging+of+Tau+pathology+in+Alzheimer%E2%80%99s+disease+and+tauopathies&doi=10.3389%2Ffneur.2015.00038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies</span></div><div class="casAuthors">James Olga G; Borges-Neto Salvador; Doraiswamy P Murali</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38</span>
        ISSN:<span class="NLM_cas:issn">1664-2295</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbDjuDw8SFIcNIRw0GKUoEfW6udTcc2eaoPuwV2V1_RLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnnslShsw%253D%253D&md5=c75d0949921acd9a9e90102a77d3aed8</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.3389%2Ffneur.2015.00038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffneur.2015.00038%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DO.%2BG.%26aulast%3DDoraiswamy%26aufirst%3DP.%2BM.%26aulast%3DBorges-Neto%26aufirst%3DS.%26atitle%3DPET%2520imaging%2520of%2520Tau%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520tauopathies%26jtitle%3DFront.%2520Neurol.%26date%3D2015%26volume%3D6%26spage%3D38%26doi%3D10.3389%2Ffneur.2015.00038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Holsinger, R. M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mclean, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyreuther, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evin, G.</span></span> <span> </span><span class="NLM_article-title">Increased expression of the amyloid precursor β-secretase in Alzheimer’s disease</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">783</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.1002/ana.10208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1002%2Fana.10208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=12112088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFygsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=783-786&author=R.+M.+D.+Holsingerauthor=C.+A.+Mcleanauthor=K.+Beyreutherauthor=C.+L.+Mastersauthor=G.+Evin&title=Increased+expression+of+the+amyloid+precursor+%CE%B2-secretase+in+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fana.10208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Increased expression of the amyloid precursor β-secretase in Alzheimer's disease</span></div><div class="casAuthors">Holsinger, R. M. Damian; McLean, Catriona A.; Beyreuther, Konrad; Masters, Colin L.; Evin, Genevieve</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">783-786</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">β-Secretase cleavage represents the first step in the generation of Aβ polypeptides and initiates the amyloid cascade that leads to neurodegeneration in Alzheimer's disease.  By comparative Western blot anal., we show a 2.7-fold increase in protein expression of the β-secretase enzyme BACE in the brain cortex of Alzheimer's disease patients as compared to age-matched controls.  Similarly, we found the levels of the amyloid precursor protein C-terminal fragment produced by β-secretase to be increased by nearly twofold in Alzheimer's disease cortex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVtXq-CrHcL7Vg90H21EOLACvtfcHk0lgKTQ8HSkcWWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFygsbc%253D&md5=f32e2584bd55943b63780659238be0f8</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1002%2Fana.10208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.10208%26sid%3Dliteratum%253Aachs%26aulast%3DHolsinger%26aufirst%3DR.%2BM.%2BD.%26aulast%3DMclean%26aufirst%3DC.%2BA.%26aulast%3DBeyreuther%26aufirst%3DK.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DEvin%26aufirst%3DG.%26atitle%3DIncreased%2520expression%2520of%2520the%2520amyloid%2520precursor%2520%25CE%25B2-secretase%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2002%26volume%3D51%26spage%3D783%26epage%3D786%26doi%3D10.1002%2Fana.10208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyman, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irizarry, M. C.</span></span> <span> </span><span class="NLM_article-title">β-Secretase protein and activity are increased in the neocortex in Alzheimer disease</span>. <i>Arch. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1381</span>– <span class="NLM_lpage">1389</span>, <span class="refDoi"> DOI: 10.1001/archneur.59.9.1381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1001%2Farchneur.59.9.1381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=12223024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A280%3ADC%252BD38vmsVSgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2002&pages=1381-1389&author=H.+Fukumotoauthor=B.+S.+Cheungauthor=B.+T.+Hymanauthor=M.+C.+Irizarry&title=%CE%B2-Secretase+protein+and+activity+are+increased+in+the+neocortex+in+Alzheimer+disease&doi=10.1001%2Farchneur.59.9.1381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease</span></div><div class="casAuthors">Fukumoto Hiroaki; Cheung Bonnie S; Hyman Bradley T; Irizarry Michael C</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1381-9</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">CONTEXT:  Amyloid plaques, a major pathological feature of Alzheimer disease (AD), are composed of an internal fragment of amyloid precursor protein (APP): the 4-kd amyloid-beta protein (Abeta).  The metabolic processing of APP that results in Abeta formation requires 2 enzymatic cleavage events, a gamma-secretase cleavage dependent on presenilin, and a beta-secretase cleavage by the aspartyl protease beta-site APP-cleaving enzyme (BACE).  OBJECTIVE:  To test the hypothesis that BACE protein and activity are increased in regions of the brain that develop amyloid plaques in AD.  METHODS:  We developed an antibody capture system to measure BACE protein level and BACE-specific beta-secretase activity in frontal, temporal, and cerebellar brain homogenates from 61 brains with AD and 33 control brains.  RESULTS:  In the brains with AD, BACE activity and protein were significantly increased (P<.001).  Enzymatic activity increased by 63% in the temporal neocortex (P =.007) and 13% in the frontal neocortex (P =.003) in brains with AD, but not in the cerebellar cortex.  Activity in the temporal neocortex increased with the duration of AD (P =.008) but did not correlate with enzyme-linked immunosorbent assay measures of insoluble Abeta in brains with AD.  Protein level was increased by 14% in the frontal cortex of brains with AD (P =.004), with a trend toward a 15% increase in BACE protein in the temporal cortex (P =.07) and no difference in the cerebellar cortex.  Immunohistochemical analysis demonstrated that BACE immunoreactivity in the brain was predominantly neuronal and was found in tangle-bearing neurons in AD.  CONCLUSIONS:  The BACE protein and activity levels are increased in brain regions affected by amyloid deposition and remain increased despite significant neuronal and synaptic loss in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRYMw94XiaQ6m52AMpI4GK2fW6udTcc2eYqlbpzEI1ymbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38vmsVSgtw%253D%253D&md5=f58eb1b75c74900ed8b8ece5ba4128a7</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1001%2Farchneur.59.9.1381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.59.9.1381%26sid%3Dliteratum%253Aachs%26aulast%3DFukumoto%26aufirst%3DH.%26aulast%3DCheung%26aufirst%3DB.%2BS.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DIrizarry%26aufirst%3DM.%2BC.%26atitle%3D%25CE%25B2-Secretase%2520protein%2520and%2520activity%2520are%2520increased%2520in%2520the%2520neocortex%2520in%2520Alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2002%26volume%3D59%26spage%3D1381%26epage%3D1389%26doi%3D10.1001%2Farchneur.59.9.1381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasvoina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maus, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">β-Site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer’s disease pathogenesis</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3639</span>– <span class="NLM_lpage">3649</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.4396-06.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1523%2FJNEUROSCI.4396-06.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=17409228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFSlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=3639-3649&author=J.+Zhaoauthor=Y.+Fuauthor=M.+Yasvoinaauthor=P.+Shaoauthor=B.+Hittauthor=T.+O%E2%80%99Connorauthor=S.+Loganauthor=E.+Mausauthor=M.+Citronauthor=R.+Berryauthor=L.+Binderauthor=R.+Vassar&title=%CE%B2-Site+amyloid+precursor+protein+cleaving+enzyme+1+levels+become+elevated+in+neurons+around+amyloid+plaques%3A+implications+for+Alzheimer%E2%80%99s+disease+pathogenesis&doi=10.1523%2FJNEUROSCI.4396-06.2007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">β-Site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis</span></div><div class="casAuthors">Zhao, Jie; Fu, Yifan; Yasvoina, Marina; Shao, Peizhen; Hitt, Brian; O'Connor, Tracy; Logan, Sreemathi; Maus, Erika; Citron, Martin; Berry, Robert; Binder, Lester; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3639-3649</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) (β-secretase) initiates generation of β-amyloid (Aβ), which plays an early role in Alzheimer's disease (AD).  BACE1 levels are increased in postmortem AD brain, suggesting BACE1 elevation promotes Aβ prodn. and AD.  Alternatively, the BACE1 increase may be an epiphenomenon of late-stage AD.  To distinguish between these possibilities, we analyzed BACE1 elevation using a highly specific BACE1 antibody, BACE-Cat1, made in BACE1-/- mice, which mount a robust anti-BACE1 immune response.  Previous BACE1 immunohistochem. studies lack consistent results because typical BACE1 antibodies produce nonspecific background, but BACE-Cat1 immunolabels BACE1 only.  BACE1 elevation was recapitulated in two amyloid precursor protein (APP) transgenic mouse lines.  5XFAD mice form amyloid plaques at young ages and exhibit neuron loss.  In contrast, Tg2576 form plaques at a more advanced age and do not show cell death.  These two mouse lines allow differentiation between early Aβ-induced events and late phenomena related to neuron death.  BACE1 levels became elevated in parallel with amyloid burden in each APP transgenic, starting early in 5XFAD and late in Tg2576.  The increase in BACE1 protein occurred without any change in BACE1 mRNA level, indicating a posttranscriptional mechanism.  In APP transgenic and AD brains, high BACE1 levels were obsd. in an annulus around Aβ42-pos. plaque cores and colocalized with neuronal proteins.  These results demonstrate that amyloid plaques induce BACE1 in surrounding neurons at early stages of pathol. before neuron death occurs.  We conclude that BACE1 elevation is most likely triggered by the amyloid pathway and may drive a pos.-feedback loop in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVszRExZJjYLVg90H21EOLACvtfcHk0liAD_4X5QL0pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFSlu7Y%253D&md5=9f4866fa5aa4d0a860c8e95e871dd84f</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4396-06.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4396-06.2007%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DYasvoina%26aufirst%3DM.%26aulast%3DShao%26aufirst%3DP.%26aulast%3DHitt%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DT.%26aulast%3DLogan%26aufirst%3DS.%26aulast%3DMaus%26aufirst%3DE.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DBerry%26aufirst%3DR.%26aulast%3DBinder%26aufirst%3DL.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3D%25CE%25B2-Site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520levels%2520become%2520elevated%2520in%2520neurons%2520around%2520amyloid%2520plaques%253A%2520implications%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520pathogenesis%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D3639%26epage%3D3649%26doi%3D10.1523%2FJNEUROSCI.4396-06.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadleir, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandalepas, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buggia-Prévot, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinakaran, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1007/s00401-016-1558-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1007%2Fs00401-016-1558-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=26993139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVOgs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2016&pages=235-256&author=K.+R.+Sadleirauthor=P.+C.+Kandalepasauthor=V.+Buggia-Pr%C3%A9votauthor=D.+A.+Nicholsonauthor=G.+Thinakaranauthor=R.+Vassar&title=Presynaptic+dystrophic+neurites+surrounding+amyloid+plaques+are+sites+of+microtubule+disruption%2C+BACE1+elevation%2C+and+increased+A%CE%B2+generation+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00401-016-1558-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease</span></div><div class="casAuthors">Sadleir, Katherine R.; Kandalepas, Patty C.; Buggia-Prevot, Virginie; Nicholson, Daniel A.; Thinakaran, Gopal; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-256</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by amyloid plaques composed of the β-amyloid (Aβ) peptide surrounded by swollen presynaptic dystrophic neurites consisting of dysfunctional axons and terminals that accumulate the β-site amyloid precursor protein (APP) cleaving enzyme (BACE1) required for Aβ generation.  The cellular and mol. mechanisms that govern presynaptic dystrophic neurite formation are unclear, and elucidating these processes may lead to novel AD therapeutic strategies.  Previous studies suggest Aβ may disrupt microtubules, which we hypothesize have a crit. role in the development of presynaptic dystrophies.  To investigate this further, here we have assessed the effects of Aβ, particularly neurotoxic Aβ42, on microtubules during the formation of presynaptic dystrophic neurites in vitro and in vivo.  Live-cell imaging of primary neurons revealed that exposure to Aβ42 oligomers caused varicose and beaded neurites with extensive microtubule disruption, and inhibited anterograde and retrograde trafficking.  In brain sections from AD patients and the 5XFAD transgenic mouse model of amyloid pathol., dystrophic neurite halos with BACE1 elevation around amyloid plaques exhibited aberrant tubulin accumulations or voids.  At the ultrastructural level, peri-plaque dystrophies were strikingly devoid of microtubules and replete with multi-lamellar vesicles resembling autophagic intermediates.  Proteins of the microtubule motors, kinesin and dynein, and other neuronal proteins were aberrantly localized in peri-plaque dystrophies.  Inactive pro-cathepsin D also accumulated in peri-plaque dystrophies, indicating reduced lysosomal function.  Most importantly, BACE1 accumulation in peri-plaque dystrophies caused increased BACE1 cleavage of APP and Aβ generation.  Our study supports the hypothesis that Aβ induces microtubule disruption in presynaptic dystrophic neurites that surround plaques, thus impairing axonal transport and leading to accumulation of BACE1 and exacerbation of amyloid pathol. in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbSN7VOiJ1l7Vg90H21EOLACvtfcHk0liAD_4X5QL0pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVOgs78%253D&md5=d66c9c600721f1f63e7ae1c185b3b4ab</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00401-016-1558-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-016-1558-9%26sid%3Dliteratum%253Aachs%26aulast%3DSadleir%26aufirst%3DK.%2BR.%26aulast%3DKandalepas%26aufirst%3DP.%2BC.%26aulast%3DBuggia-Pr%25C3%25A9vot%26aufirst%3DV.%26aulast%3DNicholson%26aufirst%3DD.%2BA.%26aulast%3DThinakaran%26aufirst%3DG.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DPresynaptic%2520dystrophic%2520neurites%2520surrounding%2520amyloid%2520plaques%2520are%2520sites%2520of%2520microtubule%2520disruption%252C%2520BACE1%2520elevation%252C%2520and%2520increased%2520A%25CE%25B2%2520generation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2016%26volume%3D132%26spage%3D235%26epage%3D256%26doi%3D10.1007%2Fs00401-016-1558-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="note"><p class="first last">For representative review articles on BACE1 inhibitors, please see:</p></div><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Larner, A. J.</span></span> <span> </span><span class="NLM_article-title">Secretases as therapeutic targets in Alzheimer’s disease: patents 2000–2004</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1403</span>– <span class="NLM_lpage">1420</span>, <span class="refDoi"> DOI: 10.1517/13543776.14.10.1403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1517%2F13543776.14.10.1403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFKgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1403-1420&author=A.+J.+Larner&title=Secretases+as+therapeutic+targets+in+Alzheimer%E2%80%99s+disease%3A+patents+2000%E2%80%932004&doi=10.1517%2F13543776.14.10.1403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Secretases as therapeutic targets in Alzheimer's disease: patents 2000 - 2004</span></div><div class="casAuthors">Larner, Aj</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1403-1420</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  This article briefly reviews the biol. of the secretase enzymes (α, β and γ) that metabolize the amyloid precursor protein, pathways that are believed to be central to the pathogenesis of Alzheimer's disease.  Therapeutic patents claiming secretase inhibitors or modulators for the treatment of Alzheimer's disease published over the last 4 yr are then considered.  Although there are many claims, no agent has yet reached the clin. arena, and the paucity of data provided in the patents makes it difficult to predict which, if any, might do so.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVFV4jcxoox7Vg90H21EOLACvtfcHk0liAD_4X5QL0pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotFKgs70%253D&md5=0767fc4461549a308be0a77c69ab90e5</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1517%2F13543776.14.10.1403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.14.10.1403%26sid%3Dliteratum%253Aachs%26aulast%3DLarner%26aufirst%3DA.%2BJ.%26atitle%3DSecretases%2520as%2520therapeutic%2520targets%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520patents%25202000%25E2%2580%25932004%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2004%26volume%3D14%26spage%3D1403%26epage%3D1420%26doi%3D10.1517%2F13543776.14.10.1403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Probst, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. Z.</span></span> <span> </span><span class="NLM_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2006–2011)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1517/13543776.2012.681302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1517%2F13543776.2012.681302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=22512789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=511-540&author=G.+Probstauthor=Y.+Z.+Xu&title=Small-molecule+BACE1+inhibitors%3A+a+patent+literature+review+%282006%E2%80%932011%29&doi=10.1517%2F13543776.2012.681302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011)</span></div><div class="casAuthors">Probst, Gary; Xu, Ying-zi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">511-540</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Alzheimer's disease is a devastating neurodegenerative disorder for which no disease-modifying therapy exists.  The amyloid hypothesis, which implicates Aβ as the toxin initiating a biol. cascade leading to neurodegeneration, is the most prominent theory concerning the underlying cause of the disease.  BACE1 is one of two aspartyl proteinases that generate Aβ, thus inhibition of BACE1 has the potential to ameliorate the progression of Alzheimer's disease by abating the prodn. of Aβ.  Areas covered: This review chronicles small-mol. BACE1 inhibitors as described in the patent literature between 2006 and 2011 and their potential use as disease-modifying treatments for Alzheimer's disease.  Over the past half a dozen years, numerous BACE1 inhibitors have been published in the patent applications, but often these contain a paltry amt. of pertinent biol. data (e.g. potency, selectivity, and efficacy).  Fortunately, numerous relevant publications contg. important data have appeared in the journal literature during this period.  The goal in this effort was to create an amalgam of the two records to add value to this review.  Expert opinion: The pharmaceutical industry has made tremendous progress in the development of small-mol. BACE1 inhibitors that lower Aβ in the central nervous system.  Assuming the amyloid hypothesis is veracious, we anticipate a disease-modifying therapy to combat Alzheimer's disease is near.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp89KaCi3q5Z7Vg90H21EOLACvtfcHk0liVjBqDB45iyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D&md5=174bdc47fbca5aa1f8248dbf03ce402b</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.681302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.681302%26sid%3Dliteratum%253Aachs%26aulast%3DProbst%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DY.%2BZ.%26atitle%3DSmall-molecule%2520BACE1%2520inhibitors%253A%2520a%2520patent%2520literature%2520review%2520%25282006%25E2%2580%25932011%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D511%26epage%3D540%26doi%3D10.1517%2F13543776.2012.681302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease</span>. <i>Alzheimer’s Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">89</span>, <span class="refDoi"> DOI: 10.1186/s13195-014-0089-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1186%2Fs13195-014-0089-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=25621019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVCqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=89&author=R.+Vassar&title=BACE1+inhibitor+drugs+in+clinical+trials+for+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs13195-014-0089-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 inhibitor drugs in clinical trials for Alzheimer's disease</span></div><div class="casAuthors">Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's Research & Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">89/1-89/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">ARTLCD</span>;
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is the β-secretase enzyme required for the prodn. of the neurotoxic β-amyloid (Aβ) peptide that is widely considered to have a crucial early role in the etiol. of Alzheimer's disease (AD).  As a result, BACE1 has emerged as a prime drug target for reducing the levels of Aβ in the AD brain, and the development of BACE1 inhibitors as therapeutic agents is being vigorously pursued.  It has proven difficult for the pharmaceutical industry to design BACE1 inhibitor drugs that pass the blood-brain barrier, however this challenge has recently been met and BACE1 inhibitors are now in human clin. trials to test for safety and efficacy in AD patients and individuals with pre-symptomatic AD.  Initial results suggest that some of these BACE1 inhibitor drugs are well tolerated, although others have dropped out because of toxicity and it is still too early to know whether any will be effective for the prevention or treatment of AD.  Addnl., based on newly identified BACE1 substrates and phenotypes of mice that lack BACE1, concerns have emerged about potential mechanism-based side effects of BACE1 inhibitor drugs with chronic administration.  It is hoped that a therapeutic window can be achieved that balances safety and efficacy.  This review summarizes the current state of progress in the development of BACE1 inhibitor drugs and the evaluation of their therapeutic potential for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR-BPlLZzu7rVg90H21EOLACvtfcHk0liVjBqDB45iyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVCqtL4%253D&md5=a9ec66c8f0254986406323efa56c6f5a</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1186%2Fs13195-014-0089-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13195-014-0089-7%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DBACE1%2520inhibitor%2520drugs%2520in%2520clinical%2520trials%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D89%26doi%3D10.1186%2Fs13195-014-0089-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+M.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0liVjBqDB45iyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Strategies to facilitate the discovery of novel CNS PET ligands</span>. <i>EJNMMI Radiopharm. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">13</span>, <span class="refDoi"> DOI: 10.1186/s41181-016-0016-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1186%2Fs41181-016-0016-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=29564389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A280%3ADC%252BC1Mnjs1egtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2017&pages=13&author=L.+Zhangauthor=A.+Villalobos&title=Strategies+to+facilitate+the+discovery+of+novel+CNS+PET+ligands&doi=10.1186%2Fs41181-016-0016-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies to facilitate the discovery of novel CNS PET ligands</span></div><div class="casAuthors">Zhang Lei; Villalobos Anabella</div><div class="citationInfo"><span class="NLM_cas:title">EJNMMI radiopharmacy and chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Positron Emission Tomography (PET), as a non-invasive translatable imaging technology, can be incorporated into various stages of the CNS drug discovery process to provide valuable information for key preclinical and clinical decision-making.  Novel CNS PET ligand discovery efforts in the industry setting, however, are facing unique challenges associated with lead design and prioritization, and budget constraints.  In this review, three strategies aiming toward improving the central nervous system (CNS) PET ligand discovery process are described: first, early determination of receptor density (Bmax) and bio-distribution to inform PET viability and resource allocation; second, rational design and design prioritization guided by CNS PET design parameters; finally, a cost-effective in vivo specific binding assessment using a liquid chromatography-mass spectrometry (LC-MS/MS) "cold tracer" method.  Implementation of these strategies allowed a more focused and rational CNS PET ligand discovery effort to identify high quality PET ligands for neuroimaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxTionUZVuaEodMGTatQ7LfW6udTcc2eZznST6qmRXN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mnjs1egtA%253D%253D&md5=c88567acb66d6bc10df1e9901bb300fb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1186%2Fs41181-016-0016-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs41181-016-0016-2%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DStrategies%2520to%2520facilitate%2520the%2520discovery%2520of%2520novel%2520CNS%2520PET%2520ligands%26jtitle%3DEJNMMI%2520Radiopharm.%2520Chem.%26date%3D2017%26volume%3D1%26spage%3D13%26doi%3D10.1186%2Fs41181-016-0016-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heck, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span> <span> </span><span class="NLM_article-title">Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4568</span>– <span class="NLM_lpage">4579</span>, <span class="refDoi"> DOI: 10.1021/jm400312y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400312y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4568-4579&author=L.+Zhangauthor=A.+Villalobosauthor=E.+M.+Beckauthor=T.+Bocanauthor=T.+A.+Chappieauthor=L.+Chenauthor=S.+Grimwoodauthor=S.+D.+Heckauthor=C.+J.+Helalauthor=X.+Houauthor=J.+M.+Humphreyauthor=J.+Luauthor=M.+B.+Skaddanauthor=T.+J.+McCarthyauthor=P.+R.+Verhoestauthor=T.+T.+Wagerauthor=K.+Zasadny&title=Design+and+selection+parameters+to+accelerate+the+discovery+of+novel+central+nervous+system+positron+emission+tomography+%28PET%29+ligands+and+their+application+in+the+development+of+a+novel+phosphodiesterase+2A+PET+ligand&doi=10.1021%2Fjm400312y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span></div><div class="casAuthors">Zhang, Lei; Villalobos, Anabella; Beck, Elizabeth M.; Bocan, Thomas; Chappie, Thomas A.; Chen, Laigao; Grimwood, Sarah; Heck, Steven D.; Helal, Christopher J.; Hou, Xinjun; Humphrey, John M.; Lu, Jiemin; Skaddan, Marc B.; McCarthy, Timothy J.; Verhoest, Patrick R.; Wager, Travis T.; Zasadny, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4568-4579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To accelerate the discovery of novel small mol. central nervous system (CNS) positron emission tomog. (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development.  Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as neg. controls.  A systematic anal. of these ligands identified a set of preferred parameters for physicochem. properties, brain permeability, and nonspecific binding (NSB).  These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines.  This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine, [18F]PF-05270430 (5).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTCG9TZE0X-bVg90H21EOLACvtfcHk0ljD9qt-PBSv6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D&md5=ee7ce04829d7456a632c02c331c4edfa</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm400312y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400312y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBocan%26aufirst%3DT.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHeck%26aufirst%3DS.%2BD.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DMcCarthy%26aufirst%3DT.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DZasadny%26aufirst%3DK.%26atitle%3DDesign%2520and%2520selection%2520parameters%2520to%2520accelerate%2520the%2520discovery%2520of%2520novel%2520central%2520nervous%2520system%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligands%2520and%2520their%2520application%2520in%2520the%2520development%2520of%2520a%2520novel%2520phosphodiesterase%25202A%2520PET%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4568%26epage%3D4579%26doi%3D10.1021%2Fjm400312y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chernet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Need, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rash, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phebus, L. A.</span></span> <span> </span><span class="NLM_article-title">Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: Dopamine D2, serotonin 2A and NK-1 receptors as examples</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">346</span>, For additional applications, please see <span class="refDoi"> DOI: 10.1016/j.lfs.2005.04.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1016%2Fj.lfs.2005.04.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=16139310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SksbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2005&pages=340-346&author=E.+Chernetauthor=L.+J.+Martinauthor=D.+Liauthor=A.+B.+Needauthor=V.+N.+Barthauthor=K.+S.+Rashauthor=L.+A.+Phebus&title=Use+of+LC%2FMS+to+assess+brain+tracer+distribution+in+preclinical%2C+in+vivo+receptor+occupancy+studies%3A+Dopamine+D2%2C+serotonin+2A+and+NK-1+receptors+as+examples&doi=10.1016%2Fj.lfs.2005.04.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: Dopamine D2, serotonin 2A and NK-1 receptors as examples</span></div><div class="casAuthors">Chernet, Eyassu; Martin, Laura J.; Li, Dominic; Need, Anne B.; Barth, Vanessa N.; Rash, Karen S.; Phebus, Lee A.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">340-346</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HPLC combined with either single quad or triple quad mass spectral detectors (LC/MS) was used to measure the brain distribution of receptor occupancy tracers targeting dopamine D2, serotonin 5-HT2A and neurokinin NK-1 receptors using the ligands raclopride, MDL-100907 and GR205171, resp.  All three non-radiolabeled tracer mols. were easily detectable in discrete rat brain areas after i.v. doses of 3, 3 and 30 μg/kg, resp.  These levels showed a differential brain distribution caused by differences in receptor d., as demonstrated by the observation that pretreatment with compds. that occupy these receptors reduced this differential distribution in a dose-dependent manner.  I.v., s.c. and oral dose-occupancy curves were generated for haloperidol at the dopamine D2 receptor as were oral curves for the antipsychotic drugs olanzapine and clozapine.  In vivo dose-occupancy curves were also generated for orally administered clozapine, olanzapine and haloperidol at the cortical 5-HT2A binding site.  In vivo occupancy at the striatal neurokinin NK-1 binding site by various doses of orally administered MK-869 was also measured.  The authors' results demonstrate the utility of LC/MS to quantify tracer distribution in preclin. brain receptor occupancy studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-89MhwV6v3rVg90H21EOLACvtfcHk0ljD9qt-PBSv6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SksbzK&md5=426fc1ce907f0e701575cc3bebbd6af5</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2005.04.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2005.04.075%26sid%3Dliteratum%253Aachs%26aulast%3DChernet%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DL.%2BJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DNeed%26aufirst%3DA.%2BB.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26aulast%3DRash%26aufirst%3DK.%2BS.%26aulast%3DPhebus%26aufirst%3DL.%2BA.%26atitle%3DUse%2520of%2520LC%252FMS%2520to%2520assess%2520brain%2520tracer%2520distribution%2520in%2520preclinical%252C%2520in%2520vivo%2520receptor%2520occupancy%2520studies%253A%2520Dopamine%2520D2%252C%2520serotonin%25202A%2520and%2520NK-1%2520receptors%2520as%2520examples%26jtitle%3DLife%2520Sci.%26date%3D2005%26volume%3D78%26spage%3D340%26epage%3D346%26doi%3D10.1016%2Fj.lfs.2005.04.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rash, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedregal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Statnick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledo, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gackenheimer, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tauscher, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innis, R. B.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2687</span>– <span class="NLM_lpage">2700</span>, <span class="refDoi"> DOI: 10.1021/jm101487v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101487v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVSisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2687-2700&author=V.+W.+Pikeauthor=K.+S.+Rashauthor=Z.+Chenauthor=C.+Pedregalauthor=M.+A.+Statnickauthor=Y.+Kimuraauthor=J.+Hongauthor=S.+S.+Zoghbiauthor=M.+Fujitaauthor=M.+A.+Toledoauthor=N.+Diazauthor=S.+L.+Gackenheimerauthor=J.+T.+Tauscherauthor=V.+N.+Barthauthor=R.+B.+Innis&title=Synthesis+and+evaluation+of+radioligands+for+imaging+brain+nociceptin%2Forphanin+FQ+peptide+%28NOP%29+receptors+with+positron+emission+tomography&doi=10.1021%2Fjm101487v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography</span></div><div class="casAuthors">Pike, Victor W.; Rash, Karen S.; Chen, Zhaogen; Pedregal, Concepcion; Statnick, Michael A.; Kimura, Yasuyuki; Hong, Jinsoo; Zoghbi, Sami S.; Fujita, Masahiro; Toledo, Miguel A.; Diaz, Nuria; Gackenheimer, Susan L.; Tauscher, Johannes T.; Barth, Vanessa N.; Innis, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2687-2700</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Positron emission tomog. (PET) coupled to an effective radioligand could provide an important tool for understanding possible links between neuropsychiatric disorders and brain NOP (nociceptin/orphanin FQ peptide) receptors.  We sought to develop such a PET radioligand.  High-affinity NOP ligands were synthesized based on a 3-(2'-fluoro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-1-yl)-2(2-halobenzyl)-N-alkylpropanamide scaffold and from exptl. screens in rats, with ex vivo LC-MS/MS measures, three ligands were identified for labeling with carbon-11 and evaluation with PET in monkey.  Each ligand was labeled by 11C-methylation of an N-demethyl precursor and studied in monkey under baseline and NOP receptor-preblock conditions.  The three radioligands, [11C](S)-I (X = F, Cl, R = H; X = F, R = iPr) gave similar results.  Baseline scans showed high entry of radioactivity into the brain to give a distribution reflecting that expected for NOP receptors.  Preblock expts. showed high early peak levels of brain radioactivity, which rapidly declined to a much lower level than seen in baseline scans, thereby indicating a high level of receptor-specific binding in baseline expts.  Overall, [11C](S)-I (X = F, R = iPr) showed the most favorable receptor-specific signal and kinetics and is now selected for evaluation in human subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLbdZG2H-gRLVg90H21EOLACvtfcHk0lhrQchVNXRWWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVSisLk%253D&md5=7519fa250770248d3c73c58e20eca3f1</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fjm101487v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101487v%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DRash%26aufirst%3DK.%2BS.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPedregal%26aufirst%3DC.%26aulast%3DStatnick%26aufirst%3DM.%2BA.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DToledo%26aufirst%3DM.%2BA.%26aulast%3DDiaz%26aufirst%3DN.%26aulast%3DGackenheimer%26aufirst%3DS.%2BL.%26aulast%3DTauscher%26aufirst%3DJ.%2BT.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520radioligands%2520for%2520imaging%2520brain%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520%2528NOP%2529%2520receptors%2520with%2520positron%2520emission%2520tomography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2687%26epage%3D2700%26doi%3D10.1021%2Fjm101487v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mitch, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quimby, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedregal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Torre, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canada, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahl, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Statnick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinzie, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benesh, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rash, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, V. N.</span></span> <span> </span><span class="NLM_article-title">Discovery of aminobenzyloxyarylamides as κ opioid receptor selective antagonists: Application to preclinical development of a κ opioid receptor antagonist receptor occupancy tracer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">8000</span>– <span class="NLM_lpage">8012</span>, <span class="refDoi"> DOI: 10.1021/jm200789r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200789r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOgu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8000-8012&author=C.+H.+Mitchauthor=S.+J.+Quimbyauthor=N.+Diazauthor=C.+Pedregalauthor=M.+G.+de+la+Torreauthor=A.+Jimenezauthor=Q.+Shiauthor=E.+J.+Canadaauthor=S.+D.+Kahlauthor=M.+A.+Statnickauthor=D.+L.+McKinzieauthor=D.+R.+Beneshauthor=K.+S.+Rashauthor=V.+N.+Barth&title=Discovery+of+aminobenzyloxyarylamides+as+%CE%BA+opioid+receptor+selective+antagonists%3A+Application+to+preclinical+development+of+a+%CE%BA+opioid+receptor+antagonist+receptor+occupancy+tracer&doi=10.1021%2Fjm200789r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Aminobenzyloxyarylamides as κ Opioid Receptor Selective Antagonists: Application to Preclinical Development of a κ Opioid Receptor Antagonist Receptor Occupancy Tracer</span></div><div class="casAuthors">Mitch, Charles H.; Quimby, Steven J.; Diaz, Nuria; Pedregal, Concepcion; de la Torre, Marta G.; Jimenez, Alma; Shi, Qing; Canada, Emily J.; Kahl, Steven D.; Statnick, Michael A.; McKinzie, David L.; Benesh, Dana R.; Rash, Karen S.; Barth, Vanessa N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8000-8012</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arylphenylpyrrolidinylmethylphenoxybenzamides were found to have high affinity and selectivity for κ opioid receptors.  On the basis of receptor binding assays in Chinese hamster ovary (CHO) cells expressing cloned human opioid receptors, (S)-3-fluoro-4-(4-((2-(3-fluorophenyl)pyrrolidin-1-yl)methyl)phenoxy)benzamide (25) had a Ki = 0.565 nM for κ opioid receptor binding while having a Ki = 35.8 nM for μ opioid receptors and a Ki = 211 nM for δ opioid receptor binding.  Compd. 25 was also a potent antagonist of κ opioid receptors when tested in vitro using a [35S]-guanosine 5'O-[3-thiotriphosphate] ([35S]GTP-γ-S) functional assay in CHO cells expressing cloned human opioid receptors.  Compds. were also evaluated for potential use as receptor occupancy tracers.  Tracer evaluation was done in vivo, using liq. chromatog.-tandem mass spectrometry (LC/MS/MS) methods, precluding the need for radiolabeling.  (S)-3-Chloro-4-(4-((2-(pyridine-3-yl)pyrrolidin-1-yl)methyl)phenoxy)benzamide (18) was found to have favorable properties for a tracer for receptor occupancy, including good specific vs. nonspecific binding and good brain uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUKlIPCr34grVg90H21EOLACvtfcHk0lhrQchVNXRWWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOgu73N&md5=a17d3133182c2c33b78a85bf153c56fd</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1021%2Fjm200789r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200789r%26sid%3Dliteratum%253Aachs%26aulast%3DMitch%26aufirst%3DC.%2BH.%26aulast%3DQuimby%26aufirst%3DS.%2BJ.%26aulast%3DDiaz%26aufirst%3DN.%26aulast%3DPedregal%26aufirst%3DC.%26aulast%3Dde%2Bla%2BTorre%26aufirst%3DM.%2BG.%26aulast%3DJimenez%26aufirst%3DA.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DCanada%26aufirst%3DE.%2BJ.%26aulast%3DKahl%26aufirst%3DS.%2BD.%26aulast%3DStatnick%26aufirst%3DM.%2BA.%26aulast%3DMcKinzie%26aufirst%3DD.%2BL.%26aulast%3DBenesh%26aufirst%3DD.%2BR.%26aulast%3DRash%26aufirst%3DK.%2BS.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26atitle%3DDiscovery%2520of%2520aminobenzyloxyarylamides%2520as%2520%25CE%25BA%2520opioid%2520receptor%2520selective%2520antagonists%253A%2520Application%2520to%2520preclinical%2520development%2520of%2520a%2520%25CE%25BA%2520opioid%2520receptor%2520antagonist%2520receptor%2520occupancy%2520tracer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8000%26epage%3D8012%26doi%3D10.1021%2Fjm200789r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Motoki, T.</span>; <span class="NLM_string-name">Takeda, K.</span>; <span class="NLM_string-name">Takaishi, M.</span>; <span class="NLM_string-name">Suzuki, Y.</span>; <span class="NLM_string-name">Ishida, T.</span></span> <span> </span><span class="NLM_article-title">Novel Fused Aminodihydrothiazine Derivatives</span>. WO <span class="NLM_patent">2010038686A1</span>, Apr 8, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Motoki&author=K.+Takeda&author=M.+Takaishi&author=Y.+Suzuki&author=T.+Ishida&title=Novel+Fused+Aminodihydrothiazine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMotoki%26aufirst%3DT.%26atitle%3DNovel%2520Fused%2520Aminodihydrothiazine%2520Derivatives%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienkowski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuck, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tory, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauley, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brashler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratman, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhl, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasselli, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parodi, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrikson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M. E.</span></span> <span> </span><span class="NLM_article-title">Membrane-anchored aspartyl protease with Alzheimer’s disease beta-secretase activity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>402</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1038/990107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1038%2F990107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10591213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADyaK1MXotFKmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashlerauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membrane-anchored+aspartyl+protease+with+Alzheimer%E2%80%99s+disease+beta-secretase+activity&doi=10.1038%2F990107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity</span></div><div class="casAuthors">Yan, Riqiang; Bienkowski, Michael J.; Shuck, Mary E.; Miao, Huiyi; Tory, Monica C.; Pauley, Adele M.; Brashler, John R.; Stratman, Nancy C.; Mathews, W. Rodney; Buhl, Allen E.; Carter, Donald B.; Tomasselli, Alfredo G.; Parodi, Luis A.; Heinrikson, Robert L.; Gurney, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue">6761</span>),
    <span class="NLM_cas:pages">533-537</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Mutations in the gene encoding the amyloid protein precursor (APP) cause autosomal dominant Alzheimer's disease.  Cleavage of APP by unidentified proteases, referred to as β- and γ-secretases, generates the amyloid β-peptide, the main component of the amyloid plaques found in Alzheimer's disease patients.  The disease-causing mutations flank the protease cleavage sites in APP and facilitate its cleavage.  Here the authors identify a new membrane-bound aspartyl protease (Asp2) with β-secretase activity.  The Asp2 gene is expressed widely in brain and other tissues.  Decreasing the expression of Asp2 in cells reduces amyloid β-peptide prodn. and blocks the accumulation of the carboxy-terminal APP fragment that is created by β-secretase cleavage.  Solubilized Asp2 protein cleaves a synthetic APP peptide substrate at the β-secretase site, and the rate of cleavage is increased tenfold by a mutation assocd. with early-onset Alzheimer's disease in Sweden.  Thus, Asp2 is a new protein target for drugs that are designed to block the prodn. of amyloid β-peptide peptide and the consequent formation of amyloid plaque in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd6iE74jtk5LVg90H21EOLACvtfcHk0lhzG5FWFZ8Tmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotFKmu7k%253D&md5=96af7cd9b7c3315de029937497f04616</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2F990107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990107%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashler%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembrane-anchored%2520aspartyl%2520protease%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520beta-secretase%2520activity%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537%26doi%3D10.1038%2F990107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu-Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeloff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louis, J. – C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">Expression analysis of BACE2 in brain and peripheral tissues</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">20647</span>– <span class="NLM_lpage">20651</span>, <span class="refDoi"> DOI: 10.1074/jbc.M002688200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1074%2Fjbc.M002688200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10749877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvVyhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=20647-20651&author=B.+D.+Bennettauthor=S.+Babu-Khanauthor=R.+Loeloffauthor=J.+%E2%80%93+C.+Louisauthor=E.+Curranauthor=M.+Citronauthor=R.+Vassar&title=Expression+analysis+of+BACE2+in+brain+and+peripheral+tissues&doi=10.1074%2Fjbc.M002688200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Expression analysis of BACE2 in brain and peripheral tissues</span></div><div class="casAuthors">Bennett, Brian D.; Babu-Khan, Safura; Loeloff, Richard; Louis, Jean-Claude; Curran, Eileen; Citron, Martin; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">20647-20651</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Beta-site amyloid precursor protein cleaving enzyme (BACE) is a novel transmembrane aspartic protease that possesses all the known characteristics of the β-secretase involved in Alzheimer's disease.  We have analyzed the sequence and expression pattern of a BACE homolog termed BACE2.  BACE and BACE2 are unique among aspartic proteases in that they possess a carboxyl-terminal extension with a predicted transmembrane region and together they define a new family.  Northern anal. reveals that BACE2 mRNA is expressed at low levels in most human peripheral tissues and at higher levels in colon, kidney, pancreas, placenta, prostate, stomach, and trachea.  Human adult and fetal whole brain and most adult brain subregions express very low or undetectable levels of BACE2 mRNA.  In addn., in situ hybridization of adult rat brain shows that BACE2 mRNA is expressed at very low levels in most brain regions.  The very low or undetectable levels of BACE2 mRNA in the brain are not consistent with the expression pattern predicted for β-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodNsksnpZwh7Vg90H21EOLACvtfcHk0lhzG5FWFZ8Tmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvVyhsbs%253D&md5=3d664572b2a1709c68fffcee3a8880d5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M002688200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M002688200%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLouis%26aufirst%3DJ.%2B%25E2%2580%2593%2BC.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DExpression%2520analysis%2520of%2520BACE2%2520in%2520brain%2520and%2520peripheral%2520tissues%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D20647%26epage%3D20651%26doi%3D10.1074%2Fjbc.M002688200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu-Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendiaz, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teplow, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amarante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeloff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edenson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lile, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biere, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louis, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span> <span> </span><span class="NLM_article-title">β-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1126/science.286.5440.735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.-C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=%CE%B2-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE&doi=10.1126%2Fscience.286.5440.735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0lhzG5FWFZ8Tmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.-C.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3D%25CE%25B2-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741%26doi%3D10.1126%2Fscience.286.5440.735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, R.</span></span> <span> </span><span class="NLM_article-title">In vivo site-directed radiotracers: a mini-review</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">815</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2008.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1016%2Fj.nucmedbio.2008.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=19026942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=805-815&author=S.+Patelauthor=R.+Gibson&title=In+vivo+site-directed+radiotracers%3A+a+mini-review&doi=10.1016%2Fj.nucmedbio.2008.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo site-directed radiotracers: a mini-review</span></div><div class="casAuthors">Patel, Shil; Gibson, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">805-815</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review on the process for developing reversible, monovalent site-specific radiotracers in drug design.  It is concerned with the characteristics of radiotracers such as binding, lipophilicity, and binding specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYUEhMFA7d7bVg90H21EOLACvtfcHk0ljMrTKgifiF4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL&md5=869985e0741d52a76cb546972097e2a8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DR.%26atitle%3DIn%2520vivo%2520site-directed%2520radiotracers%253A%2520a%2520mini-review%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D805%26epage%3D815%26doi%3D10.1016%2Fj.nucmedbio.2008.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keefer, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. R.</span></span> <span> </span><span class="NLM_article-title">Interpretable, probability-based confidence metric for continuous quantitative structure-activity relationship models</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">368</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1021/ci300554t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci300554t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Cit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=368-383&author=C.+E.+Keeferauthor=G.+W.+Kauffmanauthor=R.+R.+Gupta&title=Interpretable%2C+probability-based+confidence+metric+for+continuous+quantitative+structure-activity+relationship+models&doi=10.1021%2Fci300554t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Interpretable, Probability-Based Confidence Metric for Continuous Quantitative Structure-Activity Relationship Models</span></div><div class="casAuthors">Keefer, Christopher E.; Kauffman, Gregory W.; Gupta, Rishi Raj</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">368-383</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A great deal of research has gone into the development of robust confidence in prediction and applicability domain (AD) measures for quant. structure-activity relationship (QSAR) models in recent years.  Much of the attention has historically focused on structural similarity, which can be defined in many forms and flavors.  A concept that is frequently overlooked in the realm of the QSAR applicability domain is how the local activity landscape plays a role in how accurate a prediction is or is not.  In this work, we describe an approach that pairs information about both the chem. similarity and activity landscape of a test compd.'s neighborhood into a single calcd. confidence value.  We also present an approach for converting this value into an interpretable confidence metric that has a simple and informative meaning across data sets.  The approach will be introduced to the reader in the context of models built upon four diverse literature data sets.  The steps we will outline include the definition of similarity used to det. nearest neighbors (NN), how we incorporate the NN activity landscape with a similarity-weighted root-mean-square distance (wRMSD) value, and how that value is then calibrated to generate an intuitive confidence metric for prospective application.  Finally, we will illustrate the prospective performance of the approach on five proprietary models whose predictions and confidence metrics have been tracked for more than a year.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqvcorWVQ5O7Vg90H21EOLACvtfcHk0ljMrTKgifiF4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Cit74%253D&md5=14d2b7d42f91b5e4e90fa53b6266a178</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fci300554t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci300554t%26sid%3Dliteratum%253Aachs%26aulast%3DKeefer%26aufirst%3DC.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DGupta%26aufirst%3DR.%2BR.%26atitle%3DInterpretable%252C%2520probability-based%2520confidence%2520metric%2520for%2520continuous%2520quantitative%2520structure-activity%2520relationship%2520models%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D368%26epage%3D383%26doi%3D10.1021%2Fci300554t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, Q. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundesmann, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henegar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaChapelle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikochik, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakya, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span> <span> </span><span class="NLM_article-title">Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug–drug interactions with a novel series of centrally efficacious BACE1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3223</span>– <span class="NLM_lpage">3252</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3223-3252&author=M.+A.+Brodneyauthor=E.+M.+Beckauthor=C.+R.+Butlerauthor=G.+Barreiroauthor=E.+F.+Johnsonauthor=D.+Riddellauthor=K.+Parrisauthor=C.+E.+Nolanauthor=Y.+Fanauthor=K.+Atchisonauthor=C.+Gonzalesauthor=Q.+E.+Robshawauthor=S.+D.+Doranauthor=M.+W.+Bundesmannauthor=L.+Buzonauthor=J.+Dutraauthor=K.+Henegarauthor=E.+LaChapelleauthor=X.+Houauthor=B.+N.+Rogersauthor=J.+Panditauthor=R.+Liraauthor=L.+Martinez-Alsinaauthor=P.+Mikochikauthor=J.+C.+Murrayauthor=K.+Ogilvieauthor=L.+Priceauthor=S.+M.+Sakyaauthor=A.+Yuauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Utilizing+structures+of+CYP2D6+and+BACE1+complexes+to+reduce+risk+of+drug%E2%80%93drug+interactions+with+a+novel+series+of+centrally+efficacious+BACE1+inhibitors&doi=10.1021%2Facs.jmedchem.5b00191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00191%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DRobshaw%26aufirst%3DQ.%2BE.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DBundesmann%26aufirst%3DM.%2BW.%26aulast%3DBuzon%26aufirst%3DL.%26aulast%3DDutra%26aufirst%3DJ.%26aulast%3DHenegar%26aufirst%3DK.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DMikochik%26aufirst%3DP.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DPrice%26aufirst%3DL.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DYu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DUtilizing%2520structures%2520of%2520CYP2D6%2520and%2520BACE1%2520complexes%2520to%2520reduce%2520risk%2520of%2520drug%25E2%2580%2593drug%2520interactions%2520with%2520a%2520novel%2520series%2520of%2520centrally%2520efficacious%2520BACE1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3223%26epage%3D3252%26doi%3D10.1021%2Facs.jmedchem.5b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takaishi, M.</span>; <span class="NLM_string-name">Ishida, T.</span></span> <span> </span><span class="NLM_article-title">Fused Aminohydrothiazine Derivatives</span>. WO <span class="NLM_patent">2012098461A1</span>, Jul 26, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+Takaishi&author=T.+Ishida&title=Fused+Aminohydrothiazine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTakaishi%26aufirst%3DM.%26atitle%3DFused%2520Aminohydrothiazine%2520Derivatives%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalaeva, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tupper, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span> <span> </span><span class="NLM_article-title">ElogD<sub>oct</sub>: A tool for lipophilicity determination in drug discovery. 2. Basic and neural compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">2490</span>– <span class="NLM_lpage">2497</span>, <span class="refDoi"> DOI: 10.1021/jm0100990</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0100990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2490-2497&author=F.+Lombardoauthor=M.+Y.+Shalaevaauthor=K.+A.+Tupperauthor=F.+Gao&title=ElogDoct%3A+A+tool+for+lipophilicity+determination+in+drug+discovery.+2.+Basic+and+neural+compounds&doi=10.1021%2Fjm0100990"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm0100990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100990%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DShalaeva%26aufirst%3DM.%2BY.%26aulast%3DTupper%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DF.%26atitle%3DElogDoct%253A%2520A%2520tool%2520for%2520lipophilicity%2520determination%2520in%2520drug%2520discovery.%25202.%2520Basic%2520and%2520neural%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2490%26epage%3D2497%26doi%3D10.1021%2Fjm0100990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span> Fu_b was measured using rat brain homogenate based on species independence
in brain tissue bindings. For a reference, please see:<span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span> <span> </span><span class="NLM_article-title">Species independence in brain tissue binding using brain homogenates</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1270</span>– <span class="NLM_lpage">1277</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.038778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1124%2Fdmd.111.038778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=21474681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1270-1277&author=L.+Diauthor=J.+P.+Umlandauthor=G.+Changauthor=Y.+Huangauthor=Z.+Linauthor=D.+O.+Scottauthor=M.+D.+Troutmanauthor=T.+E.+Liston&title=Species+independence+in+brain+tissue+binding+using+brain+homogenates&doi=10.1124%2Fdmd.111.038778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Species independence in brain tissue binding using brain homogenates</span></div><div class="casAuthors">Di, Li; Umland, John P.; Chang, George; Huang, Youping; Lin, Zhen; Scott, Dennis O.; Troutman, Matthew D.; Liston, Theodore E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1270-1277</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Species independence of brain tissue binding was assessed with a large no. of structurally diverse compds. using equil. dialysis with brain homogenates of seven species and strains (Wistar Han rat, Sprague-Dawley rat, CD-1 mouse, Hartley guinea pig, beagle dog, cynomolgus monkey, and human).  The results showed that the fractions unbound of the seven species and strains were strongly correlated with correlation coeffs. ranging from 0.93 to 0.99.  The cross-species/strain correlations were not significantly different from the interassay correlation with the same species.  The linear correlation between Wistar Han and other species had a slope close to 1 and an intercept near 0.  Based on orthogonal statistical anal., no correction is needed for extrapolation of fraction unbound from Wistar Han rat to the other species or strains.  Hence, brain tissue binding of Wistar Han rat can be used to obtain binding of other species and strains in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoub4FiLWkAFrVg90H21EOLACvtfcHk0lgp7q58PgrU6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D&md5=93a51addedb22de4648e6e5ee39c6c81</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.038778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.038778%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DListon%26aufirst%3DT.%2BE.%26atitle%3DSpecies%2520independence%2520in%2520brain%2520tissue%2520binding%2520using%2520brain%2520homogenates%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D1270%26epage%3D1277%26doi%3D10.1124%2Fdmd.111.038778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Remick, D. M.</span>; <span class="NLM_string-name">Richards, S. J.</span>; <span class="NLM_string-name">Sanderson, A. J.</span></span> <span> </span><span class="NLM_article-title">Tetrahydrofurane-fused Aminohydrothiazine Derivatives Which are Useful in the Treatment of Alzheimer’s Disease</span>. WO <span class="NLM_patent">2016176118A1</span>, Nov 3, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=D.+M.+Remick&author=S.+J.+Richards&author=A.+J.+Sanderson&title=Tetrahydrofurane-fused+Aminohydrothiazine+Derivatives+Which+are+Useful+in+the+Treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRemick%26aufirst%3DD.%2BM.%26atitle%3DTetrahydrofurane-fused%2520Aminohydrothiazine%2520Derivatives%2520Which%2520are%2520Useful%2520in%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richards, S. J.</span>; <span class="NLM_string-name">Hembre, E. J.</span>; <span class="NLM_string-name">Lopez, J. E.</span>; <span class="NLM_string-name">Winneroski, L. L.,  Jr.</span>; <span class="NLM_string-name">Woods, T. A.</span>; <span class="NLM_string-name">McMahon, J. A.</span></span> <span> </span><span class="NLM_article-title">Selective BACE1 Inhibitors</span>. US <span class="NLM_patent">20160244465AA</span>, Aug 25, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+J.+Richards&author=E.+J.+Hembre&author=J.+E.+Lopez&author=L.+L.+Winneroski&author=T.+A.+Woods&author=J.+A.+McMahon&title=Selective+BACE1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DS.%2BJ.%26atitle%3DSelective%2520BACE1%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goriya, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramana, C. V.</span></span> <span> </span><span class="NLM_article-title">The [Cu]-catalyzed S<sub>N</sub>Ar reactions: direct amination of electron deficient aryl halides with sodium azide and the synthesis of arylthioethers under Cu (II)-ascorbate redox system</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">7642</span>– <span class="NLM_lpage">7650</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2010.07.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1016%2Fj.tet.2010.07.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGrtbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=7642-7650&author=Y.+Goriyaauthor=C.+V.+Ramana&title=The+%5BCu%5D-catalyzed+SNAr+reactions%3A+direct+amination+of+electron+deficient+aryl+halides+with+sodium+azide+and+the+synthesis+of+arylthioethers+under+Cu+%28II%29-ascorbate+redox+system&doi=10.1016%2Fj.tet.2010.07.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The [Cu]-catalyzed SNAR reactions: direct amination of electron deficient aryl halides with sodium azide and the synthesis of arylthioethers under Cu(II)-ascorbate redox system</span></div><div class="casAuthors">Goriya, Yogesh; Ramana, C. V.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">7642-7650</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A one pot [Cu]-promoted SNAr reaction of electron-deficient halobenzenes with sodium azide and the redn. of the intermediate aryl azides under the same Cu(II)-ascorbate redox conditions leading to anilines has been documented.  Control expts. revealed that both ascorbate and proline play important role in the reaction path way.  Further, the use of this catalytic Cu(II)-ascorbate redox system has been explored for the synthesis of arylthioethers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8qeehlF19sLVg90H21EOLACvtfcHk0ljio1oFuSS6JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGrtbfK&md5=e0c4b3a1646453ee9cd38a651d4985af</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2010.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2010.07.032%26sid%3Dliteratum%253Aachs%26aulast%3DGoriya%26aufirst%3DY.%26aulast%3DRamana%26aufirst%3DC.%2BV.%26atitle%3DThe%2520%255BCu%255D-catalyzed%2520SNAr%2520reactions%253A%2520direct%2520amination%2520of%2520electron%2520deficient%2520aryl%2520halides%2520with%2520sodium%2520azide%2520and%2520the%2520synthesis%2520of%2520arylthioethers%2520under%2520Cu%2520%2528II%2529-ascorbate%2520redox%2520system%26jtitle%3DTetrahedron%26date%3D2010%26volume%3D66%26spage%3D7642%26epage%3D7650%26doi%3D10.1016%2Fj.tet.2010.07.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span> Compound <b>36</b> in<span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varghese, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span> <span> </span><span class="NLM_article-title">Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2678</span>– <span class="NLM_lpage">2702</span>, <span class="refDoi"> DOI: 10.1021/jm501833t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501833t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2678-2702&author=C.+R.+Butlerauthor=M.+A.+Brodneyauthor=E.+M.+Beckauthor=G.+Barreiroauthor=C.+E.+Nolanauthor=F.+Panauthor=F.+Vajdosauthor=K.+Parrisauthor=A.+H.+Vargheseauthor=C.+J.+Helalauthor=R.+Liraauthor=S.+D.+Doranauthor=D.+R.+Riddellauthor=L.+M.+Buzonauthor=J.+K.+Dutraauthor=L.+A.+Martinez-Alsinaauthor=K.+Ogilvieauthor=J.+C.+Murrayauthor=J.+M.+Youngauthor=K.+Atchisonauthor=A.+Robshawauthor=C.+Gonzalesauthor=J.+Wangauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Discovery+of+a+series+of+efficient%2C+centrally+efficacious+BACE1+inhibitors+through+structure-based+drug+design&doi=10.1021%2Fjm501833t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design</span></div><div class="casAuthors">Butler, Christopher R.; Brodney, Michael A.; Beck, Elizabeth M.; Barreiro, Gabriela; Nolan, Charles E.; Pan, Feng; Vajdos, Felix; Parris, Kevin; Varghese, Alison H.; Helal, Christopher J.; Lira, Ricardo; Doran, Shawn D.; Riddell, David R.; Buzon, Leanne M.; Dutra, Jason K.; Martinez-Alsina, Luis A.; Ogilvie, Kevin; Murray, John C.; Young, Joseph M.; Atchison, Kevin; Robshaw, Ashley; Gonzales, Cathleen; Wang, Jinlong; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2678-2702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease (AD) has historically been thwarted by an inability to maintain alignment of potency, brain availability, and desired absorption, distribution, metab., and excretion (ADME) properties.  In this paper, the authors describe a series of truncated, fused thioamidines that are efficiently selective in garnering BACE1 activity without simultaneously inhibiting the closely related cathepsin D or neg. impacting brain penetration and ADME alignment, as exemplified by I.  Upon oral administration, these inhibitors exhibit robust brain availability and are efficacious in lowering central Amyloid β (Aβ) levels in mouse and dog.  In addn., chronic treatment in aged PS1/APP mice effects a decrease in the no. and size of Aβ-derived plaques.  Most importantly, evaluation of I in a 2-wk exploratory toxicol. study revealed no accumulation of autofluorescent material in retinal pigment epithelium or histol. findings in the eye, issues obsd. with earlier BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiNT62AGyml7Vg90H21EOLACvtfcHk0ljio1oFuSS6JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D&md5=ac2a6fd661f7e9fd8b925deffd5e1010</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm501833t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501833t%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DVarghese%26aufirst%3DA.%2BH.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%2BA.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DRobshaw%26aufirst%3DA.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DDiscovery%2520of%2520a%2520series%2520of%2520efficient%252C%2520centrally%2520efficacious%2520BACE1%2520inhibitors%2520through%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2678%26epage%3D2702%26doi%3D10.1021%2Fjm501833t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span>; <span class="NLM_string-name">Beck, E. M.</span>; <span class="NLM_string-name">Butler, C. R.</span>; <span class="NLM_string-name">Zhang, L.</span>; <span class="NLM_string-name">O’Neill, B. T.</span>; <span class="NLM_string-name">Barreiro, G.</span>; <span class="NLM_string-name">Lachapelle, E. A.</span>; <span class="NLM_string-name">Rogers, B. N.</span></span> <span> </span><span class="NLM_article-title">Preparation of <i>N</i>-(2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl) Amides as Inhibitors of Beta-site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span>. WO <span class="NLM_patent">2015155626A1</span>, Oct 15, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+A.+Brodney&author=E.+M.+Beck&author=C.+R.+Butler&author=L.+Zhang&author=B.+T.+O%E2%80%99Neill&author=G.+Barreiro&author=E.+A.+Lachapelle&author=B.+N.+Rogers&title=Preparation+of+N-%282-amino-6-methyl-4%2C4a%2C5%2C6-tetrahydropyrano%5B3%2C4-d%5D%5B1%2C3%5Dthiazin-8a%288h%29-yl-1%2C3-thiazol-4-yl%29+Amides+as+Inhibitors+of+Beta-site+Amyloid+Precursor+Protein+Cleaving+Enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DPreparation%2520of%2520N-%25282-amino-6-methyl-4%252C4a%252C5%252C6-tetrahydropyrano%255B3%252C4-d%255D%255B1%252C3%255Dthiazin-8a%25288h%2529-yl-1%252C3-thiazol-4-yl%2529%2520Amides%2520as%2520Inhibitors%2520of%2520Beta-site%2520Amyloid%2520Precursor%2520Protein%2520Cleaving%2520Enzyme%25201%2520%2528BACE1%2529%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borders, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brier, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevorkyan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komjathy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathes, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaught, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winneroski, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span> <span> </span><span class="NLM_article-title">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1199</span>– <span class="NLM_lpage">1210</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.4129-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1523%2FJNEUROSCI.4129-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=25609634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=1199-1210&author=P.+C.+Mayauthor=B.+A.+Willisauthor=S.+L.+Loweauthor=R.+A.+Deanauthor=S.+A.+Monkauthor=P.+J.+Cockeauthor=J.+E.+Audiaauthor=L.+N.+Boggsauthor=A.+R.+Bordersauthor=R.+A.+Brierauthor=D.+O.+Calligaroauthor=T.+A.+Dayauthor=L.+Ereshefskyauthor=J.+A.+Ericksonauthor=H.+Gevorkyanauthor=C.+R.+Gonzalesauthor=D.+E.+Jamesauthor=S.+S.+Jheeauthor=S.+F.+Komjathyauthor=L.+Liauthor=T.+D.+Lindstromauthor=B.+M.+Mathesauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=G.+M.+Vaughtauthor=B.+M.+Watsonauthor=L.+L.+Winneroskiauthor=Z.+Yangauthor=D.+J.+Mergott&title=The+potent+BACE1+inhibitor+LY2886721+elicits+robust+central+A%CE%B2+pharmacodynamic+responses+in+mice%2C+dogs%2C+and+humans&doi=10.1523%2FJNEUROSCI.4129-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span></div><div class="casAuthors">May, Patrick C.; Willis, Brian A.; Lowe, Stephen L.; Dean, Robert A.; Monk, Scott A.; Cocke, Patrick J.; Audia, James E.; Boggs, Leonard N.; Borders, Anthony R.; Brier, Richard A.; Calligaro, David O.; Day, Theresa A.; Ereshefsky, Larry; Erickso, Jon A.; Gevorkyan, Hykop; Gonzales, Celedon R.; James, Douglas E.; Jhee, Stanford S.; Komjathy, Steven F.; Li, Linglin; Lindstrom, Terry D.; Mathe, Brian M.; Martenyi, Ferenc; Sheehan, Scott M.; Stout, Stephanie L.; Timm, David E.; Vaught, Grant M.; Watson, Brian M.; Winneroski, Leonard L.; Yang, Zhixiang; Mergott, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1199-1210, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">BACE1 is a key protease controlling the formation of amyloid β, a peptide hypothesized to play a significant role in the pathogenesis of Alzheimer's disease (AD).  Therefore, the development of potent and selective inhibitors of BACE1 has been a focus of many drug discovery efforts in academia and industry.  Herein, we report the nonclin. and early clin. development of LY2886721, a BACE1 active site inhibitor that reached phase 2 clin. trials in AD.  LY2886721 has high selectivity against key off-target proteases, which efficiently translates in vitro activity into robust in vivo amyloid β lowering in nonclin. animal models.  Similar potent and persistent amyloid β lowering was obsd. in plasma and lumbar CSF when single and multiple doses of LY2886721 were administered to healthy human subjects.  Collectively, these data add support for BACE1 inhibition as an effective means of amyloid lowering and as an attractive target for potential disease modification therapy in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDFLhcsiUDLVg90H21EOLACvtfcHk0lhKg_lFR7M0fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D&md5=7e16cc00767a8af4da7dd17b6e40e8f5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4129-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4129-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DWillis%26aufirst%3DB.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DBorders%26aufirst%3DA.%2BR.%26aulast%3DBrier%26aufirst%3DR.%2BA.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DDay%26aufirst%3DT.%2BA.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DErickson%26aufirst%3DJ.%2BA.%26aulast%3DGevorkyan%26aufirst%3DH.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DJames%26aufirst%3DD.%2BE.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DKomjathy%26aufirst%3DS.%2BF.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DVaught%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520potent%2520BACE1%2520inhibitor%2520LY2886721%2520elicits%2520robust%2520central%2520A%25CE%25B2%2520pharmacodynamic%2520responses%2520in%2520mice%252C%2520dogs%252C%2520and%2520humans%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D1199%26epage%3D1210%26doi%3D10.1523%2FJNEUROSCI.4129-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K. – H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuszpit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachapelle, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciabola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">The discovery of a novel phosphodiesterase (PDE)4B-preferring radioligand for positron emission tomography (PET) imaging</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8538</span>– <span class="NLM_lpage">8551</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01050</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01050" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8538-8551&author=L.+Zhangauthor=L.+Chenauthor=E.+M.+Beckauthor=T.+A.+Chappieauthor=R.+V.+Coelhoauthor=S.+Doranauthor=K.+%E2%80%93+H.+Fanauthor=C.+J.+Helalauthor=J.+M.+Humphreyauthor=Z.+Hughesauthor=K.+Kuszpitauthor=E.+A.+Lachapelleauthor=J.+T.+Lazzaroauthor=C.+Leeauthor=R.+J.+Matherauthor=N.+C.+Patelauthor=M.+B.+Skaddanauthor=S.+Sciabolaauthor=P.+R.+Verhoestauthor=J.+M.+Youngauthor=K.+Zasadnyauthor=A.+Villalobos&title=The+discovery+of+a+novel+phosphodiesterase+%28PDE%294B-preferring+radioligand+for+positron+emission+tomography+%28PET%29+imaging&doi=10.1021%2Facs.jmedchem.7b01050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01050%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DCoelho%26aufirst%3DR.%2BV.%26aulast%3DDoran%26aufirst%3DS.%26aulast%3DFan%26aufirst%3DK.%2B%25E2%2580%2593%2BH.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DHughes%26aufirst%3DZ.%26aulast%3DKuszpit%26aufirst%3DK.%26aulast%3DLachapelle%26aufirst%3DE.%2BA.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DSciabola%26aufirst%3DS.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DZasadny%26aufirst%3DK.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520of%2520a%2520novel%2520phosphodiesterase%2520%2528PDE%25294B-preferring%2520radioligand%2520for%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8538%26epage%3D8551%26doi%3D10.1021%2Facs.jmedchem.7b01050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varghese, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span> <span> </span><span class="NLM_article-title">Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2678</span>– <span class="NLM_lpage">2702</span>, <span class="refDoi"> DOI: 10.1021/jm501833t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501833t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2678-2702&author=C.+R.+Butlerauthor=M.+A.+Brodneyauthor=E.+M.+Beckauthor=G.+Barreiroauthor=C.+E.+Nolanauthor=F.+Panauthor=F.+Vajdosauthor=K.+Parrisauthor=A.+H.+Vargheseauthor=C.+J.+Helalauthor=R.+Liraauthor=S.+D.+Doranauthor=D.+R.+Riddellauthor=L.+M.+Buzonauthor=J.+K.+Dutraauthor=L.+A.+Martinez-Alsinaauthor=K.+Ogilvieauthor=J.+C.+Murrayauthor=J.+M.+Youngauthor=K.+Atchisonauthor=A.+Robshawauthor=C.+Gonzalesauthor=J.+Wangauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Discovery+of+a+series+of+efficient%2C+centrally+efficacious+BACE1+inhibitors+through+structure-based+drug+design&doi=10.1021%2Fjm501833t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design</span></div><div class="casAuthors">Butler, Christopher R.; Brodney, Michael A.; Beck, Elizabeth M.; Barreiro, Gabriela; Nolan, Charles E.; Pan, Feng; Vajdos, Felix; Parris, Kevin; Varghese, Alison H.; Helal, Christopher J.; Lira, Ricardo; Doran, Shawn D.; Riddell, David R.; Buzon, Leanne M.; Dutra, Jason K.; Martinez-Alsina, Luis A.; Ogilvie, Kevin; Murray, John C.; Young, Joseph M.; Atchison, Kevin; Robshaw, Ashley; Gonzales, Cathleen; Wang, Jinlong; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2678-2702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease (AD) has historically been thwarted by an inability to maintain alignment of potency, brain availability, and desired absorption, distribution, metab., and excretion (ADME) properties.  In this paper, the authors describe a series of truncated, fused thioamidines that are efficiently selective in garnering BACE1 activity without simultaneously inhibiting the closely related cathepsin D or neg. impacting brain penetration and ADME alignment, as exemplified by I.  Upon oral administration, these inhibitors exhibit robust brain availability and are efficacious in lowering central Amyloid β (Aβ) levels in mouse and dog.  In addn., chronic treatment in aged PS1/APP mice effects a decrease in the no. and size of Aβ-derived plaques.  Most importantly, evaluation of I in a 2-wk exploratory toxicol. study revealed no accumulation of autofluorescent material in retinal pigment epithelium or histol. findings in the eye, issues obsd. with earlier BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiNT62AGyml7Vg90H21EOLACvtfcHk0lhKg_lFR7M0fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D&md5=ac2a6fd661f7e9fd8b925deffd5e1010</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm501833t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501833t%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DVarghese%26aufirst%3DA.%2BH.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%2BA.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DRobshaw%26aufirst%3DA.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DDiscovery%2520of%2520a%2520series%2520of%2520efficient%252C%2520centrally%2520efficacious%2520BACE1%2520inhibitors%2520through%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2678%26epage%3D2702%26doi%3D10.1021%2Fjm501833t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalvass, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span> <span> </span><span class="NLM_article-title">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">338</span>, <span class="refDoi"> DOI: 10.1002/bdd.325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1002%2Fbdd.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=12415573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=327-338&author=J.+C.+Kalvassauthor=T.+S.+Maurer&title=Influence+of+nonspecific+brain+and+plasma+binding+on+CNS+exposure%3A+implications+for+rational+drug+discovery&doi=10.1002%2Fbdd.325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span></div><div class="casAuthors">Kalvass, J. Cory; Maurer, Tristan S.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">327-338</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Relative plasma, brain and cerebrospinal fluid (CSF) exposures and unbound fractions in plasma and brain were examd. for 18 proprietary compds. in rats.  The relation between in vivo brain-to-plasma ratio and in vitro plasma-to-brain unbound fraction (fu) was examd.  In addn., plasma fu and brain fu were examd. for their relation to in vivo CSF-to-plasma and CSF-to-brain ratios, resp.  Findings were delineated based on the presence or absence of active efflux.  Finally, the same comparisons were examd. in FVB vs. MDR 1a/1b knockout mice for a selected P-glycoprotein (Pgp) substrate.  For the nine compds. without indications of active efflux, predictive correlations were obsd. between ratios of brain-to-plasma exposure and plasma-to-brain fu (r2 = 0.98), CSF-to-brain exposure vs. brain fu (r2 = 0.72), and CSF-to-plasma exposure vs. plasma fu (r2 = 0.82).  For the nine compds. with indications of active efflux, nonspecific binding data tended to over predict the brain-to-plasma and CSF-to-plasma exposure ratios.  Interestingly, CSF-to-brain exposure ratio was consistently under predicted by brain fu for this set.  Using a select Pgp substrate, it was demonstrated that the brain-to-plasma exposure ratio was identical to that predicted by plasma-to-brain fu ratio in MDR 1a/1b knockout mice.  In FVB mice, plasma-to-brain fu over predicted brain-to-plasma exposure ratio to the same degree as the difference in brain-to-plasma exposure ratio between MDR 1a/1b and FVB mice.  Consistent results were obtained in rats, suggesting a similar kinetic behavior between species.  These data illustrate how an understanding of relative tissue binding (plasma, brain) can allow for a quant. examn. of active processes that det. CNS exposure.  The general applicability of this approach offers advantages over species- and mechanism-specific approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfFvLLvDQohLVg90H21EOLACvtfcHk0lh2E01nMA8dbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D&md5=96b80d1a745b254f74b9c19e8e8af627</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fbdd.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.325%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26atitle%3DInfluence%2520of%2520nonspecific%2520brain%2520and%2520plasma%2520binding%2520on%2520CNS%2520exposure%253A%2520implications%2520for%2520rational%2520drug%2520discovery%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2002%26volume%3D23%26spage%3D327%26epage%3D338%26doi%3D10.1002%2Fbdd.325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c','cit7d'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b','cit10c'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Lei Zhang, Christopher R. Butler, Kevin P. Maresca, Akihiro Takano, Sangram Nag, Zhisheng Jia, Ryosuke Arakawa, Justin R. Piro, Tarek Samad, Deborah L. Smith, Deane M. Nason, Steven O’Neil, Laura McAllister, Klaas Schildknegt, Patrick Trapa, Timothy J. McCarthy, Anabella Villalobos, <span class="NLM_string-name hlFld-ContribAuthor">Christer Halldin</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Development of an Irreversible Monoacylglycerol Lipase (MAGL) Positron Emission Tomography (PET) Radioligand with High Specificity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (18)
                                     , 8532-8543. <a href="https://doi.org/10.1021/acs.jmedchem.9b00847" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00847</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00847%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252BDevelopment%252Bof%252Ban%252BIrreversible%252BMonoacylglycerol%252BLipase%252B%252528MAGL%252529%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252BRadioligand%252Bwith%252BHigh%252BSpecificity%26aulast%3DZhang%26aufirst%3DLei%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24052019%26date%3D16092019%26date%3D04092019%26volume%3D62%26issue%3D18%26spage%3D8532%26epage%3D8543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Salvatore Bongarzone, <span class="NLM_string-name hlFld-ContribAuthor">Antony D. Gee</span>. </span><span class="cited-content_cbyCitation_article-title">BACE1: Now We Can See You. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3293-3295. <a href="https://doi.org/10.1021/acs.jmedchem.8b00474" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00474</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00474%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBACE1%25253A%252BNow%252BWe%252BCan%252BSee%252BYou%26aulast%3DBongarzone%26aufirst%3DSalvatore%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D26032018%26date%3D04042018%26volume%3D61%26issue%3D8%26spage%3D3293%26epage%3D3295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tauqeerunnisa  Syeda</span>, <span class="hlFld-ContribAuthor ">Jason R.  Cannon</span>. </span><span class="cited-content_cbyCitation_article-title">Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biochemical and Molecular Toxicology</span><span> <strong>2021,</strong> <em>35 </em>
                                    (4)
                                     <a href="https://doi.org/10.1002/jbt.22694" title="DOI URL">https://doi.org/10.1002/jbt.22694</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jbt.22694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjbt.22694%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biochemical%2520and%2520Molecular%2520Toxicology%26atitle%3DEnvironmental%252Bexposures%252Band%252Bthe%252Betiopathogenesis%252Bof%252BAlzheimer%252527s%252Bdisease%25253A%252BThe%252Bpotential%252Brole%252Bof%252BBACE1%252Bas%252Ba%252Bcritical%252Bneurotoxic%252Btarget%26aulast%3DSyeda%26aufirst%3DTauqeerunnisa%26date%3D2021%26date%3D2021%26volume%3D35%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yulong  Xu</span>, <span class="hlFld-ContribAuthor ">Changning  Wang</span>, <span class="hlFld-ContribAuthor ">Hsiao-Ying  Wey</span>, <span class="hlFld-ContribAuthor ">Yingxia  Liang</span>, <span class="hlFld-ContribAuthor ">Zude  Chen</span>, <span class="hlFld-ContribAuthor ">Se Hoon  Choi</span>, <span class="hlFld-ContribAuthor ">Chongzhao  Ran</span>, <span class="hlFld-ContribAuthor ">Kevin D.  Rynearson</span>, <span class="hlFld-ContribAuthor ">Daniela R.  Bernales</span>, <span class="hlFld-ContribAuthor ">Robert E.  Koegel</span>, <span class="hlFld-ContribAuthor ">Stephanie A.  Fiedler</span>, <span class="hlFld-ContribAuthor ">Robin  Striar</span>, <span class="hlFld-ContribAuthor ">Steven L.  Wagner</span>, <span class="hlFld-ContribAuthor ">Rudolph E.  Tanzi</span>, <span class="hlFld-ContribAuthor ">Can  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular imaging of Alzheimer’s disease–related gamma-secretase in mice and nonhuman primates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental Medicine</span><span> <strong>2020,</strong> <em>217 </em>
                                    (12)
                                     <a href="https://doi.org/10.1084/jem.20182266" title="DOI URL">https://doi.org/10.1084/jem.20182266</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1084/jem.20182266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1084%2Fjem.20182266%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520Medicine%26atitle%3DMolecular%252Bimaging%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%2525E2%252580%252593related%252Bgamma-secretase%252Bin%252Bmice%252Band%252Bnonhuman%252Bprimates%26aulast%3DXu%26aufirst%3DYulong%26date%3D2020%26date%3D2020%26volume%3D217%26issue%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, <span class="hlFld-ContribAuthor ">Harald  Hampel</span>, <span class="hlFld-ContribAuthor ">Simone  Lista</span>, <span class="hlFld-ContribAuthor ">Eugeen  Vanmechelen</span>, <span class="hlFld-ContribAuthor ">Henrik  Zetterberg</span>, <span class="hlFld-ContribAuthor ">Filippo Sean  Giorgi</span>, <span class="hlFld-ContribAuthor ">Alessandro  Galgani</span>, <span class="hlFld-ContribAuthor ">Kaj  Blennow</span>, <span class="hlFld-ContribAuthor ">Filippo  Caraci</span>, <span class="hlFld-ContribAuthor ">Brati  Das</span>, <span class="hlFld-ContribAuthor ">Riqiang  Yan</span>, <span class="hlFld-ContribAuthor ">Andrea  Vergallo</span>. </span><span class="cited-content_cbyCitation_article-title">β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification. </span><span class="cited-content_cbyCitation_journal-name">Alzheimer's Research & Therapy</span><span> <strong>2020,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13195-020-00686-3" title="DOI URL">https://doi.org/10.1186/s13195-020-00686-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13195-020-00686-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13195-020-00686-3%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%2527s%2520Research%2520%2526%2520Therapy%26atitle%3D%2525CE%2525B2-Secretase1%252Bbiological%252Bmarkers%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Bstate-of-art%252Bof%252Bvalidation%252Band%252Bqualification%26aulast%3DHampel%26aufirst%3DHarald%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryosuke  Arakawa</span>, <span class="hlFld-ContribAuthor ">Akihiro  Takano</span>, <span class="hlFld-ContribAuthor ">Per  Stenkrona</span>, <span class="hlFld-ContribAuthor ">Vladimir  Stepanov</span>, <span class="hlFld-ContribAuthor ">Sangram  Nag</span>, <span class="hlFld-ContribAuthor ">Mahabuba  Jahan</span>, <span class="hlFld-ContribAuthor ">Per  Grybäck</span>, <span class="hlFld-ContribAuthor ">Martin  Bolin</span>, <span class="hlFld-ContribAuthor ">Laigao  Chen</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Ping  He</span>, <span class="hlFld-ContribAuthor ">Anabella  Villalobos</span>, <span class="hlFld-ContribAuthor ">Timothy J.  McCarthy</span>, <span class="hlFld-ContribAuthor ">Christer  Halldin</span>, <span class="hlFld-ContribAuthor ">Andrea  Varrone</span>. </span><span class="cited-content_cbyCitation_article-title">PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [18F]PF-06684511. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2020,</strong> <em>47 </em>
                                    (10)
                                     , 2429-2439. <a href="https://doi.org/10.1007/s00259-020-04739-5" title="DOI URL">https://doi.org/10.1007/s00259-020-04739-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-020-04739-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-020-04739-5%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DPET%252Bimaging%252Bof%252Bbeta-secretase%252B1%252Bin%252Bthe%252Bhuman%252Bbrain%25253A%252Bradiation%252Bdosimetry%25252C%252Bquantification%25252C%252Band%252Btest-retest%252Bexamination%252Bof%252B%25255B18F%25255DPF-06684511%26aulast%3DArakawa%26aufirst%3DRyosuke%26date%3D2020%26date%3D2020%26volume%3D47%26issue%3D10%26spage%3D2429%26epage%3D2439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miren  Ettcheto</span>, <span class="hlFld-ContribAuthor ">Oriol  Busquets</span>, <span class="hlFld-ContribAuthor ">Triana  Espinosa-Jiménez</span>, <span class="hlFld-ContribAuthor ">Ester  Verdaguer</span>, <span class="hlFld-ContribAuthor ">Carme  Auladell</span>, <span class="hlFld-ContribAuthor ">Antoni  Camins</span>. </span><span class="cited-content_cbyCitation_article-title">A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2020,</strong> <em>26 </em>
                                    (12)
                                     , 1286-1299. <a href="https://doi.org/10.2174/1381612826666200211121416" title="DOI URL">https://doi.org/10.2174/1381612826666200211121416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612826666200211121416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612826666200211121416%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DA%252BChronological%252BReview%252Bof%252BPotential%252BDisease-Modifying%252BTherapeutic%252BStrategies%252Bfor%252BAlzheimer%252527s%252BDisease%26aulast%3DEttcheto%26aufirst%3DMiren%26date%3D2020%26volume%3D26%26issue%3D12%26spage%3D1286%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhidong  Xu</span>, <span class="hlFld-ContribAuthor ">Caihong  Miao</span>, <span class="hlFld-ContribAuthor ">Fugui  Dong</span>, <span class="hlFld-ContribAuthor ">Limeng  Jia</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Wenqing  Liu</span>, <span class="hlFld-ContribAuthor ">Qi-Huang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis of a carbon-11 labeled tetrahydrobenzisoxazole derivative as a new PET probe for γ-secretase imaging in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Applied Radiation and Isotopes</span><span> <strong>2020,</strong> <em>155 </em>, 108915. <a href="https://doi.org/10.1016/j.apradiso.2019.108915" title="DOI URL">https://doi.org/10.1016/j.apradiso.2019.108915</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apradiso.2019.108915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apradiso.2019.108915%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Radiation%2520and%2520Isotopes%26atitle%3DRadiosynthesis%252Bof%252Ba%252Bcarbon-11%252Blabeled%252Btetrahydrobenzisoxazole%252Bderivative%252Bas%252Ba%252Bnew%252BPET%252Bprobe%252Bfor%252B%2525CE%2525B3-secretase%252Bimaging%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3DXu%26aufirst%3DZhidong%26date%3D2020%26volume%3D155%26spage%3D108915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nalini  Schaduangrat</span>, <span class="hlFld-ContribAuthor ">Veda  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Saowapak  Choomwattana</span>, <span class="hlFld-ContribAuthor ">Prapimpun  Wongchitrat</span>, <span class="hlFld-ContribAuthor ">Kamonrat  Phopin</span>, <span class="hlFld-ContribAuthor ">Wilasinee  Suwanjang</span>, <span class="hlFld-ContribAuthor ">Aijaz Ahmad  Malik</span>, <span class="hlFld-ContribAuthor ">Bruno  Vincent</span>, <span class="hlFld-ContribAuthor ">Chanin  Nantasenamat</span>. </span><span class="cited-content_cbyCitation_article-title">Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (5)
                                     , 1730-1778. <a href="https://doi.org/10.1002/med.21563" title="DOI URL">https://doi.org/10.1002/med.21563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21563%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMultidisciplinary%252Bapproaches%252Bfor%252Btargeting%252Bthe%252Bsecretase%252Bprotein%252Bfamily%252Bas%252Ba%252Btherapeutic%252Broute%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DSchaduangrat%26aufirst%3DNalini%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D5%26spage%3D1730%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akihiro  Takano</span>, <span class="hlFld-ContribAuthor ">Laigao  Chen</span>, <span class="hlFld-ContribAuthor ">Sangram  Nag</span>, <span class="hlFld-ContribAuthor ">Michael A.  Brodney</span>, <span class="hlFld-ContribAuthor ">Ryosuke  Arakawa</span>, <span class="hlFld-ContribAuthor ">Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Nahid  Amini</span>, <span class="hlFld-ContribAuthor ">Shawn D.  Doran</span>, <span class="hlFld-ContribAuthor ">Jason K.  Dutra</span>, <span class="hlFld-ContribAuthor ">Timothy J.  McCarthy</span>, <span class="hlFld-ContribAuthor ">Charles E.  Nolan</span>, <span class="hlFld-ContribAuthor ">Brian T.  O’Neill</span>, <span class="hlFld-ContribAuthor ">Anabella  Villalobos</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Christer  Halldin</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative Analysis of
              18
              F-PF-06684511, a Novel PET Radioligand for Selective β-Secretase 1 Imaging, in Nonhuman Primate Brain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2019,</strong> <em>60 </em>
                                    (7)
                                     , 992-997. <a href="https://doi.org/10.2967/jnumed.118.217372" title="DOI URL">https://doi.org/10.2967/jnumed.118.217372</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.118.217372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.118.217372%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DQuantitative%252BAnalysis%252Bof%252B18%252BF-PF-06684511%25252C%252Ba%252BNovel%252BPET%252BRadioligand%252Bfor%252BSelective%252B%2525CE%2525B2-Secretase%252B1%252BImaging%25252C%252Bin%252BNonhuman%252BPrimate%252BBrain%26aulast%3DTakano%26aufirst%3DAkihiro%26date%3D2019%26date%3D2018%26volume%3D60%26issue%3D7%26spage%3D992%26epage%3D997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob M.  Hooker</span>, <span class="hlFld-ContribAuthor ">Richard E.  Carson</span>. </span><span class="cited-content_cbyCitation_article-title">Human Positron Emission Tomography Neuroimaging. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Biomedical Engineering</span><span> <strong>2019,</strong> <em>21 </em>
                                    (1)
                                     , 551-581. <a href="https://doi.org/10.1146/annurev-bioeng-062117-121056" title="DOI URL">https://doi.org/10.1146/annurev-bioeng-062117-121056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-bioeng-062117-121056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-bioeng-062117-121056%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Biomedical%2520Engineering%26atitle%3DHuman%252BPositron%252BEmission%252BTomography%252BNeuroimaging%26aulast%3DHooker%26aufirst%3DJacob%2BM.%26date%3D2019%26volume%3D21%26issue%3D1%26spage%3D551%26epage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. A rational and cost-effective CNS PET ligand discovery process.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Profile of <b>1</b> and binding studies of [<sup>3</sup>H]<b>1</b>: (A) saturation binding of [<sup>3</sup>H]<b>1</b> in brain frontal cortex homogenates of wild-type (WT), BACE1 heterozygous knockout (KO) and BACE1 homozygous KO mice; (B) BACE1 expression (<i>B</i><sub>max</sub>) and <i>K</i><sub>d</sub> determination in WT mice frontal cortex homogenate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. BACE1 PET ligand triaging based on CNS PET ligand design parameters.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 5-hydroxypyrazine-2-carboxylic acid, HBTU, DIPEA, DMF, rt, 34%; (b) [<sup>3</sup>H]CH<sub>3</sub>I, Ag<sub>2</sub>CO<sub>3</sub>, CHCl<sub>3</sub>, rt; (c) TFA, DCM, rt, 80 Ci/mmol specific activity, >99% radiochemical purity.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HCO<sub>2</sub>H (neat), 0 °C to rt; (b) LiOH, THF/H<sub>2</sub>O (1/1 v/v), rt; (c) perfluorobutanesulfonyl fluoride (NfF), Et<sub>3</sub>N·3HF, Et<sub>3</sub>N, THF, 0–40 °C, 52% for 3 steps; (d) NaN<sub>3</sub>, <i>N</i>,<i>N</i>′-dimethylcyclohexane-1, 2-diamine, sodium <span class="smallcaps smallerCapital">l</span>-ascorbate, CuI, EtOH/H<sub>2</sub>O (3/1 v/v), 70 °C, 72%; (e) 5-methoxypyrazine-2-carboxylic acid, HATU, DIPEA, CH<sub>3</sub>CN, rt, 93%; (f) DBU, MeOH, 60 °C, 77%.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaN<sub>3</sub>, <i>N</i>,<i>N</i>′-dimethylcyclohexane-1, 2-diamine, sodium <span class="smallcaps smallerCapital">l</span>-ascorbate, CuI, EtOH/H<sub>2</sub>O (3.5/1 v/v), 70 °C; (b) 5-methoxypyrazine-2-carboxylic acid, propane phosphonic acid anhydride (T3P), pyridine, DCM, rt, 41% over two steps; (c) HCO<sub>2</sub>H (neat), 0 °C to rt; (d) LiOH, THF/H<sub>2</sub>O (1/1 v/v), rt, quantitative yield; (e) DBU, MeOH, 60 °C; (f) Boc<sub>2</sub>O, Et<sub>3</sub>N, THF, 60 °C, 58% over two steps; (g) TsCl, DIPEA, DMAP, DCM, rt, 56%; (h) [<sup>18</sup>F]fluoride/kryptofix 222, DMSO, 150 °C, 5 min, followed by 1.5 M HCl, 100 °C, 3 min, 4% and 7% radiochemical yield (>99% purity), 187 and 417 MBq of delivered radioactivity, and 84 and 175 GBq/μmol of specific radioactivity at the time of injection.</p></p></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo specific binding assessment of <b>2</b> and <b>3</b> in male 129/sve mice using LC-MS/MS “cold tracer” method. (A) Distribution of <b>2</b> in cerebellum, frontal cortex, hippocampus, striatum, and plasma, pretreated with either vehicle or BACE1 inhibitor A<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (100 mg/kg, SC) 60 min prior to ligand administration. (B) Distribution of <b>3</b> in cerebellum, frontal cortex, hippocampus, striatum, and plasma, pretreated with either vehicle or BACE1 inhibitor B<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (1, 10, 80 mg/kg, SC) 60 min prior to ligand administration. For both studies, brain tissues and plasma were collected at 45 min post administration (<i>n</i> = 5 per animal group) at which the highest brain tissue/plasma ratios were achieved for <b>2</b> and <b>3</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01769/suppl_file/jm7b01769_si_001.pdf" class="ext-link">Supporting Information</a>, section 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo specific binding assessment of <b>3</b> in BACE1 WT and KO mice, using LC-MS/MS “cold tracer” method: four brain regions (cerebellum, frontal cortex, hippocampus, and striatum) and plasma were collected at 45 min post administration (<i>n</i> = 5 per animal group).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. MRI (A) and PET images of [<sup>18</sup>F]<b>3</b> in NHP summed from 32 to 180 min under (B) baseline and (C) blocking (pretreatment with a BACE1 inhibitor, LY2886721, 5 mg/kg, PO) conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/medium/jm-2017-017697_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Standardized uptake values (SUVs) of [<sup>18</sup>F]<b>3</b> in representative brain regions under baseline and blocking conditions. CB, cerebellum; ACC, anterior cingulate cortex; FC, frontal cortex; TC, temporal cortex; CAU, caudate; PUT, putamen; THA, thalamus; OC, occipital cortex; PC, parietal cortex; AMY, amygdala; HIP, hippocampus.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-8/acs.jmedchem.7b01769/20180420/images/large/jm-2017-017697_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01769&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88657" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88657" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 29 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span> <i>2012
Alzheimer’s Disease facts and figures</i>; <span class="NLM_publisher-name">Alzheimer’s Association</span>: <span class="NLM_publisher-loc">Washington
DC</span>, <span class="NLM_year">2012</span>; <a href="https://www.alz.org/downloads/facts_figures_2012.pdf" class="extLink">https://www.alz.org/downloads/facts_figures_2012.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+2012%0AAlzheimer%E2%80%99s+Disease+facts+and+figures%3B+Alzheimer%E2%80%99s+Association%3A+Washington%0ADC%2C+2012%3B+https%3A%2F%2Fwww.alz.org%2Fdownloads%2Ffacts_figures_2012.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3D2012%250AAlzheimer%25E2%2580%2599s%2520Disease%2520facts%2520and%2520figures%26pub%3DAlzheimer%25E2%2580%2599s%2520Association%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morstorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, K.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease drug-development pipeline: few candidates, frequent failures</span>. <i>Alzheimer’s Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">37</span>, <span class="refDoi"> DOI: 10.1186/alzrt269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1186%2Falzrt269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=25024750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=37&author=J.+L.+Cummingsauthor=T.+Morstorfauthor=K.+Zhong&title=Alzheimer%E2%80%99s+disease+drug-development+pipeline%3A+few+candidates%2C+frequent+failures&doi=10.1186%2Falzrt269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease drug-development pipeline: few candidates, frequent failures</span></div><div class="casAuthors">Cummings Jeffrey L; Zhong Kate; Morstorf Travis</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    </div><div class="casAbstract">INTRODUCTION:  Alzheimer's disease (AD) is increasing in frequency as the global population ages.  Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist.  We have an urgent need to find new therapies for AD.  METHODS:  We examined Clinicaltrials.gov, a public website that records ongoing clinical trials.  We examined the decade of 2002 to 2012, to better understand AD-drug development.  We reviewed trials by sponsor, sites, drug mechanism of action, duration, number of patients required, and rate of success in terms of advancement from one phase to the next.  We also reviewed the current AD therapy pipeline.  RESULTS:  During the 2002 to 2012 observation period, 413 AD trials were performed: 124 Phase 1 trials, 206 Phase 2 trials, and 83 Phase 3 trials.  Seventy-eight percent were sponsored by pharmaceutical companies.  The United States of America (U.S.) remains the single world region with the greatest number of trials; cumulatively, more non-U.S. than U.S. trials are performed.  The largest number of registered trials addressed symptomatic agents aimed at improving cognition (36.6%), followed by trials of disease-modifying small molecules (35.1%) and trials of disease-modifying immunotherapies (18%).  The mean length of trials increases from Phase 2 to Phase 3, and the number of participants in trials increases between Phase 2 and Phase 3.  Trials of disease-modifying agents are larger and longer than those for symptomatic agents.  A very high attrition rate was found, with an overall success rate during the 2002 to 2012 period of 0.4% (99.6% failure).  CONCLUSIONS:  The Clinicaltrials.gov database demonstrates that relatively few clinical trials are undertaken for AD therapeutics, considering the magnitude of the problem.  The success rate for advancing from one phase to another is low, and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area.  The AD drug-development ecosystem requires support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__DMPwHFhGGPgL4LrC-0VfW6udTcc2eYtZ0MiX73mObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D&md5=85b84800ce02d7031a4c1046e837e568</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1186%2Falzrt269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt269%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DMorstorf%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DK.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520drug-development%2520pipeline%253A%2520few%2520candidates%252C%2520frequent%2520failures%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D37%26doi%3D10.1186%2Falzrt269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangialasche, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreasen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacobini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantua, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecocci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winblad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kivipelto, M.</span></span> <span> </span><span class="NLM_article-title">Clinical trials and late-stage drug development for Alzheimer’s disease: an appraisal from 1984 to 2014</span>. <i>J. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1111/joim.12191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1111%2Fjoim.12191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=24605808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A280%3ADC%252BC2crhsFaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2014&pages=251-283&author=L.+S.+Schneiderauthor=F.+Mangialascheauthor=N.+Andreasenauthor=H.+Feldmanauthor=E.+Giacobiniauthor=R.+Jonesauthor=V.+Mantuaauthor=P.+Mecocciauthor=L.+Paniauthor=B.+Winbladauthor=M.+Kivipelto&title=Clinical+trials+and+late-stage+drug+development+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+from+1984+to+2014&doi=10.1111%2Fjoim.12191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014</span></div><div class="casAuthors">Schneider L S; Mangialasche F; Andreasen N; Feldman H; Giacobini E; Jones R; Mantua V; Mecocci P; Pani L; Winblad B; Kivipelto M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of internal medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The modern era of drug development for Alzheimer's disease began with the proposal of the cholinergic hypothesis of memory impairment and the 1984 research criteria for Alzheimer's disease.  Since then, despite the evaluation of numerous potential treatments in clinical trials, only four cholinesterase inhibitors and memantine have shown sufficient safety and efficacy to allow marketing approval at an international level.  Although this is probably because the other drugs tested were ineffective, inadequate clinical development methods have also been blamed for the failures.  Here, we review the development of treatments for Alzheimer's disease during the past 30 years, considering the drugs, potential targets, late-stage clinical trials, development methods, emerging use of biomarkers and evolution of regulatory considerations in order to summarize advances and anticipate future developments.  We have considered late-stage Alzheimer's disease drug development from 1984 to 2013, including individual clinical trials, systematic and qualitative reviews, meta-analyses, methods, commentaries, position papers and guidelines.  We then review the evolution of drugs in late clinical development, methods, biomarkers and regulatory issues.  Although a range of small molecules and biological products against many targets have been investigated in clinical trials, the predominant drug targets have been the cholinergic system and the amyloid cascade.  Trial methods have evolved incrementally: inclusion criteria have largely remained focused on mild-to-moderate Alzheimer's disease criteria, recently extending to early or prodromal Alzheimer disease or 'mild cognitive impairment due to Alzheimer's disease', for drugs considered to be disease modifying.  The duration of trials has remained at 6-12 months for drugs intended to improve symptoms; 18- to 24-month trials have been established for drugs expected to attenuate clinical course.  Cognitive performance, activities of daily living, global change and severity ratings have persisted as the primary clinically relevant outcomes.  Regulatory guidance and oversight have evolved to allow for enrichment of early-stage Alzheimer's disease trial samples using biomarkers and phase-specific outcomes.  In conclusion, validated drug targets for Alzheimer's disease remain to be developed.  Only drugs that affect an aspect of cholinergic function have shown consistent, but modest, clinical effects in late-phase trials.  There is opportunity for substantial improvements in drug discovery and clinical development methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSiLqeiU50WDCA3UY9EwTNrfW6udTcc2ebgzQv4X4XeKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crhsFaqug%253D%253D&md5=7e34762560c7cb2ce25084827c348cdc</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1111%2Fjoim.12191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjoim.12191%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DL.%2BS.%26aulast%3DMangialasche%26aufirst%3DF.%26aulast%3DAndreasen%26aufirst%3DN.%26aulast%3DFeldman%26aufirst%3DH.%26aulast%3DGiacobini%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DMantua%26aufirst%3DV.%26aulast%3DMecocci%26aufirst%3DP.%26aulast%3DPani%26aufirst%3DL.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DKivipelto%26aufirst%3DM.%26atitle%3DClinical%2520trials%2520and%2520late-stage%2520drug%2520development%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520from%25201984%2520to%25202014%26jtitle%3DJ.%2520Intern.%2520Med.%26date%3D2014%26volume%3D275%26spage%3D251%26epage%3D283%26doi%3D10.1111%2Fjoim.12191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nordberg, A.</span></span> <span> </span><span class="NLM_article-title">PET imaging of amyloid in Alzheimer’s disease</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">527</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(04)00853-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1016%2FS1474-4422%2804%2900853-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=15324720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFKjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=519-527&author=A.+Nordberg&title=PET+imaging+of+amyloid+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS1474-4422%2804%2900853-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">PET imaging of amyloid in Alzheimer's disease</span></div><div class="casAuthors">Nordberg, Agneta</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">519-527</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Lancet Neurology</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia and is characterized by progressive impairment in cognitive function and behavior.  The pathol. features of AD include neuritic plaques composed of amyloid-β peptide (Aβ) fibrils, neurofibrillary tangles of hyperphosphorylated tau, and neurotransmitter deficits.  Increases in the concn. of Aβ in the course of the disease with subtle effects on synaptic efficacy will lead to gradual increase in the load of amyloid plaques and progression in cognitive impairment.  Direct imaging of amyloid load in patients with AD in vivo would be very useful for the early diagnosis of AD and the development and assessment of new treatment strategies.  Three different strategies are being used to develop compds. suitable for in vivo imaging of amyloid deposits in human brains.  Monoclonal antibodies against Aβ and peptide fragments have had limited uptake by the brain when tested in patients with AD.  When putrescine-gadolinium-Aβ has been injected into transgenic mice overexpressing amyloid, labeling has been obsd. with MRI.  The small mol. approach for amyloid imaging has so far been most successful.  The binding of different derivs. of Congo red and thioflavin has been studied in human autopsy brain tissue and in transgenic mice.  Two compds., fluorine-18-labeled-FDDNP and carbon-11-labeled-PIB , both show more binding in the brains of patients with AD than in those of healthy people.  Addnl. compds. will probably be developed that are suitable not only for PET but also for single photon emission CT (SPECT).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtXFlYIU0ZiLVg90H21EOLACvtfcHk0lgKjGv2XafLiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFKjtL4%253D&md5=63b16473fbf8954c74566fda57fd9e71</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2804%2900853-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252804%252900853-1%26sid%3Dliteratum%253Aachs%26aulast%3DNordberg%26aufirst%3DA.%26atitle%3DPET%2520imaging%2520of%2520amyloid%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%2520Neurol.%26date%3D2004%26volume%3D3%26spage%3D519%26epage%3D527%26doi%3D10.1016%2FS1474-4422%2804%2900853-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Landau, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurfjell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margolin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontecorvo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagust, W. J.</span></span> <span> </span><span class="NLM_article-title">Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1398</span>– <span class="NLM_lpage">1407</span>, <span class="refDoi"> DOI: 10.1007/s00259-014-2753-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1007%2Fs00259-014-2753-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=24647577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslSqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=1398-1407&author=S.+M.+Landauauthor=B.+A.+Thomasauthor=L.+Thurfjellauthor=M.+Schmidtauthor=R.+Margolinauthor=M.+Mintunauthor=M.+Pontecorvoauthor=S.+L.+Bakerauthor=W.+J.+Jagust&title=Amyloid+PET+imaging+in+Alzheimer%E2%80%99s+disease%3A+a+comparison+of+three+radiotracers&doi=10.1007%2Fs00259-014-2753-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers</span></div><div class="casAuthors">Landau, S. M.; Thomas, B. A.; Thurfjell, L.; Schmidt, M.; Margolin, R.; Mintun, M.; Pontecorvo, M.; Baker, S. L.; Jagust, W. J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1398-1407</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: The increasing use of amyloid PET in Alzheimer's disease research and clin. trials has motivated efforts to standardize methodol.  We compared retention of the 11C radiotracer Pittsburgh Compd. B (PiB) and that of two 18F amyloid radiotracers (florbetapir and flutemetamol) using two study populations.  We also examd. the feasibility of converting between tracer-specific measures, using PiB as the common link between the two 18F tracers.  Methods: One group of 40 subjects underwent PiB and flutemetamol imaging sessions and a sep. group of 32 subjects underwent PiB and florbetapir imaging sessions.  We compared cortical and white matter retention for each 18F tracer relative to that of PiB, as well as retention in several ref. regions and image anal. methods.  Correlations between tracer pairs were used to convert tracer-specific threshold values for amyloid positivity between tracers.  Results: Cortical retention for each pair of tracers was strongly correlated regardless of ref. region (PiB-flutemetamol, ρ = 0.84-0.99; PiB-florbetapir, ρ = 0.83-0.97) and anal. method (ρ = 0.90-0.99).  Compared to PiB, flutemetamol had higher white matter retention, while florbetapir had lower cortical retention.  Two previously established independent thresholds for amyloid positivity were highly consistent when values were converted between tracer pairs.  Conclusion: Despite differing white and gray matter retention characteristics, cortical retention for each 18F tracer was highly correlated with that of PiB, enabling conversion of thresholds across tracer measurement scales with a high level of internal consistency.  Standardization of anal. methods and measurement scales may facilitate the comparison of amyloid PET data obtained using different tracers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn78zTuzp6drVg90H21EOLACvtfcHk0lgKjGv2XafLiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslSqu7o%253D&md5=dec3dc2c6e9eed9370697afa921ea999</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1007%2Fs00259-014-2753-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-014-2753-3%26sid%3Dliteratum%253Aachs%26aulast%3DLandau%26aufirst%3DS.%2BM.%26aulast%3DThomas%26aufirst%3DB.%2BA.%26aulast%3DThurfjell%26aufirst%3DL.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DMargolin%26aufirst%3DR.%26aulast%3DMintun%26aufirst%3DM.%26aulast%3DPontecorvo%26aufirst%3DM.%26aulast%3DBaker%26aufirst%3DS.%2BL.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26atitle%3DAmyloid%2520PET%2520imaging%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520comparison%2520of%2520three%2520radiotracers%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2014%26volume%3D41%26spage%3D1398%26epage%3D1407%26doi%3D10.1007%2Fs00259-014-2753-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Okamura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudo, Y.</span></span> <span> </span><span class="NLM_article-title">Tau PET imaging in Alzheimer’s disease</span>. <i>Curr. Neurol. Neurosci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">500</span>, <span class="refDoi"> DOI: 10.1007/s11910-014-0500-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1007%2Fs11910-014-0500-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=25239654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A280%3ADC%252BC2M7jsFSrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=500&author=N.+Okamuraauthor=R.+Haradaauthor=S.+Furumotoauthor=H.+Araiauthor=K.+Yanaiauthor=Y.+Kudo&title=Tau+PET+imaging+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs11910-014-0500-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Tau PET imaging in Alzheimer's disease</span></div><div class="casAuthors">Okamura Nobuyuki; Harada Ryuichi; Furumoto Shozo; Arai Hiroyuki; Yanai Kazuhiko; Kudo Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Current neurology and neuroscience reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">500</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In several neurodegenerative diseases that are collectively called tauopathies, progressive accumulation of tau in the brain is closely associated with neurodegeneration and cognitive impairment.  Noninvasive detection of tau protein deposits in the brain would be useful to diagnose tauopathies as well as to track and predict disease progression.  Recently, several tau PET tracers including T807, THK-5117, and PBB3 have been developed and succeeded in imaging neurofibrillary pathology in vivo.  For use of tau PET as a biomarker of tau pathology in Alzheimer's disease, PET tracers should have high affinity to PHF-tau and high selectivity for tau over amyloid-β and other protein deposits.  PET tau imaging enables the longitudinal assessment of the spatial pattern of tau deposition and its relation to amyloid-β pathology and neurodegeneration.  This technology could also be applied to the pharmacological assessment of anti-tau therapy, thereby allowing preventive interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTy6LVoglwXzIqdXsLcGTEUfW6udTcc2ebOS4djWQFaqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7jsFSrtA%253D%253D&md5=343715c63553be883942f9829da91648</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1007%2Fs11910-014-0500-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11910-014-0500-6%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DTau%2520PET%2520imaging%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Neurol.%2520Neurosci.%2520Rep.%26date%3D2014%26volume%3D14%26spage%3D500%26doi%3D10.1007%2Fs11910-014-0500-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">James, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doraiswamy, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges-Neto, S.</span></span> <span> </span><span class="NLM_article-title">PET imaging of Tau pathology in Alzheimer’s disease and tauopathies</span>. <i>Front. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">38</span>, <span class="refDoi"> DOI: 10.3389/fneur.2015.00038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.3389%2Ffneur.2015.00038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=25806018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A280%3ADC%252BC2MnnslShsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=38&author=O.+G.+Jamesauthor=P.+M.+Doraiswamyauthor=S.+Borges-Neto&title=PET+imaging+of+Tau+pathology+in+Alzheimer%E2%80%99s+disease+and+tauopathies&doi=10.3389%2Ffneur.2015.00038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies</span></div><div class="casAuthors">James Olga G; Borges-Neto Salvador; Doraiswamy P Murali</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38</span>
        ISSN:<span class="NLM_cas:issn">1664-2295</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbDjuDw8SFIcNIRw0GKUoEfW6udTcc2ebOS4djWQFaqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnnslShsw%253D%253D&md5=c75d0949921acd9a9e90102a77d3aed8</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.3389%2Ffneur.2015.00038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffneur.2015.00038%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DO.%2BG.%26aulast%3DDoraiswamy%26aufirst%3DP.%2BM.%26aulast%3DBorges-Neto%26aufirst%3DS.%26atitle%3DPET%2520imaging%2520of%2520Tau%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520tauopathies%26jtitle%3DFront.%2520Neurol.%26date%3D2015%26volume%3D6%26spage%3D38%26doi%3D10.3389%2Ffneur.2015.00038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Holsinger, R. M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mclean, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyreuther, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evin, G.</span></span> <span> </span><span class="NLM_article-title">Increased expression of the amyloid precursor β-secretase in Alzheimer’s disease</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">783</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.1002/ana.10208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1002%2Fana.10208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=12112088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFygsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=783-786&author=R.+M.+D.+Holsingerauthor=C.+A.+Mcleanauthor=K.+Beyreutherauthor=C.+L.+Mastersauthor=G.+Evin&title=Increased+expression+of+the+amyloid+precursor+%CE%B2-secretase+in+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fana.10208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Increased expression of the amyloid precursor β-secretase in Alzheimer's disease</span></div><div class="casAuthors">Holsinger, R. M. Damian; McLean, Catriona A.; Beyreuther, Konrad; Masters, Colin L.; Evin, Genevieve</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">783-786</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">β-Secretase cleavage represents the first step in the generation of Aβ polypeptides and initiates the amyloid cascade that leads to neurodegeneration in Alzheimer's disease.  By comparative Western blot anal., we show a 2.7-fold increase in protein expression of the β-secretase enzyme BACE in the brain cortex of Alzheimer's disease patients as compared to age-matched controls.  Similarly, we found the levels of the amyloid precursor protein C-terminal fragment produced by β-secretase to be increased by nearly twofold in Alzheimer's disease cortex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVtXq-CrHcL7Vg90H21EOLACvtfcHk0lgYPiYz0Tbl0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFygsbc%253D&md5=f32e2584bd55943b63780659238be0f8</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1002%2Fana.10208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.10208%26sid%3Dliteratum%253Aachs%26aulast%3DHolsinger%26aufirst%3DR.%2BM.%2BD.%26aulast%3DMclean%26aufirst%3DC.%2BA.%26aulast%3DBeyreuther%26aufirst%3DK.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DEvin%26aufirst%3DG.%26atitle%3DIncreased%2520expression%2520of%2520the%2520amyloid%2520precursor%2520%25CE%25B2-secretase%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2002%26volume%3D51%26spage%3D783%26epage%3D786%26doi%3D10.1002%2Fana.10208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyman, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irizarry, M. C.</span></span> <span> </span><span class="NLM_article-title">β-Secretase protein and activity are increased in the neocortex in Alzheimer disease</span>. <i>Arch. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1381</span>– <span class="NLM_lpage">1389</span>, <span class="refDoi"> DOI: 10.1001/archneur.59.9.1381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1001%2Farchneur.59.9.1381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=12223024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A280%3ADC%252BD38vmsVSgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2002&pages=1381-1389&author=H.+Fukumotoauthor=B.+S.+Cheungauthor=B.+T.+Hymanauthor=M.+C.+Irizarry&title=%CE%B2-Secretase+protein+and+activity+are+increased+in+the+neocortex+in+Alzheimer+disease&doi=10.1001%2Farchneur.59.9.1381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease</span></div><div class="casAuthors">Fukumoto Hiroaki; Cheung Bonnie S; Hyman Bradley T; Irizarry Michael C</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1381-9</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">CONTEXT:  Amyloid plaques, a major pathological feature of Alzheimer disease (AD), are composed of an internal fragment of amyloid precursor protein (APP): the 4-kd amyloid-beta protein (Abeta).  The metabolic processing of APP that results in Abeta formation requires 2 enzymatic cleavage events, a gamma-secretase cleavage dependent on presenilin, and a beta-secretase cleavage by the aspartyl protease beta-site APP-cleaving enzyme (BACE).  OBJECTIVE:  To test the hypothesis that BACE protein and activity are increased in regions of the brain that develop amyloid plaques in AD.  METHODS:  We developed an antibody capture system to measure BACE protein level and BACE-specific beta-secretase activity in frontal, temporal, and cerebellar brain homogenates from 61 brains with AD and 33 control brains.  RESULTS:  In the brains with AD, BACE activity and protein were significantly increased (P<.001).  Enzymatic activity increased by 63% in the temporal neocortex (P =.007) and 13% in the frontal neocortex (P =.003) in brains with AD, but not in the cerebellar cortex.  Activity in the temporal neocortex increased with the duration of AD (P =.008) but did not correlate with enzyme-linked immunosorbent assay measures of insoluble Abeta in brains with AD.  Protein level was increased by 14% in the frontal cortex of brains with AD (P =.004), with a trend toward a 15% increase in BACE protein in the temporal cortex (P =.07) and no difference in the cerebellar cortex.  Immunohistochemical analysis demonstrated that BACE immunoreactivity in the brain was predominantly neuronal and was found in tangle-bearing neurons in AD.  CONCLUSIONS:  The BACE protein and activity levels are increased in brain regions affected by amyloid deposition and remain increased despite significant neuronal and synaptic loss in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRYMw94XiaQ6m52AMpI4GK2fW6udTcc2ea5iHku0h-M1Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38vmsVSgtw%253D%253D&md5=f58eb1b75c74900ed8b8ece5ba4128a7</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1001%2Farchneur.59.9.1381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.59.9.1381%26sid%3Dliteratum%253Aachs%26aulast%3DFukumoto%26aufirst%3DH.%26aulast%3DCheung%26aufirst%3DB.%2BS.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DIrizarry%26aufirst%3DM.%2BC.%26atitle%3D%25CE%25B2-Secretase%2520protein%2520and%2520activity%2520are%2520increased%2520in%2520the%2520neocortex%2520in%2520Alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2002%26volume%3D59%26spage%3D1381%26epage%3D1389%26doi%3D10.1001%2Farchneur.59.9.1381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasvoina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maus, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">β-Site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer’s disease pathogenesis</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3639</span>– <span class="NLM_lpage">3649</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.4396-06.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1523%2FJNEUROSCI.4396-06.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=17409228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFSlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=3639-3649&author=J.+Zhaoauthor=Y.+Fuauthor=M.+Yasvoinaauthor=P.+Shaoauthor=B.+Hittauthor=T.+O%E2%80%99Connorauthor=S.+Loganauthor=E.+Mausauthor=M.+Citronauthor=R.+Berryauthor=L.+Binderauthor=R.+Vassar&title=%CE%B2-Site+amyloid+precursor+protein+cleaving+enzyme+1+levels+become+elevated+in+neurons+around+amyloid+plaques%3A+implications+for+Alzheimer%E2%80%99s+disease+pathogenesis&doi=10.1523%2FJNEUROSCI.4396-06.2007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">β-Site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis</span></div><div class="casAuthors">Zhao, Jie; Fu, Yifan; Yasvoina, Marina; Shao, Peizhen; Hitt, Brian; O'Connor, Tracy; Logan, Sreemathi; Maus, Erika; Citron, Martin; Berry, Robert; Binder, Lester; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3639-3649</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) (β-secretase) initiates generation of β-amyloid (Aβ), which plays an early role in Alzheimer's disease (AD).  BACE1 levels are increased in postmortem AD brain, suggesting BACE1 elevation promotes Aβ prodn. and AD.  Alternatively, the BACE1 increase may be an epiphenomenon of late-stage AD.  To distinguish between these possibilities, we analyzed BACE1 elevation using a highly specific BACE1 antibody, BACE-Cat1, made in BACE1-/- mice, which mount a robust anti-BACE1 immune response.  Previous BACE1 immunohistochem. studies lack consistent results because typical BACE1 antibodies produce nonspecific background, but BACE-Cat1 immunolabels BACE1 only.  BACE1 elevation was recapitulated in two amyloid precursor protein (APP) transgenic mouse lines.  5XFAD mice form amyloid plaques at young ages and exhibit neuron loss.  In contrast, Tg2576 form plaques at a more advanced age and do not show cell death.  These two mouse lines allow differentiation between early Aβ-induced events and late phenomena related to neuron death.  BACE1 levels became elevated in parallel with amyloid burden in each APP transgenic, starting early in 5XFAD and late in Tg2576.  The increase in BACE1 protein occurred without any change in BACE1 mRNA level, indicating a posttranscriptional mechanism.  In APP transgenic and AD brains, high BACE1 levels were obsd. in an annulus around Aβ42-pos. plaque cores and colocalized with neuronal proteins.  These results demonstrate that amyloid plaques induce BACE1 in surrounding neurons at early stages of pathol. before neuron death occurs.  We conclude that BACE1 elevation is most likely triggered by the amyloid pathway and may drive a pos.-feedback loop in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVszRExZJjYLVg90H21EOLACvtfcHk0ljcqhaxMS-kDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFSlu7Y%253D&md5=9f4866fa5aa4d0a860c8e95e871dd84f</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4396-06.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4396-06.2007%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DYasvoina%26aufirst%3DM.%26aulast%3DShao%26aufirst%3DP.%26aulast%3DHitt%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DT.%26aulast%3DLogan%26aufirst%3DS.%26aulast%3DMaus%26aufirst%3DE.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DBerry%26aufirst%3DR.%26aulast%3DBinder%26aufirst%3DL.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3D%25CE%25B2-Site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520levels%2520become%2520elevated%2520in%2520neurons%2520around%2520amyloid%2520plaques%253A%2520implications%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520pathogenesis%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D3639%26epage%3D3649%26doi%3D10.1523%2FJNEUROSCI.4396-06.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadleir, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandalepas, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buggia-Prévot, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinakaran, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1007/s00401-016-1558-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1007%2Fs00401-016-1558-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=26993139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVOgs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2016&pages=235-256&author=K.+R.+Sadleirauthor=P.+C.+Kandalepasauthor=V.+Buggia-Pr%C3%A9votauthor=D.+A.+Nicholsonauthor=G.+Thinakaranauthor=R.+Vassar&title=Presynaptic+dystrophic+neurites+surrounding+amyloid+plaques+are+sites+of+microtubule+disruption%2C+BACE1+elevation%2C+and+increased+A%CE%B2+generation+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00401-016-1558-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease</span></div><div class="casAuthors">Sadleir, Katherine R.; Kandalepas, Patty C.; Buggia-Prevot, Virginie; Nicholson, Daniel A.; Thinakaran, Gopal; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-256</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by amyloid plaques composed of the β-amyloid (Aβ) peptide surrounded by swollen presynaptic dystrophic neurites consisting of dysfunctional axons and terminals that accumulate the β-site amyloid precursor protein (APP) cleaving enzyme (BACE1) required for Aβ generation.  The cellular and mol. mechanisms that govern presynaptic dystrophic neurite formation are unclear, and elucidating these processes may lead to novel AD therapeutic strategies.  Previous studies suggest Aβ may disrupt microtubules, which we hypothesize have a crit. role in the development of presynaptic dystrophies.  To investigate this further, here we have assessed the effects of Aβ, particularly neurotoxic Aβ42, on microtubules during the formation of presynaptic dystrophic neurites in vitro and in vivo.  Live-cell imaging of primary neurons revealed that exposure to Aβ42 oligomers caused varicose and beaded neurites with extensive microtubule disruption, and inhibited anterograde and retrograde trafficking.  In brain sections from AD patients and the 5XFAD transgenic mouse model of amyloid pathol., dystrophic neurite halos with BACE1 elevation around amyloid plaques exhibited aberrant tubulin accumulations or voids.  At the ultrastructural level, peri-plaque dystrophies were strikingly devoid of microtubules and replete with multi-lamellar vesicles resembling autophagic intermediates.  Proteins of the microtubule motors, kinesin and dynein, and other neuronal proteins were aberrantly localized in peri-plaque dystrophies.  Inactive pro-cathepsin D also accumulated in peri-plaque dystrophies, indicating reduced lysosomal function.  Most importantly, BACE1 accumulation in peri-plaque dystrophies caused increased BACE1 cleavage of APP and Aβ generation.  Our study supports the hypothesis that Aβ induces microtubule disruption in presynaptic dystrophic neurites that surround plaques, thus impairing axonal transport and leading to accumulation of BACE1 and exacerbation of amyloid pathol. in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbSN7VOiJ1l7Vg90H21EOLACvtfcHk0ljcqhaxMS-kDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVOgs78%253D&md5=d66c9c600721f1f63e7ae1c185b3b4ab</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00401-016-1558-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-016-1558-9%26sid%3Dliteratum%253Aachs%26aulast%3DSadleir%26aufirst%3DK.%2BR.%26aulast%3DKandalepas%26aufirst%3DP.%2BC.%26aulast%3DBuggia-Pr%25C3%25A9vot%26aufirst%3DV.%26aulast%3DNicholson%26aufirst%3DD.%2BA.%26aulast%3DThinakaran%26aufirst%3DG.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DPresynaptic%2520dystrophic%2520neurites%2520surrounding%2520amyloid%2520plaques%2520are%2520sites%2520of%2520microtubule%2520disruption%252C%2520BACE1%2520elevation%252C%2520and%2520increased%2520A%25CE%25B2%2520generation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2016%26volume%3D132%26spage%3D235%26epage%3D256%26doi%3D10.1007%2Fs00401-016-1558-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="note"><p class="first last">For representative review articles on BACE1 inhibitors, please see:</p></div><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Larner, A. J.</span></span> <span> </span><span class="NLM_article-title">Secretases as therapeutic targets in Alzheimer’s disease: patents 2000–2004</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1403</span>– <span class="NLM_lpage">1420</span>, <span class="refDoi"> DOI: 10.1517/13543776.14.10.1403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1517%2F13543776.14.10.1403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFKgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1403-1420&author=A.+J.+Larner&title=Secretases+as+therapeutic+targets+in+Alzheimer%E2%80%99s+disease%3A+patents+2000%E2%80%932004&doi=10.1517%2F13543776.14.10.1403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Secretases as therapeutic targets in Alzheimer's disease: patents 2000 - 2004</span></div><div class="casAuthors">Larner, Aj</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1403-1420</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  This article briefly reviews the biol. of the secretase enzymes (α, β and γ) that metabolize the amyloid precursor protein, pathways that are believed to be central to the pathogenesis of Alzheimer's disease.  Therapeutic patents claiming secretase inhibitors or modulators for the treatment of Alzheimer's disease published over the last 4 yr are then considered.  Although there are many claims, no agent has yet reached the clin. arena, and the paucity of data provided in the patents makes it difficult to predict which, if any, might do so.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVFV4jcxoox7Vg90H21EOLACvtfcHk0lilUBz6SnlX2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotFKgs70%253D&md5=0767fc4461549a308be0a77c69ab90e5</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1517%2F13543776.14.10.1403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.14.10.1403%26sid%3Dliteratum%253Aachs%26aulast%3DLarner%26aufirst%3DA.%2BJ.%26atitle%3DSecretases%2520as%2520therapeutic%2520targets%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520patents%25202000%25E2%2580%25932004%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2004%26volume%3D14%26spage%3D1403%26epage%3D1420%26doi%3D10.1517%2F13543776.14.10.1403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Probst, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. Z.</span></span> <span> </span><span class="NLM_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2006–2011)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1517/13543776.2012.681302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1517%2F13543776.2012.681302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=22512789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=511-540&author=G.+Probstauthor=Y.+Z.+Xu&title=Small-molecule+BACE1+inhibitors%3A+a+patent+literature+review+%282006%E2%80%932011%29&doi=10.1517%2F13543776.2012.681302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011)</span></div><div class="casAuthors">Probst, Gary; Xu, Ying-zi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">511-540</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Alzheimer's disease is a devastating neurodegenerative disorder for which no disease-modifying therapy exists.  The amyloid hypothesis, which implicates Aβ as the toxin initiating a biol. cascade leading to neurodegeneration, is the most prominent theory concerning the underlying cause of the disease.  BACE1 is one of two aspartyl proteinases that generate Aβ, thus inhibition of BACE1 has the potential to ameliorate the progression of Alzheimer's disease by abating the prodn. of Aβ.  Areas covered: This review chronicles small-mol. BACE1 inhibitors as described in the patent literature between 2006 and 2011 and their potential use as disease-modifying treatments for Alzheimer's disease.  Over the past half a dozen years, numerous BACE1 inhibitors have been published in the patent applications, but often these contain a paltry amt. of pertinent biol. data (e.g. potency, selectivity, and efficacy).  Fortunately, numerous relevant publications contg. important data have appeared in the journal literature during this period.  The goal in this effort was to create an amalgam of the two records to add value to this review.  Expert opinion: The pharmaceutical industry has made tremendous progress in the development of small-mol. BACE1 inhibitors that lower Aβ in the central nervous system.  Assuming the amyloid hypothesis is veracious, we anticipate a disease-modifying therapy to combat Alzheimer's disease is near.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp89KaCi3q5Z7Vg90H21EOLACvtfcHk0lilUBz6SnlX2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D&md5=174bdc47fbca5aa1f8248dbf03ce402b</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.681302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.681302%26sid%3Dliteratum%253Aachs%26aulast%3DProbst%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DY.%2BZ.%26atitle%3DSmall-molecule%2520BACE1%2520inhibitors%253A%2520a%2520patent%2520literature%2520review%2520%25282006%25E2%2580%25932011%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D511%26epage%3D540%26doi%3D10.1517%2F13543776.2012.681302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease</span>. <i>Alzheimer’s Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">89</span>, <span class="refDoi"> DOI: 10.1186/s13195-014-0089-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1186%2Fs13195-014-0089-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=25621019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVCqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=89&author=R.+Vassar&title=BACE1+inhibitor+drugs+in+clinical+trials+for+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs13195-014-0089-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 inhibitor drugs in clinical trials for Alzheimer's disease</span></div><div class="casAuthors">Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's Research & Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">89/1-89/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">ARTLCD</span>;
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is the β-secretase enzyme required for the prodn. of the neurotoxic β-amyloid (Aβ) peptide that is widely considered to have a crucial early role in the etiol. of Alzheimer's disease (AD).  As a result, BACE1 has emerged as a prime drug target for reducing the levels of Aβ in the AD brain, and the development of BACE1 inhibitors as therapeutic agents is being vigorously pursued.  It has proven difficult for the pharmaceutical industry to design BACE1 inhibitor drugs that pass the blood-brain barrier, however this challenge has recently been met and BACE1 inhibitors are now in human clin. trials to test for safety and efficacy in AD patients and individuals with pre-symptomatic AD.  Initial results suggest that some of these BACE1 inhibitor drugs are well tolerated, although others have dropped out because of toxicity and it is still too early to know whether any will be effective for the prevention or treatment of AD.  Addnl., based on newly identified BACE1 substrates and phenotypes of mice that lack BACE1, concerns have emerged about potential mechanism-based side effects of BACE1 inhibitor drugs with chronic administration.  It is hoped that a therapeutic window can be achieved that balances safety and efficacy.  This review summarizes the current state of progress in the development of BACE1 inhibitor drugs and the evaluation of their therapeutic potential for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR-BPlLZzu7rVg90H21EOLACvtfcHk0lilUBz6SnlX2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVCqtL4%253D&md5=a9ec66c8f0254986406323efa56c6f5a</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1186%2Fs13195-014-0089-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13195-014-0089-7%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DBACE1%2520inhibitor%2520drugs%2520in%2520clinical%2520trials%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D89%26doi%3D10.1186%2Fs13195-014-0089-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+M.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0lilUBz6SnlX2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Strategies to facilitate the discovery of novel CNS PET ligands</span>. <i>EJNMMI Radiopharm. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">13</span>, <span class="refDoi"> DOI: 10.1186/s41181-016-0016-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1186%2Fs41181-016-0016-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=29564389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A280%3ADC%252BC1Mnjs1egtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2017&pages=13&author=L.+Zhangauthor=A.+Villalobos&title=Strategies+to+facilitate+the+discovery+of+novel+CNS+PET+ligands&doi=10.1186%2Fs41181-016-0016-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies to facilitate the discovery of novel CNS PET ligands</span></div><div class="casAuthors">Zhang Lei; Villalobos Anabella</div><div class="citationInfo"><span class="NLM_cas:title">EJNMMI radiopharmacy and chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Positron Emission Tomography (PET), as a non-invasive translatable imaging technology, can be incorporated into various stages of the CNS drug discovery process to provide valuable information for key preclinical and clinical decision-making.  Novel CNS PET ligand discovery efforts in the industry setting, however, are facing unique challenges associated with lead design and prioritization, and budget constraints.  In this review, three strategies aiming toward improving the central nervous system (CNS) PET ligand discovery process are described: first, early determination of receptor density (Bmax) and bio-distribution to inform PET viability and resource allocation; second, rational design and design prioritization guided by CNS PET design parameters; finally, a cost-effective in vivo specific binding assessment using a liquid chromatography-mass spectrometry (LC-MS/MS) "cold tracer" method.  Implementation of these strategies allowed a more focused and rational CNS PET ligand discovery effort to identify high quality PET ligands for neuroimaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxTionUZVuaEodMGTatQ7LfW6udTcc2eZVMP57WFQE4bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mnjs1egtA%253D%253D&md5=c88567acb66d6bc10df1e9901bb300fb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1186%2Fs41181-016-0016-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs41181-016-0016-2%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DStrategies%2520to%2520facilitate%2520the%2520discovery%2520of%2520novel%2520CNS%2520PET%2520ligands%26jtitle%3DEJNMMI%2520Radiopharm.%2520Chem.%26date%3D2017%26volume%3D1%26spage%3D13%26doi%3D10.1186%2Fs41181-016-0016-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heck, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span> <span> </span><span class="NLM_article-title">Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4568</span>– <span class="NLM_lpage">4579</span>, <span class="refDoi"> DOI: 10.1021/jm400312y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400312y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4568-4579&author=L.+Zhangauthor=A.+Villalobosauthor=E.+M.+Beckauthor=T.+Bocanauthor=T.+A.+Chappieauthor=L.+Chenauthor=S.+Grimwoodauthor=S.+D.+Heckauthor=C.+J.+Helalauthor=X.+Houauthor=J.+M.+Humphreyauthor=J.+Luauthor=M.+B.+Skaddanauthor=T.+J.+McCarthyauthor=P.+R.+Verhoestauthor=T.+T.+Wagerauthor=K.+Zasadny&title=Design+and+selection+parameters+to+accelerate+the+discovery+of+novel+central+nervous+system+positron+emission+tomography+%28PET%29+ligands+and+their+application+in+the+development+of+a+novel+phosphodiesterase+2A+PET+ligand&doi=10.1021%2Fjm400312y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span></div><div class="casAuthors">Zhang, Lei; Villalobos, Anabella; Beck, Elizabeth M.; Bocan, Thomas; Chappie, Thomas A.; Chen, Laigao; Grimwood, Sarah; Heck, Steven D.; Helal, Christopher J.; Hou, Xinjun; Humphrey, John M.; Lu, Jiemin; Skaddan, Marc B.; McCarthy, Timothy J.; Verhoest, Patrick R.; Wager, Travis T.; Zasadny, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4568-4579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To accelerate the discovery of novel small mol. central nervous system (CNS) positron emission tomog. (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development.  Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as neg. controls.  A systematic anal. of these ligands identified a set of preferred parameters for physicochem. properties, brain permeability, and nonspecific binding (NSB).  These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines.  This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine, [18F]PF-05270430 (5).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTCG9TZE0X-bVg90H21EOLACvtfcHk0lhwxZPBEo-lhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D&md5=ee7ce04829d7456a632c02c331c4edfa</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm400312y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400312y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBocan%26aufirst%3DT.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHeck%26aufirst%3DS.%2BD.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DMcCarthy%26aufirst%3DT.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DZasadny%26aufirst%3DK.%26atitle%3DDesign%2520and%2520selection%2520parameters%2520to%2520accelerate%2520the%2520discovery%2520of%2520novel%2520central%2520nervous%2520system%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligands%2520and%2520their%2520application%2520in%2520the%2520development%2520of%2520a%2520novel%2520phosphodiesterase%25202A%2520PET%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4568%26epage%3D4579%26doi%3D10.1021%2Fjm400312y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chernet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Need, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rash, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phebus, L. A.</span></span> <span> </span><span class="NLM_article-title">Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: Dopamine D2, serotonin 2A and NK-1 receptors as examples</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">346</span>, For additional applications, please see <span class="refDoi"> DOI: 10.1016/j.lfs.2005.04.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1016%2Fj.lfs.2005.04.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=16139310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SksbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2005&pages=340-346&author=E.+Chernetauthor=L.+J.+Martinauthor=D.+Liauthor=A.+B.+Needauthor=V.+N.+Barthauthor=K.+S.+Rashauthor=L.+A.+Phebus&title=Use+of+LC%2FMS+to+assess+brain+tracer+distribution+in+preclinical%2C+in+vivo+receptor+occupancy+studies%3A+Dopamine+D2%2C+serotonin+2A+and+NK-1+receptors+as+examples&doi=10.1016%2Fj.lfs.2005.04.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: Dopamine D2, serotonin 2A and NK-1 receptors as examples</span></div><div class="casAuthors">Chernet, Eyassu; Martin, Laura J.; Li, Dominic; Need, Anne B.; Barth, Vanessa N.; Rash, Karen S.; Phebus, Lee A.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">340-346</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HPLC combined with either single quad or triple quad mass spectral detectors (LC/MS) was used to measure the brain distribution of receptor occupancy tracers targeting dopamine D2, serotonin 5-HT2A and neurokinin NK-1 receptors using the ligands raclopride, MDL-100907 and GR205171, resp.  All three non-radiolabeled tracer mols. were easily detectable in discrete rat brain areas after i.v. doses of 3, 3 and 30 μg/kg, resp.  These levels showed a differential brain distribution caused by differences in receptor d., as demonstrated by the observation that pretreatment with compds. that occupy these receptors reduced this differential distribution in a dose-dependent manner.  I.v., s.c. and oral dose-occupancy curves were generated for haloperidol at the dopamine D2 receptor as were oral curves for the antipsychotic drugs olanzapine and clozapine.  In vivo dose-occupancy curves were also generated for orally administered clozapine, olanzapine and haloperidol at the cortical 5-HT2A binding site.  In vivo occupancy at the striatal neurokinin NK-1 binding site by various doses of orally administered MK-869 was also measured.  The authors' results demonstrate the utility of LC/MS to quantify tracer distribution in preclin. brain receptor occupancy studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-89MhwV6v3rVg90H21EOLACvtfcHk0lhwxZPBEo-lhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SksbzK&md5=426fc1ce907f0e701575cc3bebbd6af5</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2005.04.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2005.04.075%26sid%3Dliteratum%253Aachs%26aulast%3DChernet%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DL.%2BJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DNeed%26aufirst%3DA.%2BB.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26aulast%3DRash%26aufirst%3DK.%2BS.%26aulast%3DPhebus%26aufirst%3DL.%2BA.%26atitle%3DUse%2520of%2520LC%252FMS%2520to%2520assess%2520brain%2520tracer%2520distribution%2520in%2520preclinical%252C%2520in%2520vivo%2520receptor%2520occupancy%2520studies%253A%2520Dopamine%2520D2%252C%2520serotonin%25202A%2520and%2520NK-1%2520receptors%2520as%2520examples%26jtitle%3DLife%2520Sci.%26date%3D2005%26volume%3D78%26spage%3D340%26epage%3D346%26doi%3D10.1016%2Fj.lfs.2005.04.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rash, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedregal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Statnick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledo, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gackenheimer, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tauscher, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innis, R. B.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2687</span>– <span class="NLM_lpage">2700</span>, <span class="refDoi"> DOI: 10.1021/jm101487v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101487v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVSisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2687-2700&author=V.+W.+Pikeauthor=K.+S.+Rashauthor=Z.+Chenauthor=C.+Pedregalauthor=M.+A.+Statnickauthor=Y.+Kimuraauthor=J.+Hongauthor=S.+S.+Zoghbiauthor=M.+Fujitaauthor=M.+A.+Toledoauthor=N.+Diazauthor=S.+L.+Gackenheimerauthor=J.+T.+Tauscherauthor=V.+N.+Barthauthor=R.+B.+Innis&title=Synthesis+and+evaluation+of+radioligands+for+imaging+brain+nociceptin%2Forphanin+FQ+peptide+%28NOP%29+receptors+with+positron+emission+tomography&doi=10.1021%2Fjm101487v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography</span></div><div class="casAuthors">Pike, Victor W.; Rash, Karen S.; Chen, Zhaogen; Pedregal, Concepcion; Statnick, Michael A.; Kimura, Yasuyuki; Hong, Jinsoo; Zoghbi, Sami S.; Fujita, Masahiro; Toledo, Miguel A.; Diaz, Nuria; Gackenheimer, Susan L.; Tauscher, Johannes T.; Barth, Vanessa N.; Innis, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2687-2700</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Positron emission tomog. (PET) coupled to an effective radioligand could provide an important tool for understanding possible links between neuropsychiatric disorders and brain NOP (nociceptin/orphanin FQ peptide) receptors.  We sought to develop such a PET radioligand.  High-affinity NOP ligands were synthesized based on a 3-(2'-fluoro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-1-yl)-2(2-halobenzyl)-N-alkylpropanamide scaffold and from exptl. screens in rats, with ex vivo LC-MS/MS measures, three ligands were identified for labeling with carbon-11 and evaluation with PET in monkey.  Each ligand was labeled by 11C-methylation of an N-demethyl precursor and studied in monkey under baseline and NOP receptor-preblock conditions.  The three radioligands, [11C](S)-I (X = F, Cl, R = H; X = F, R = iPr) gave similar results.  Baseline scans showed high entry of radioactivity into the brain to give a distribution reflecting that expected for NOP receptors.  Preblock expts. showed high early peak levels of brain radioactivity, which rapidly declined to a much lower level than seen in baseline scans, thereby indicating a high level of receptor-specific binding in baseline expts.  Overall, [11C](S)-I (X = F, R = iPr) showed the most favorable receptor-specific signal and kinetics and is now selected for evaluation in human subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLbdZG2H-gRLVg90H21EOLACvtfcHk0ljeL2qcC17xlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVSisLk%253D&md5=7519fa250770248d3c73c58e20eca3f1</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fjm101487v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101487v%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DRash%26aufirst%3DK.%2BS.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPedregal%26aufirst%3DC.%26aulast%3DStatnick%26aufirst%3DM.%2BA.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DToledo%26aufirst%3DM.%2BA.%26aulast%3DDiaz%26aufirst%3DN.%26aulast%3DGackenheimer%26aufirst%3DS.%2BL.%26aulast%3DTauscher%26aufirst%3DJ.%2BT.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520radioligands%2520for%2520imaging%2520brain%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520%2528NOP%2529%2520receptors%2520with%2520positron%2520emission%2520tomography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2687%26epage%3D2700%26doi%3D10.1021%2Fjm101487v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mitch, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quimby, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedregal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Torre, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canada, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahl, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Statnick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinzie, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benesh, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rash, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, V. N.</span></span> <span> </span><span class="NLM_article-title">Discovery of aminobenzyloxyarylamides as κ opioid receptor selective antagonists: Application to preclinical development of a κ opioid receptor antagonist receptor occupancy tracer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">8000</span>– <span class="NLM_lpage">8012</span>, <span class="refDoi"> DOI: 10.1021/jm200789r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200789r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOgu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8000-8012&author=C.+H.+Mitchauthor=S.+J.+Quimbyauthor=N.+Diazauthor=C.+Pedregalauthor=M.+G.+de+la+Torreauthor=A.+Jimenezauthor=Q.+Shiauthor=E.+J.+Canadaauthor=S.+D.+Kahlauthor=M.+A.+Statnickauthor=D.+L.+McKinzieauthor=D.+R.+Beneshauthor=K.+S.+Rashauthor=V.+N.+Barth&title=Discovery+of+aminobenzyloxyarylamides+as+%CE%BA+opioid+receptor+selective+antagonists%3A+Application+to+preclinical+development+of+a+%CE%BA+opioid+receptor+antagonist+receptor+occupancy+tracer&doi=10.1021%2Fjm200789r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Aminobenzyloxyarylamides as κ Opioid Receptor Selective Antagonists: Application to Preclinical Development of a κ Opioid Receptor Antagonist Receptor Occupancy Tracer</span></div><div class="casAuthors">Mitch, Charles H.; Quimby, Steven J.; Diaz, Nuria; Pedregal, Concepcion; de la Torre, Marta G.; Jimenez, Alma; Shi, Qing; Canada, Emily J.; Kahl, Steven D.; Statnick, Michael A.; McKinzie, David L.; Benesh, Dana R.; Rash, Karen S.; Barth, Vanessa N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8000-8012</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arylphenylpyrrolidinylmethylphenoxybenzamides were found to have high affinity and selectivity for κ opioid receptors.  On the basis of receptor binding assays in Chinese hamster ovary (CHO) cells expressing cloned human opioid receptors, (S)-3-fluoro-4-(4-((2-(3-fluorophenyl)pyrrolidin-1-yl)methyl)phenoxy)benzamide (25) had a Ki = 0.565 nM for κ opioid receptor binding while having a Ki = 35.8 nM for μ opioid receptors and a Ki = 211 nM for δ opioid receptor binding.  Compd. 25 was also a potent antagonist of κ opioid receptors when tested in vitro using a [35S]-guanosine 5'O-[3-thiotriphosphate] ([35S]GTP-γ-S) functional assay in CHO cells expressing cloned human opioid receptors.  Compds. were also evaluated for potential use as receptor occupancy tracers.  Tracer evaluation was done in vivo, using liq. chromatog.-tandem mass spectrometry (LC/MS/MS) methods, precluding the need for radiolabeling.  (S)-3-Chloro-4-(4-((2-(pyridine-3-yl)pyrrolidin-1-yl)methyl)phenoxy)benzamide (18) was found to have favorable properties for a tracer for receptor occupancy, including good specific vs. nonspecific binding and good brain uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUKlIPCr34grVg90H21EOLACvtfcHk0ljeL2qcC17xlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOgu73N&md5=a17d3133182c2c33b78a85bf153c56fd</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1021%2Fjm200789r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200789r%26sid%3Dliteratum%253Aachs%26aulast%3DMitch%26aufirst%3DC.%2BH.%26aulast%3DQuimby%26aufirst%3DS.%2BJ.%26aulast%3DDiaz%26aufirst%3DN.%26aulast%3DPedregal%26aufirst%3DC.%26aulast%3Dde%2Bla%2BTorre%26aufirst%3DM.%2BG.%26aulast%3DJimenez%26aufirst%3DA.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DCanada%26aufirst%3DE.%2BJ.%26aulast%3DKahl%26aufirst%3DS.%2BD.%26aulast%3DStatnick%26aufirst%3DM.%2BA.%26aulast%3DMcKinzie%26aufirst%3DD.%2BL.%26aulast%3DBenesh%26aufirst%3DD.%2BR.%26aulast%3DRash%26aufirst%3DK.%2BS.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26atitle%3DDiscovery%2520of%2520aminobenzyloxyarylamides%2520as%2520%25CE%25BA%2520opioid%2520receptor%2520selective%2520antagonists%253A%2520Application%2520to%2520preclinical%2520development%2520of%2520a%2520%25CE%25BA%2520opioid%2520receptor%2520antagonist%2520receptor%2520occupancy%2520tracer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8000%26epage%3D8012%26doi%3D10.1021%2Fjm200789r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Motoki, T.</span>; <span class="NLM_string-name">Takeda, K.</span>; <span class="NLM_string-name">Takaishi, M.</span>; <span class="NLM_string-name">Suzuki, Y.</span>; <span class="NLM_string-name">Ishida, T.</span></span> <span> </span><span class="NLM_article-title">Novel Fused Aminodihydrothiazine Derivatives</span>. WO <span class="NLM_patent">2010038686A1</span>, Apr 8, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Motoki&author=K.+Takeda&author=M.+Takaishi&author=Y.+Suzuki&author=T.+Ishida&title=Novel+Fused+Aminodihydrothiazine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMotoki%26aufirst%3DT.%26atitle%3DNovel%2520Fused%2520Aminodihydrothiazine%2520Derivatives%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienkowski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuck, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tory, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauley, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brashler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratman, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhl, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasselli, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parodi, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrikson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M. E.</span></span> <span> </span><span class="NLM_article-title">Membrane-anchored aspartyl protease with Alzheimer’s disease beta-secretase activity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>402</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1038/990107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1038%2F990107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10591213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADyaK1MXotFKmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashlerauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membrane-anchored+aspartyl+protease+with+Alzheimer%E2%80%99s+disease+beta-secretase+activity&doi=10.1038%2F990107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity</span></div><div class="casAuthors">Yan, Riqiang; Bienkowski, Michael J.; Shuck, Mary E.; Miao, Huiyi; Tory, Monica C.; Pauley, Adele M.; Brashler, John R.; Stratman, Nancy C.; Mathews, W. Rodney; Buhl, Allen E.; Carter, Donald B.; Tomasselli, Alfredo G.; Parodi, Luis A.; Heinrikson, Robert L.; Gurney, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue">6761</span>),
    <span class="NLM_cas:pages">533-537</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Mutations in the gene encoding the amyloid protein precursor (APP) cause autosomal dominant Alzheimer's disease.  Cleavage of APP by unidentified proteases, referred to as β- and γ-secretases, generates the amyloid β-peptide, the main component of the amyloid plaques found in Alzheimer's disease patients.  The disease-causing mutations flank the protease cleavage sites in APP and facilitate its cleavage.  Here the authors identify a new membrane-bound aspartyl protease (Asp2) with β-secretase activity.  The Asp2 gene is expressed widely in brain and other tissues.  Decreasing the expression of Asp2 in cells reduces amyloid β-peptide prodn. and blocks the accumulation of the carboxy-terminal APP fragment that is created by β-secretase cleavage.  Solubilized Asp2 protein cleaves a synthetic APP peptide substrate at the β-secretase site, and the rate of cleavage is increased tenfold by a mutation assocd. with early-onset Alzheimer's disease in Sweden.  Thus, Asp2 is a new protein target for drugs that are designed to block the prodn. of amyloid β-peptide peptide and the consequent formation of amyloid plaque in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd6iE74jtk5LVg90H21EOLACvtfcHk0ljD7h3B14oL9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotFKmu7k%253D&md5=96af7cd9b7c3315de029937497f04616</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2F990107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F990107%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashler%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembrane-anchored%2520aspartyl%2520protease%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520beta-secretase%2520activity%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537%26doi%3D10.1038%2F990107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu-Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeloff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louis, J. – C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">Expression analysis of BACE2 in brain and peripheral tissues</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">20647</span>– <span class="NLM_lpage">20651</span>, <span class="refDoi"> DOI: 10.1074/jbc.M002688200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1074%2Fjbc.M002688200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10749877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvVyhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=20647-20651&author=B.+D.+Bennettauthor=S.+Babu-Khanauthor=R.+Loeloffauthor=J.+%E2%80%93+C.+Louisauthor=E.+Curranauthor=M.+Citronauthor=R.+Vassar&title=Expression+analysis+of+BACE2+in+brain+and+peripheral+tissues&doi=10.1074%2Fjbc.M002688200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Expression analysis of BACE2 in brain and peripheral tissues</span></div><div class="casAuthors">Bennett, Brian D.; Babu-Khan, Safura; Loeloff, Richard; Louis, Jean-Claude; Curran, Eileen; Citron, Martin; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">20647-20651</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Beta-site amyloid precursor protein cleaving enzyme (BACE) is a novel transmembrane aspartic protease that possesses all the known characteristics of the β-secretase involved in Alzheimer's disease.  We have analyzed the sequence and expression pattern of a BACE homolog termed BACE2.  BACE and BACE2 are unique among aspartic proteases in that they possess a carboxyl-terminal extension with a predicted transmembrane region and together they define a new family.  Northern anal. reveals that BACE2 mRNA is expressed at low levels in most human peripheral tissues and at higher levels in colon, kidney, pancreas, placenta, prostate, stomach, and trachea.  Human adult and fetal whole brain and most adult brain subregions express very low or undetectable levels of BACE2 mRNA.  In addn., in situ hybridization of adult rat brain shows that BACE2 mRNA is expressed at very low levels in most brain regions.  The very low or undetectable levels of BACE2 mRNA in the brain are not consistent with the expression pattern predicted for β-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodNsksnpZwh7Vg90H21EOLACvtfcHk0ljD7h3B14oL9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvVyhsbs%253D&md5=3d664572b2a1709c68fffcee3a8880d5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M002688200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M002688200%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLouis%26aufirst%3DJ.%2B%25E2%2580%2593%2BC.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DExpression%2520analysis%2520of%2520BACE2%2520in%2520brain%2520and%2520peripheral%2520tissues%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D20647%26epage%3D20651%26doi%3D10.1074%2Fjbc.M002688200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu-Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendiaz, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teplow, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amarante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeloff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edenson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lile, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biere, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louis, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span> <span> </span><span class="NLM_article-title">β-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">741</span>, <span class="refDoi"> DOI: 10.1126/science.286.5440.735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.-C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=%CE%B2-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE&doi=10.1126%2Fscience.286.5440.735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0ljD7h3B14oL9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.-C.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3D%25CE%25B2-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741%26doi%3D10.1126%2Fscience.286.5440.735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, R.</span></span> <span> </span><span class="NLM_article-title">In vivo site-directed radiotracers: a mini-review</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">815</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2008.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1016%2Fj.nucmedbio.2008.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=19026942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=805-815&author=S.+Patelauthor=R.+Gibson&title=In+vivo+site-directed+radiotracers%3A+a+mini-review&doi=10.1016%2Fj.nucmedbio.2008.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo site-directed radiotracers: a mini-review</span></div><div class="casAuthors">Patel, Shil; Gibson, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">805-815</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review on the process for developing reversible, monovalent site-specific radiotracers in drug design.  It is concerned with the characteristics of radiotracers such as binding, lipophilicity, and binding specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYUEhMFA7d7bVg90H21EOLACvtfcHk0lhl067gqEMuiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL&md5=869985e0741d52a76cb546972097e2a8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DR.%26atitle%3DIn%2520vivo%2520site-directed%2520radiotracers%253A%2520a%2520mini-review%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D805%26epage%3D815%26doi%3D10.1016%2Fj.nucmedbio.2008.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keefer, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. R.</span></span> <span> </span><span class="NLM_article-title">Interpretable, probability-based confidence metric for continuous quantitative structure-activity relationship models</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">368</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1021/ci300554t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci300554t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Cit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=368-383&author=C.+E.+Keeferauthor=G.+W.+Kauffmanauthor=R.+R.+Gupta&title=Interpretable%2C+probability-based+confidence+metric+for+continuous+quantitative+structure-activity+relationship+models&doi=10.1021%2Fci300554t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Interpretable, Probability-Based Confidence Metric for Continuous Quantitative Structure-Activity Relationship Models</span></div><div class="casAuthors">Keefer, Christopher E.; Kauffman, Gregory W.; Gupta, Rishi Raj</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">368-383</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A great deal of research has gone into the development of robust confidence in prediction and applicability domain (AD) measures for quant. structure-activity relationship (QSAR) models in recent years.  Much of the attention has historically focused on structural similarity, which can be defined in many forms and flavors.  A concept that is frequently overlooked in the realm of the QSAR applicability domain is how the local activity landscape plays a role in how accurate a prediction is or is not.  In this work, we describe an approach that pairs information about both the chem. similarity and activity landscape of a test compd.'s neighborhood into a single calcd. confidence value.  We also present an approach for converting this value into an interpretable confidence metric that has a simple and informative meaning across data sets.  The approach will be introduced to the reader in the context of models built upon four diverse literature data sets.  The steps we will outline include the definition of similarity used to det. nearest neighbors (NN), how we incorporate the NN activity landscape with a similarity-weighted root-mean-square distance (wRMSD) value, and how that value is then calibrated to generate an intuitive confidence metric for prospective application.  Finally, we will illustrate the prospective performance of the approach on five proprietary models whose predictions and confidence metrics have been tracked for more than a year.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqvcorWVQ5O7Vg90H21EOLACvtfcHk0lhl067gqEMuiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Cit74%253D&md5=14d2b7d42f91b5e4e90fa53b6266a178</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fci300554t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci300554t%26sid%3Dliteratum%253Aachs%26aulast%3DKeefer%26aufirst%3DC.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DGupta%26aufirst%3DR.%2BR.%26atitle%3DInterpretable%252C%2520probability-based%2520confidence%2520metric%2520for%2520continuous%2520quantitative%2520structure-activity%2520relationship%2520models%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D368%26epage%3D383%26doi%3D10.1021%2Fci300554t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, Q. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundesmann, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henegar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaChapelle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikochik, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakya, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span> <span> </span><span class="NLM_article-title">Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug–drug interactions with a novel series of centrally efficacious BACE1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3223</span>– <span class="NLM_lpage">3252</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3223-3252&author=M.+A.+Brodneyauthor=E.+M.+Beckauthor=C.+R.+Butlerauthor=G.+Barreiroauthor=E.+F.+Johnsonauthor=D.+Riddellauthor=K.+Parrisauthor=C.+E.+Nolanauthor=Y.+Fanauthor=K.+Atchisonauthor=C.+Gonzalesauthor=Q.+E.+Robshawauthor=S.+D.+Doranauthor=M.+W.+Bundesmannauthor=L.+Buzonauthor=J.+Dutraauthor=K.+Henegarauthor=E.+LaChapelleauthor=X.+Houauthor=B.+N.+Rogersauthor=J.+Panditauthor=R.+Liraauthor=L.+Martinez-Alsinaauthor=P.+Mikochikauthor=J.+C.+Murrayauthor=K.+Ogilvieauthor=L.+Priceauthor=S.+M.+Sakyaauthor=A.+Yuauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Utilizing+structures+of+CYP2D6+and+BACE1+complexes+to+reduce+risk+of+drug%E2%80%93drug+interactions+with+a+novel+series+of+centrally+efficacious+BACE1+inhibitors&doi=10.1021%2Facs.jmedchem.5b00191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00191%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DRobshaw%26aufirst%3DQ.%2BE.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DBundesmann%26aufirst%3DM.%2BW.%26aulast%3DBuzon%26aufirst%3DL.%26aulast%3DDutra%26aufirst%3DJ.%26aulast%3DHenegar%26aufirst%3DK.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DMikochik%26aufirst%3DP.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DPrice%26aufirst%3DL.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DYu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DUtilizing%2520structures%2520of%2520CYP2D6%2520and%2520BACE1%2520complexes%2520to%2520reduce%2520risk%2520of%2520drug%25E2%2580%2593drug%2520interactions%2520with%2520a%2520novel%2520series%2520of%2520centrally%2520efficacious%2520BACE1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3223%26epage%3D3252%26doi%3D10.1021%2Facs.jmedchem.5b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takaishi, M.</span>; <span class="NLM_string-name">Ishida, T.</span></span> <span> </span><span class="NLM_article-title">Fused Aminohydrothiazine Derivatives</span>. WO <span class="NLM_patent">2012098461A1</span>, Jul 26, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+Takaishi&author=T.+Ishida&title=Fused+Aminohydrothiazine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTakaishi%26aufirst%3DM.%26atitle%3DFused%2520Aminohydrothiazine%2520Derivatives%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalaeva, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tupper, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span> <span> </span><span class="NLM_article-title">ElogD<sub>oct</sub>: A tool for lipophilicity determination in drug discovery. 2. Basic and neural compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">2490</span>– <span class="NLM_lpage">2497</span>, <span class="refDoi"> DOI: 10.1021/jm0100990</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0100990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2490-2497&author=F.+Lombardoauthor=M.+Y.+Shalaevaauthor=K.+A.+Tupperauthor=F.+Gao&title=ElogDoct%3A+A+tool+for+lipophilicity+determination+in+drug+discovery.+2.+Basic+and+neural+compounds&doi=10.1021%2Fjm0100990"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm0100990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100990%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DShalaeva%26aufirst%3DM.%2BY.%26aulast%3DTupper%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DF.%26atitle%3DElogDoct%253A%2520A%2520tool%2520for%2520lipophilicity%2520determination%2520in%2520drug%2520discovery.%25202.%2520Basic%2520and%2520neural%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2490%26epage%3D2497%26doi%3D10.1021%2Fjm0100990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span> Fu_b was measured using rat brain homogenate based on species independence
in brain tissue bindings. For a reference, please see:<span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span> <span> </span><span class="NLM_article-title">Species independence in brain tissue binding using brain homogenates</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1270</span>– <span class="NLM_lpage">1277</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.038778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1124%2Fdmd.111.038778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=21474681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1270-1277&author=L.+Diauthor=J.+P.+Umlandauthor=G.+Changauthor=Y.+Huangauthor=Z.+Linauthor=D.+O.+Scottauthor=M.+D.+Troutmanauthor=T.+E.+Liston&title=Species+independence+in+brain+tissue+binding+using+brain+homogenates&doi=10.1124%2Fdmd.111.038778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Species independence in brain tissue binding using brain homogenates</span></div><div class="casAuthors">Di, Li; Umland, John P.; Chang, George; Huang, Youping; Lin, Zhen; Scott, Dennis O.; Troutman, Matthew D.; Liston, Theodore E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1270-1277</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Species independence of brain tissue binding was assessed with a large no. of structurally diverse compds. using equil. dialysis with brain homogenates of seven species and strains (Wistar Han rat, Sprague-Dawley rat, CD-1 mouse, Hartley guinea pig, beagle dog, cynomolgus monkey, and human).  The results showed that the fractions unbound of the seven species and strains were strongly correlated with correlation coeffs. ranging from 0.93 to 0.99.  The cross-species/strain correlations were not significantly different from the interassay correlation with the same species.  The linear correlation between Wistar Han and other species had a slope close to 1 and an intercept near 0.  Based on orthogonal statistical anal., no correction is needed for extrapolation of fraction unbound from Wistar Han rat to the other species or strains.  Hence, brain tissue binding of Wistar Han rat can be used to obtain binding of other species and strains in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoub4FiLWkAFrVg90H21EOLACvtfcHk0ljQWXHLli8tiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D&md5=93a51addedb22de4648e6e5ee39c6c81</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.038778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.038778%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DListon%26aufirst%3DT.%2BE.%26atitle%3DSpecies%2520independence%2520in%2520brain%2520tissue%2520binding%2520using%2520brain%2520homogenates%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D1270%26epage%3D1277%26doi%3D10.1124%2Fdmd.111.038778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Remick, D. M.</span>; <span class="NLM_string-name">Richards, S. J.</span>; <span class="NLM_string-name">Sanderson, A. J.</span></span> <span> </span><span class="NLM_article-title">Tetrahydrofurane-fused Aminohydrothiazine Derivatives Which are Useful in the Treatment of Alzheimer’s Disease</span>. WO <span class="NLM_patent">2016176118A1</span>, Nov 3, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=D.+M.+Remick&author=S.+J.+Richards&author=A.+J.+Sanderson&title=Tetrahydrofurane-fused+Aminohydrothiazine+Derivatives+Which+are+Useful+in+the+Treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRemick%26aufirst%3DD.%2BM.%26atitle%3DTetrahydrofurane-fused%2520Aminohydrothiazine%2520Derivatives%2520Which%2520are%2520Useful%2520in%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richards, S. J.</span>; <span class="NLM_string-name">Hembre, E. J.</span>; <span class="NLM_string-name">Lopez, J. E.</span>; <span class="NLM_string-name">Winneroski, L. L.,  Jr.</span>; <span class="NLM_string-name">Woods, T. A.</span>; <span class="NLM_string-name">McMahon, J. A.</span></span> <span> </span><span class="NLM_article-title">Selective BACE1 Inhibitors</span>. US <span class="NLM_patent">20160244465AA</span>, Aug 25, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+J.+Richards&author=E.+J.+Hembre&author=J.+E.+Lopez&author=L.+L.+Winneroski&author=T.+A.+Woods&author=J.+A.+McMahon&title=Selective+BACE1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DS.%2BJ.%26atitle%3DSelective%2520BACE1%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goriya, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramana, C. V.</span></span> <span> </span><span class="NLM_article-title">The [Cu]-catalyzed S<sub>N</sub>Ar reactions: direct amination of electron deficient aryl halides with sodium azide and the synthesis of arylthioethers under Cu (II)-ascorbate redox system</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">7642</span>– <span class="NLM_lpage">7650</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2010.07.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1016%2Fj.tet.2010.07.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGrtbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=7642-7650&author=Y.+Goriyaauthor=C.+V.+Ramana&title=The+%5BCu%5D-catalyzed+SNAr+reactions%3A+direct+amination+of+electron+deficient+aryl+halides+with+sodium+azide+and+the+synthesis+of+arylthioethers+under+Cu+%28II%29-ascorbate+redox+system&doi=10.1016%2Fj.tet.2010.07.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The [Cu]-catalyzed SNAR reactions: direct amination of electron deficient aryl halides with sodium azide and the synthesis of arylthioethers under Cu(II)-ascorbate redox system</span></div><div class="casAuthors">Goriya, Yogesh; Ramana, C. V.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">7642-7650</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A one pot [Cu]-promoted SNAr reaction of electron-deficient halobenzenes with sodium azide and the redn. of the intermediate aryl azides under the same Cu(II)-ascorbate redox conditions leading to anilines has been documented.  Control expts. revealed that both ascorbate and proline play important role in the reaction path way.  Further, the use of this catalytic Cu(II)-ascorbate redox system has been explored for the synthesis of arylthioethers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8qeehlF19sLVg90H21EOLACvtfcHk0ljQWXHLli8tiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGrtbfK&md5=e0c4b3a1646453ee9cd38a651d4985af</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2010.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2010.07.032%26sid%3Dliteratum%253Aachs%26aulast%3DGoriya%26aufirst%3DY.%26aulast%3DRamana%26aufirst%3DC.%2BV.%26atitle%3DThe%2520%255BCu%255D-catalyzed%2520SNAr%2520reactions%253A%2520direct%2520amination%2520of%2520electron%2520deficient%2520aryl%2520halides%2520with%2520sodium%2520azide%2520and%2520the%2520synthesis%2520of%2520arylthioethers%2520under%2520Cu%2520%2528II%2529-ascorbate%2520redox%2520system%26jtitle%3DTetrahedron%26date%3D2010%26volume%3D66%26spage%3D7642%26epage%3D7650%26doi%3D10.1016%2Fj.tet.2010.07.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span> Compound <b>36</b> in<span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varghese, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span> <span> </span><span class="NLM_article-title">Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2678</span>– <span class="NLM_lpage">2702</span>, <span class="refDoi"> DOI: 10.1021/jm501833t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501833t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2678-2702&author=C.+R.+Butlerauthor=M.+A.+Brodneyauthor=E.+M.+Beckauthor=G.+Barreiroauthor=C.+E.+Nolanauthor=F.+Panauthor=F.+Vajdosauthor=K.+Parrisauthor=A.+H.+Vargheseauthor=C.+J.+Helalauthor=R.+Liraauthor=S.+D.+Doranauthor=D.+R.+Riddellauthor=L.+M.+Buzonauthor=J.+K.+Dutraauthor=L.+A.+Martinez-Alsinaauthor=K.+Ogilvieauthor=J.+C.+Murrayauthor=J.+M.+Youngauthor=K.+Atchisonauthor=A.+Robshawauthor=C.+Gonzalesauthor=J.+Wangauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Discovery+of+a+series+of+efficient%2C+centrally+efficacious+BACE1+inhibitors+through+structure-based+drug+design&doi=10.1021%2Fjm501833t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design</span></div><div class="casAuthors">Butler, Christopher R.; Brodney, Michael A.; Beck, Elizabeth M.; Barreiro, Gabriela; Nolan, Charles E.; Pan, Feng; Vajdos, Felix; Parris, Kevin; Varghese, Alison H.; Helal, Christopher J.; Lira, Ricardo; Doran, Shawn D.; Riddell, David R.; Buzon, Leanne M.; Dutra, Jason K.; Martinez-Alsina, Luis A.; Ogilvie, Kevin; Murray, John C.; Young, Joseph M.; Atchison, Kevin; Robshaw, Ashley; Gonzales, Cathleen; Wang, Jinlong; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2678-2702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease (AD) has historically been thwarted by an inability to maintain alignment of potency, brain availability, and desired absorption, distribution, metab., and excretion (ADME) properties.  In this paper, the authors describe a series of truncated, fused thioamidines that are efficiently selective in garnering BACE1 activity without simultaneously inhibiting the closely related cathepsin D or neg. impacting brain penetration and ADME alignment, as exemplified by I.  Upon oral administration, these inhibitors exhibit robust brain availability and are efficacious in lowering central Amyloid β (Aβ) levels in mouse and dog.  In addn., chronic treatment in aged PS1/APP mice effects a decrease in the no. and size of Aβ-derived plaques.  Most importantly, evaluation of I in a 2-wk exploratory toxicol. study revealed no accumulation of autofluorescent material in retinal pigment epithelium or histol. findings in the eye, issues obsd. with earlier BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiNT62AGyml7Vg90H21EOLACvtfcHk0lj-1oHvIP-OvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D&md5=ac2a6fd661f7e9fd8b925deffd5e1010</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm501833t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501833t%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DVarghese%26aufirst%3DA.%2BH.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%2BA.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DRobshaw%26aufirst%3DA.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DDiscovery%2520of%2520a%2520series%2520of%2520efficient%252C%2520centrally%2520efficacious%2520BACE1%2520inhibitors%2520through%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2678%26epage%3D2702%26doi%3D10.1021%2Fjm501833t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span>; <span class="NLM_string-name">Beck, E. M.</span>; <span class="NLM_string-name">Butler, C. R.</span>; <span class="NLM_string-name">Zhang, L.</span>; <span class="NLM_string-name">O’Neill, B. T.</span>; <span class="NLM_string-name">Barreiro, G.</span>; <span class="NLM_string-name">Lachapelle, E. A.</span>; <span class="NLM_string-name">Rogers, B. N.</span></span> <span> </span><span class="NLM_article-title">Preparation of <i>N</i>-(2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl) Amides as Inhibitors of Beta-site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span>. WO <span class="NLM_patent">2015155626A1</span>, Oct 15, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+A.+Brodney&author=E.+M.+Beck&author=C.+R.+Butler&author=L.+Zhang&author=B.+T.+O%E2%80%99Neill&author=G.+Barreiro&author=E.+A.+Lachapelle&author=B.+N.+Rogers&title=Preparation+of+N-%282-amino-6-methyl-4%2C4a%2C5%2C6-tetrahydropyrano%5B3%2C4-d%5D%5B1%2C3%5Dthiazin-8a%288h%29-yl-1%2C3-thiazol-4-yl%29+Amides+as+Inhibitors+of+Beta-site+Amyloid+Precursor+Protein+Cleaving+Enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DPreparation%2520of%2520N-%25282-amino-6-methyl-4%252C4a%252C5%252C6-tetrahydropyrano%255B3%252C4-d%255D%255B1%252C3%255Dthiazin-8a%25288h%2529-yl-1%252C3-thiazol-4-yl%2529%2520Amides%2520as%2520Inhibitors%2520of%2520Beta-site%2520Amyloid%2520Precursor%2520Protein%2520Cleaving%2520Enzyme%25201%2520%2528BACE1%2529%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borders, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brier, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevorkyan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komjathy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathes, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaught, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winneroski, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span> <span> </span><span class="NLM_article-title">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1199</span>– <span class="NLM_lpage">1210</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.4129-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1523%2FJNEUROSCI.4129-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=25609634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=1199-1210&author=P.+C.+Mayauthor=B.+A.+Willisauthor=S.+L.+Loweauthor=R.+A.+Deanauthor=S.+A.+Monkauthor=P.+J.+Cockeauthor=J.+E.+Audiaauthor=L.+N.+Boggsauthor=A.+R.+Bordersauthor=R.+A.+Brierauthor=D.+O.+Calligaroauthor=T.+A.+Dayauthor=L.+Ereshefskyauthor=J.+A.+Ericksonauthor=H.+Gevorkyanauthor=C.+R.+Gonzalesauthor=D.+E.+Jamesauthor=S.+S.+Jheeauthor=S.+F.+Komjathyauthor=L.+Liauthor=T.+D.+Lindstromauthor=B.+M.+Mathesauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=G.+M.+Vaughtauthor=B.+M.+Watsonauthor=L.+L.+Winneroskiauthor=Z.+Yangauthor=D.+J.+Mergott&title=The+potent+BACE1+inhibitor+LY2886721+elicits+robust+central+A%CE%B2+pharmacodynamic+responses+in+mice%2C+dogs%2C+and+humans&doi=10.1523%2FJNEUROSCI.4129-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span></div><div class="casAuthors">May, Patrick C.; Willis, Brian A.; Lowe, Stephen L.; Dean, Robert A.; Monk, Scott A.; Cocke, Patrick J.; Audia, James E.; Boggs, Leonard N.; Borders, Anthony R.; Brier, Richard A.; Calligaro, David O.; Day, Theresa A.; Ereshefsky, Larry; Erickso, Jon A.; Gevorkyan, Hykop; Gonzales, Celedon R.; James, Douglas E.; Jhee, Stanford S.; Komjathy, Steven F.; Li, Linglin; Lindstrom, Terry D.; Mathe, Brian M.; Martenyi, Ferenc; Sheehan, Scott M.; Stout, Stephanie L.; Timm, David E.; Vaught, Grant M.; Watson, Brian M.; Winneroski, Leonard L.; Yang, Zhixiang; Mergott, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1199-1210, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">BACE1 is a key protease controlling the formation of amyloid β, a peptide hypothesized to play a significant role in the pathogenesis of Alzheimer's disease (AD).  Therefore, the development of potent and selective inhibitors of BACE1 has been a focus of many drug discovery efforts in academia and industry.  Herein, we report the nonclin. and early clin. development of LY2886721, a BACE1 active site inhibitor that reached phase 2 clin. trials in AD.  LY2886721 has high selectivity against key off-target proteases, which efficiently translates in vitro activity into robust in vivo amyloid β lowering in nonclin. animal models.  Similar potent and persistent amyloid β lowering was obsd. in plasma and lumbar CSF when single and multiple doses of LY2886721 were administered to healthy human subjects.  Collectively, these data add support for BACE1 inhibition as an effective means of amyloid lowering and as an attractive target for potential disease modification therapy in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDFLhcsiUDLVg90H21EOLACvtfcHk0ljXHjL7ykhztg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D&md5=7e16cc00767a8af4da7dd17b6e40e8f5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4129-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4129-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DWillis%26aufirst%3DB.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DBorders%26aufirst%3DA.%2BR.%26aulast%3DBrier%26aufirst%3DR.%2BA.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DDay%26aufirst%3DT.%2BA.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DErickson%26aufirst%3DJ.%2BA.%26aulast%3DGevorkyan%26aufirst%3DH.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DJames%26aufirst%3DD.%2BE.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DKomjathy%26aufirst%3DS.%2BF.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DVaught%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520potent%2520BACE1%2520inhibitor%2520LY2886721%2520elicits%2520robust%2520central%2520A%25CE%25B2%2520pharmacodynamic%2520responses%2520in%2520mice%252C%2520dogs%252C%2520and%2520humans%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D1199%26epage%3D1210%26doi%3D10.1523%2FJNEUROSCI.4129-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K. – H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuszpit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachapelle, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciabola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">The discovery of a novel phosphodiesterase (PDE)4B-preferring radioligand for positron emission tomography (PET) imaging</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8538</span>– <span class="NLM_lpage">8551</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01050</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01050" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8538-8551&author=L.+Zhangauthor=L.+Chenauthor=E.+M.+Beckauthor=T.+A.+Chappieauthor=R.+V.+Coelhoauthor=S.+Doranauthor=K.+%E2%80%93+H.+Fanauthor=C.+J.+Helalauthor=J.+M.+Humphreyauthor=Z.+Hughesauthor=K.+Kuszpitauthor=E.+A.+Lachapelleauthor=J.+T.+Lazzaroauthor=C.+Leeauthor=R.+J.+Matherauthor=N.+C.+Patelauthor=M.+B.+Skaddanauthor=S.+Sciabolaauthor=P.+R.+Verhoestauthor=J.+M.+Youngauthor=K.+Zasadnyauthor=A.+Villalobos&title=The+discovery+of+a+novel+phosphodiesterase+%28PDE%294B-preferring+radioligand+for+positron+emission+tomography+%28PET%29+imaging&doi=10.1021%2Facs.jmedchem.7b01050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01050%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DCoelho%26aufirst%3DR.%2BV.%26aulast%3DDoran%26aufirst%3DS.%26aulast%3DFan%26aufirst%3DK.%2B%25E2%2580%2593%2BH.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DHughes%26aufirst%3DZ.%26aulast%3DKuszpit%26aufirst%3DK.%26aulast%3DLachapelle%26aufirst%3DE.%2BA.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DSciabola%26aufirst%3DS.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DZasadny%26aufirst%3DK.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520of%2520a%2520novel%2520phosphodiesterase%2520%2528PDE%25294B-preferring%2520radioligand%2520for%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8538%26epage%3D8551%26doi%3D10.1021%2Facs.jmedchem.7b01050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varghese, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span> <span> </span><span class="NLM_article-title">Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2678</span>– <span class="NLM_lpage">2702</span>, <span class="refDoi"> DOI: 10.1021/jm501833t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501833t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2678-2702&author=C.+R.+Butlerauthor=M.+A.+Brodneyauthor=E.+M.+Beckauthor=G.+Barreiroauthor=C.+E.+Nolanauthor=F.+Panauthor=F.+Vajdosauthor=K.+Parrisauthor=A.+H.+Vargheseauthor=C.+J.+Helalauthor=R.+Liraauthor=S.+D.+Doranauthor=D.+R.+Riddellauthor=L.+M.+Buzonauthor=J.+K.+Dutraauthor=L.+A.+Martinez-Alsinaauthor=K.+Ogilvieauthor=J.+C.+Murrayauthor=J.+M.+Youngauthor=K.+Atchisonauthor=A.+Robshawauthor=C.+Gonzalesauthor=J.+Wangauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Discovery+of+a+series+of+efficient%2C+centrally+efficacious+BACE1+inhibitors+through+structure-based+drug+design&doi=10.1021%2Fjm501833t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design</span></div><div class="casAuthors">Butler, Christopher R.; Brodney, Michael A.; Beck, Elizabeth M.; Barreiro, Gabriela; Nolan, Charles E.; Pan, Feng; Vajdos, Felix; Parris, Kevin; Varghese, Alison H.; Helal, Christopher J.; Lira, Ricardo; Doran, Shawn D.; Riddell, David R.; Buzon, Leanne M.; Dutra, Jason K.; Martinez-Alsina, Luis A.; Ogilvie, Kevin; Murray, John C.; Young, Joseph M.; Atchison, Kevin; Robshaw, Ashley; Gonzales, Cathleen; Wang, Jinlong; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2678-2702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease (AD) has historically been thwarted by an inability to maintain alignment of potency, brain availability, and desired absorption, distribution, metab., and excretion (ADME) properties.  In this paper, the authors describe a series of truncated, fused thioamidines that are efficiently selective in garnering BACE1 activity without simultaneously inhibiting the closely related cathepsin D or neg. impacting brain penetration and ADME alignment, as exemplified by I.  Upon oral administration, these inhibitors exhibit robust brain availability and are efficacious in lowering central Amyloid β (Aβ) levels in mouse and dog.  In addn., chronic treatment in aged PS1/APP mice effects a decrease in the no. and size of Aβ-derived plaques.  Most importantly, evaluation of I in a 2-wk exploratory toxicol. study revealed no accumulation of autofluorescent material in retinal pigment epithelium or histol. findings in the eye, issues obsd. with earlier BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiNT62AGyml7Vg90H21EOLACvtfcHk0lhIyyeG9uDwyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D&md5=ac2a6fd661f7e9fd8b925deffd5e1010</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm501833t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501833t%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DVarghese%26aufirst%3DA.%2BH.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%2BA.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DRobshaw%26aufirst%3DA.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DDiscovery%2520of%2520a%2520series%2520of%2520efficient%252C%2520centrally%2520efficacious%2520BACE1%2520inhibitors%2520through%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2678%26epage%3D2702%26doi%3D10.1021%2Fjm501833t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalvass, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span> <span> </span><span class="NLM_article-title">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">338</span>, <span class="refDoi"> DOI: 10.1002/bdd.325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=10.1002%2Fbdd.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=12415573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=327-338&author=J.+C.+Kalvassauthor=T.+S.+Maurer&title=Influence+of+nonspecific+brain+and+plasma+binding+on+CNS+exposure%3A+implications+for+rational+drug+discovery&doi=10.1002%2Fbdd.325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span></div><div class="casAuthors">Kalvass, J. Cory; Maurer, Tristan S.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">327-338</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Relative plasma, brain and cerebrospinal fluid (CSF) exposures and unbound fractions in plasma and brain were examd. for 18 proprietary compds. in rats.  The relation between in vivo brain-to-plasma ratio and in vitro plasma-to-brain unbound fraction (fu) was examd.  In addn., plasma fu and brain fu were examd. for their relation to in vivo CSF-to-plasma and CSF-to-brain ratios, resp.  Findings were delineated based on the presence or absence of active efflux.  Finally, the same comparisons were examd. in FVB vs. MDR 1a/1b knockout mice for a selected P-glycoprotein (Pgp) substrate.  For the nine compds. without indications of active efflux, predictive correlations were obsd. between ratios of brain-to-plasma exposure and plasma-to-brain fu (r2 = 0.98), CSF-to-brain exposure vs. brain fu (r2 = 0.72), and CSF-to-plasma exposure vs. plasma fu (r2 = 0.82).  For the nine compds. with indications of active efflux, nonspecific binding data tended to over predict the brain-to-plasma and CSF-to-plasma exposure ratios.  Interestingly, CSF-to-brain exposure ratio was consistently under predicted by brain fu for this set.  Using a select Pgp substrate, it was demonstrated that the brain-to-plasma exposure ratio was identical to that predicted by plasma-to-brain fu ratio in MDR 1a/1b knockout mice.  In FVB mice, plasma-to-brain fu over predicted brain-to-plasma exposure ratio to the same degree as the difference in brain-to-plasma exposure ratio between MDR 1a/1b and FVB mice.  Consistent results were obtained in rats, suggesting a similar kinetic behavior between species.  These data illustrate how an understanding of relative tissue binding (plasma, brain) can allow for a quant. examn. of active processes that det. CNS exposure.  The general applicability of this approach offers advantages over species- and mechanism-specific approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfFvLLvDQohLVg90H21EOLACvtfcHk0lhIyyeG9uDwyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D&md5=96b80d1a745b254f74b9c19e8e8af627</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fbdd.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.325%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26atitle%3DInfluence%2520of%2520nonspecific%2520brain%2520and%2520plasma%2520binding%2520on%2520CNS%2520exposure%253A%2520implications%2520for%2520rational%2520drug%2520discovery%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2002%26volume%3D23%26spage%3D327%26epage%3D338%26doi%3D10.1002%2Fbdd.325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i36"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01769">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_32608"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01769">10.1021/acs.jmedchem.7b01769</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra for compound <b>3</b> and tosylate precursor <b>18</b> with peak assignments; selectivity profile of compound <b>3</b> in the CEREP selectivity panel; uptake and tissue distribution of compounds <b>2</b> and <b>3</b> (5–75 min survival interval) in male wild-type mice (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01769/suppl_file/jm7b01769_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01769/suppl_file/jm7b01769_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01769/suppl_file/jm7b01769_si_001.pdf">jm7b01769_si_001.pdf (753.4 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01769/suppl_file/jm7b01769_si_002.csv">jm7b01769_si_002.csv (0.49 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01769&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-8%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01769%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01769" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990bedab563c9a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
